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Summary
Many degenerative diseases of the nervous system, including Multiple Sclerosis and
peripheral neuropathies, are triggered by an impaired interaction between the axons and
their surrounding myelin sheaths. The cause for this disturbed axon-myelin interaction,
and the secondary neuronal damage that produces the clinical symptoms, lies in a primary
defect of the myelin sheath. The myelin sheath itself is formed and maintained by
oligodendrocytes and Schwann cells, the myelinating glial cells of the central and
peripheral nervous system, respectively.
The isoforms of the myelin-associated glycoprotein (MAG) are thought to be potential key
elements of axon-myelin interaction, since these immunoglobulin-like cell signalling
proteins are known to be localized in the periaxonal and paranodal myelin membranes.
The MAG isoforms each display one of two possible intracellular C-termini as a result of
alternative mRNA splicing. The C-terminus of the large isoform (L-MAG) has been shown
to mediate downstream signals via the non-receptor tyrosine kinase Fyn, while the C-
terminus of the short isoform (S-MAG) is thought to interact with the glial cytoskeleton.
We have investigated the regulation and differential expression of L- and S-MAG in
oligodendroglial cells and in transgenic mice by the use of genomic constructs that encode
individually green fluorescent protein-tagged MAG isoforms. In the oligodendroglial cells L-
MAG was the dominant isoform prior to the stimulation of cells with cyclicAMP, whereas
upon cyclicAMP stimulation, S-MAG was predominantly expressed in cells exhibiting
advanced morphological differentiation. The investigation of our transgenic mice revealed
that the two MAG isoforms are differentially expressed in distinct fibre tracts of the striatum
and that S-MAG seems to be predominantly expressed in the long projecting fibres of the
corpus callosum. Thus, the two MAG isoforms appear not only to be differentially
expressed during development and in the adult, but they seem to mediate isoform-specific
aspects of the axon-myelin interaction in distinct regions of the adult brain.
A major question in the formation and maintenance of the myelin-axon interaction
concerns the coordinated targeting of myelin signalling molecules and lipids to the different
myelin compartments. Recent results suggest that glycolipid-enriched microdomains, so-
called 'lipid-rafts', are involved in special sorting and trafficking mechanisms of membrane
proteins and lipids. Furthermore, they are thought to serve as platforms for signal
transduction processes. This makes them to interesting candidates for axon-myelin
interactions, as well as for interactions between the apposed myelin membranes. The
integral membrane protein 'Myelin and Lymphocyte Protein' (MAL) is suggested to be
involved in lipid-raft-mediated protein targeting and signalling in myelinating cells. Our
investigation of adult brain tissue of MAL-deficient mice showed that the incorporation of
particular myelin components, such as MAG, into myelin membranes was significantly
reduced. Thus, the targeting of L- and S-MAG to the myelin membranes appears to be
dependent on the lipid-raft protein MAL. Furthermore, the MAL-deficient mice showed
several ultra structural alterations comparable to those of the MAG-deficient mice and that
reflect an impaired axon-myelin interaction.
Our data supports the idea that-raft mediated trafficking of myelin constituents, such as
MAG, to the different myelin compartments is a major task of adult oligodendrocytes in the
context of maintaining the axonal contact of the myelin sheath.
With the use of the isoform specific tagged MAG expressing mice, it will be possible for the
first time, to investigate their differential function in axon-glia interaction as well as their
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Introduction
1. Myelin
The myelin sheath is a unique and fundamental adaptation of both the central and
peripheral nervous system (CNS and PNS) of vertebrates. The myelin sheath forms as a
myelinating cell wraps layer upon layer of its own plasma membrane around an axon in a
tight spiral, forming an electrically insulating sheath (Figure 1). This insulation is needed
for rapid and efficient nerve impulse conduction along myelinated axons, known as
saltatory conduction. The direct advantage of the saltatory conduction due to myelination
is to increase the speed of conduction without requiring large increases in axon diameter
and energy consumption. The myelin membrane sheaths are arranged as segments along
the axon and are periodically separated by the non-myelinated nodes of Ranvier. It is
within these restricted nodal sites that voltage-gated sodium-channels aggregate and the
electrical activity of fibres are processed (for details, see Figures 3,4,5). However, the
requirements for the myelin sheath are twofold, which is reflected by its architecture. On
the one hand, almost all electrically conductive cytoplasm needs to be excluded from the
myelin sheath for its insulating properties. On the other hand, access to all membranes
within the sheath must be possible to maintain and nourish the whole structure. Therefore,
non-compact myelin domains are found within the continuous myelin internodes.
The formation of myelin sheaths around large-calibre axons requires the coordinate
interplay of distinct axonal and glial cell surface molecules. This complex and
developmentally regulated process includes the coordinated expression of genes
encoding myelin proteins and enzymes associated with the synthesis of myelin specific
lipids (for review, see Garbay et al. 2000). The myelinating glial cells differ between the
CNS and the PNS. The CNS myelin is produced by oligodendrocytes, whereas Schwann
cells myelinate axons in the PNS. During development, both cells synthesize as much as
5000 mm2 of myelin membrane per day, which they wrap tightly around the axon (Pfeiffer
et al. 1993). Within the future compact myelin domains all cytoplasm gets excluded from
the myelin spirals, resulting in the close apposition of both the intracellular and
extracellular leaflets of the plasma membranes. These electron-dense structures are
called major dense line (MDL) and intraperiod line (IPL), respectively (Figure 1).
One of the major biochemical characteristics that distinguish myelin from other biological
membranes is its high lipid-to-protein ratio: isolated myelin contains 70-80% lipids and
Figure 1 Ultrastructure of a PNS Myelinated Fibre
A This electron micrograph shows an axon, its
myelin sheath (m), and basal lamina
(arrowheads), as well as the inner (i) and outer (o)
mesaxons.
B This image shows that the compact myelin
sheath is composed of alternating major dense
(arrows) and intraperiod lines. Note the “double
nature” of the intraperiod line (Revel and Hamilton
1969).
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20-30% proteins. This relatively high lipid content, and the particular characteristics of the
lipids present in the sheath, provides the electrically insulating property required for the
saltatory propagation of the nervous influx.
The inherited, or acquired failures of myelinating cells to form, or maintain the myelin
sheath correctly results in severe neurological diseases, such as Multiple Sclerosis and
demyelinating peripheral neuropathies (for review, see Garbay et al. 2000).
2. Myelinating Cells of the Central and Peripheral Nervous System
2.1. Schwann Cells
The Schwann cell precursor cells originate from the neural crest and, while they migrate
into the periphery along the axonal tracts, they give rise to immature Schwann cells
(Cameron-Curry et al. 1991). Their fate is tightly controlled by axonal signals, e.g. by b
neuregulin acting via the ErbB2/ErbB3 receptors and by fibroblast growth factor 2 (FGF2;
Dong et al. 1999). On the one hand, immature Schwann cells can develop into pro-
myelinating Schwann cells. The pro-myelinating Schwann cells form a 1:1 relationship with
the large-calibre axons prior to myelination. This step is probably controlled by ATP, that
acts as an activity-dependent axon-glial transmitter to inhibit Schwann cell proliferation,
differentiation, and myelination (Fields and Stevens 2000). This inhibitory mechanism may
help to coordinate Schwann cell development with the onset of functional activity in the
nervous system and prevent premature Schwann cell differentiation (Fields and Stevens
2000). On the other hand, immature Schwann cells can develop into non-myelinating
Schwann cells. Each non-myelinating Schwann cell ensheathes bundles of 5-30 axons
(Friede and Samorajski 1968). Both types of Schwann cells, myelinating and non-
myelinating, are surrounded by a basal lamina (Figure 1), which separates them from
other components of the endoneurium in the peripheral nerve and anchors them to the
extracellular matrix (Bunge 1993).
2.2. Oligodendrocytes
Oligodendrocyte precursor cells arise from neuroepithelial cells in the ventral spinal cord
that generate both neurons and oligodendrocytes (Kessaris et al. 2001). These
neuroepithelial cells of the subventricular zone are characterized by the expression of the
transcription factor Olig2. They do first generate motor neurons, whereas later in
development, they generate oligodendrocyte precursor cells (Zhou et al. 2001; Zhou and
Anderson 2002). The combined expression of the transcription factors Olig2 and
neurogenin-1 and -2 are thought to generate motor neurons (Figure 2, left). However,
towards the end of spinal cord motor neuron induction, the expression of neurogenins is
down-regulated (Zhou et al. 2001). This allows the overlapping expression of Olig1 and
Olig2 and of the previously more ventrally expressed transcription factor Nkx2.2 (Figure 2,
right), resulting in the generation of oligodendrocyte precursor cells (Zhou et al. 2001). In
the absence of both Olig1 and Olig2, the cells that would normally give rise to motor
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neurons and oligodendrocytes generate a specific class of interneurons and astrocytes
(Zhou and Anderson 2002).
Once committed to the oligodendrocyte lineage, precursors express cell surface antigens
recognized by the monoclonal antibody A2B5 (Raff et al. 1984). In vitro, these cells have
the capacity to give rise to both oligodendrocytes and astrocytes and have thus been
termed oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells (Raff et al. 1984). The
combination of platelet-derived growth factor alpha (PDGF-A) and basic FGF (bFGF)
promotes the extended proliferation of oligodendrocyte precursors (Bogler et al. 1990).
These proliferating oligodendrocyte precursors can be identified through the expression of
the PDGF receptor alpha (PDGF-RA; Pringle et al. 1992; Pringle and Richardson 1993),
the expression of several myelin-associated components, including mRNA for the myelin
genes 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP), the DM20 isoform of the major
myelin proteolipid protein (PLP) gene (Timsit et al. 1995), and the sulphated
galactosylceramide (sulfatide) that is recognized by the monoclonal antibody O4 (Sommer
and Schachner 1981). Further differentiation of oligodendrocyte precursors is
characterized by a withdrawal from the cell cycle and expression of the major myelin
glycolipid galactosylceramide (GalC; Raff et al. 1978). Promyelinating oligodendrocytes
exhibit a multi-processed phenotype and their maturation results in the coordinated
elevated expression of a number of major myelin components, such as myelin basic
protein (MBP) and proteolipid protein (PLP; Roth et al. 1985; Lemke 1988).
A recent report identified adenosine as a novel antiproliferative and differentiating factor
for oligodendrocyte precursor cells, which is derived from axons and promotes myelination
in an activity-dependent manner. This axon-glial signalling mechanism provides a potent
form of communication, coordinating oligodendrocyte proliferation, differentiation and
myelination in response to action potentials in axons (Stevens et al. 2002).
Early silver impregnation studies identified four distinct morphologies of myelinating
oligodendrocytes, and this was largely confirmed by ultra structural analyses in a variety of
species (Stensaas and Stensaas 1968; Remahl and Hildebrand 1990). Oligodendrocyte
Figure 2 The Neuron-Oligodendrocyte Fate Switch in Chick Spinal Cord
At early times (E3–E5 chick), motor neurons are generated from the pMN domain under the influence of
Olig2 in conjunction with Ngns. Later (E6–E7), Ngn1 and Ngn2 (neurogulin) are down-regulated in this part
of the cord. Subsequently, the expression domains of Nkx2.2 and Olig2 shift relative to one another and
generate a region of overlap. This triggers a switch in the activity of Olig2 in the overlap, which now
generates oligodendrocyte progenitors (OLPs; according to Kessaris et al. 2001); FP: floor plate; pMN: motor
neuron progenitor domain; p2,p3: V2 and V3 interneuron progenitor domain; Ngn,Olig: basic-helix-loop-helix
transcription factors; Nkx,pax: homeodomain transcription factors.
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morphology is closely correlated to the diameter of the axons with which the cell
associates (Butt et al. 1997, 1998a). Oligodendrocyte types I and II arise late in
development and myelinate many internodes on predominantly small diameter axons,
while oligodendrocyte types III and IV arise later and myelinate mainly large diameter
axons. Oligodendrocytes that myelinate small diameter fibres (types I and II) express
higher levels of carbonic anhydrase 11 (CA11; Butt et al. 1995; Butt et al. 1998a), while
those myelinating larger axons (types III and IV) express the small isoform of the myelin-
associated glycoprotein (S-MAG; Butt et al. 1998b). Whether such differences represent
the response of homogeneous cell populations to different environments, or the existence
of distinct cell lineages is unclear.
2.2.1. The Mouse Oligodendrocyte Cell Line Oli-neu
The cell line Oli-neu was generated by immortalisation of mitotic oligodendrocyte
precursor cells with retroviral vectors containing the t-neu oncogene (Jung et al. 1995). In
vitro and in vivo studies showed that the mouse oligodendrocyte cell line Oli-neu mimics
the behaviour of primary oligodendrocytes in many aspects (Jung et al. 1995; Koch et al.
1997; Kramer et al. 1997; Kramer et al. 1999; Klein et al. 2002). Oli-neu cells express the
typical myelin lipids, GalC and sulfatide (Jung et al. 1995), and have been shown to
express the GPI-anchored proteins, F3/contactin and NCAM120 (Koch et al. 1997), and
the microtubule associated proteins Tau-1 and Tau-5 (Klein et al. 2002), in a manner
similar to that observed in primary oligodendrocytes. The interactions of Tau and the non-
receptor kinase Fyn with tubulin have been shown to be responsible for process outgrowth
in Oli-neu cells (Klein et al. 2002). Transplantation experiments into demyelinated CNS
lesions showed that Oli-neu cells do express the components necessary for axonal
interaction (Jung et al. 1995). Oli-neu cells grown in SATO medium proliferate and most of
them have a bipolar shape. Under the influence of cAMP, Oli-neu cells stop their
proliferation and develop a radial morphology with many processes. In parallel with their
morphological maturation, they also up-regulate the expression of MAG (Jung et al. 1995).
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3. Organization of the Myelin Sheath
3.1. Architecture of the Peripheral Nervous System Myelin Sheath
The PNS myelin sheath itself can be divided into two domains, compact and non-compact
myelin (Figure 3). Compact myelin forms the bulk of the myelin sheath. Non-compact
myelin is found at the lateral borders of the myelin sheath that flank the nodes of Ranvier
(Æparanodal loops), in funnel-shaped interruptions in the compact myelin (ÆSchmidt-
Lanterman incisures), and in the inner and outer membranes of the myelin sheath
(Æperiaxonal and abaxonal membranes, respectively; see Figure 3 and for review Arroyo
and Scherer 2000). One Schmidt-Lanterman incisure, that can be seen in a cross-section
as a ring-like structure and in a longitudinal section as a V-shaped structure (Figure 3), is
in fact a single spiral-shaped domain of Schwann cell cytoplasm that runs through the
myelin sheath.
By analogy with epithelial cells, the basal/abaxonal surface of the PNS myelin sheath
apposes the Schwann cell basal lamina (Figure 1, 4). This basal lamina contains laminin
2, type IV collagens, fibronectin, N-syndecan, and glypican (Bunge 1993; Scherer 1996).
The underlying basal/abaxonal Schwann cell membrane contains integrin a6b4 and
dystroglycan, both of which probably bind to laminin 2 (Einheber et al. 1993; Feltri et al.
1994; Rambukkana et al. 1998; Saito et al. 1999). The apical/adaxonal, or periaxonal,
myelin membrane apposes the axon and is highly enriched in myelin-associated
Figure 3 Schmidt-Lanterman incisures of the peripheral myelin sheath
A: Ramon y Cajal’s depiction of incisures from 1928. B: Scheme of an incisure within a myelin sheath with an
enlarged view of the incisure itself. The incisure represents a single, spiral-shaped domain of Schwann cell
cytoplasm within the compact myelin sheath. The inner leaflets of the myelin membranes are separated by
the cytoplasm, whereas the outer leaflets are still apposing each other, as in the compact myelin. SC:
Schwann cell.
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glycoprotein (MAG), which may bind to molecules on the axonal surface (Yang et al. 1996;
Sawada et al. 1999). The lateral borders of the Schwann cell membrane define the
paranodes (Figure 5). The inner and outer edges of the Schwann cell membrane, which
contact the adjacent layer of the myelin sheath, are called the inner and outer mesaxons,
respectively. Adherens junctions (“desmosome-like” junctions) are found in both the inner
and outer mesaxons as well as in paranodes and incisures (Fannon et al. 1995). The
adherens junctions in the paranodes and incisures form a series of radially arranged
junctions; these typically span many layers and are most prominent in the outer layers of
the myelin sheath. Gap junctions were occasionally noted between the rows of adherens
junctions (Yasargil et al. 1982). The gap junction protein connexin32 is localized to the
same places (Bergoffen et al. 1993; Scherer et al. 1995; Chandross et al. 1996). Dye
transfer studies demonstrated a radial pathway of dye diffusion across incisures, from the
outer/abaxonal to the inner/adaxonal cytoplasm (Balice-Gordon et al. 1998). These
findings provide functional evidence that gap junctions mediate a radial pathway of
diffusion across incisures and, by extension, across the paranodes too. Such a radial
pathway for diffusion could be about 3 million times faster than diffusion through the
cytoplasm.
The lateral borders of the Schwann cell processes are tipped with microvilli (Figure 4,5).
These tips of the microvilli contact the nodal axolemma (Raine 1982; Ichimura and
Ellisman 1991) and contain F-actin (Trapp et al. 1989), voltage-sensitive Na+ channels
(Howe and Ritchie 1990; Devor et al. 1993) and inwardly rectifying K+ channels IRK1 and
IRK3, which may allow them to accumulate K+ during axonal activity (Mi et al. 1999).
3.2. Architecture of the Central Nervous System Myelin Sheath
Oligodendrocytes have neither a basal lamina nor microvilli like Schwann cells, and their
“incisures” (Peters et al. 1991) have not distinguishing molecular markers, such as Cx32,
MAG, or E-cadherin. “Perinodal astrocytes” contact CNS nodes (Black and Waxman
1988), and are thought to have a function analogous to Schwann cell microvilli (Figure 5).
The molecular components of the CNS myelin sheaths partially overlap with those of the
Figure 4 Schematic view of a myelinated
axon in the PNS
One myelinating Schwann cell has been
'unrolled', revealing the regions that form
the non-compact myelin, the incisures and
paranodes. Adherens junctions are
depicted as two continuous (purple) lines;
these form a circumferential belt and are
also found in incisures. Gap junctions are
depicted as (orange) ovals; these are
found between the rows of adherens
junctions. The nodal, paranodal and
juxtaparanodal regions of the axonal
membrane are colored blue, red and
green, respectively (Arroyo et al., 2000).
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PNS (Hudson 1990). Thus, in both the CNS and the PNS, compact myelin contains MBP
and the adaxonal surface contains MAG (Trapp 1990). Like myelinating Schwann cells,
oligodendrocytes also express Cx32, but mainly on their cell bodies and proximal
processes; whether there is Cx32 in the paranodal myelin is not settled (Scherer et al.
1995; Kunzelmann et al. 1997). Unlike myelinating Schwann cells, oligodendrocytes
express Cx45 and are coupled to other oligodendrocytes as well as astrocytes (Dermietzel
et al. 1997; Kunzelmann et al. 1997). CNS myelin has a distinctive structural feature that is
not seen in PNS myelin, the so-called “radial component” (Peters et al. 1991). The radial
component is a series of radially arranged intralamellar strands that span the myelin
sheath, usually in a single sector. These intralamellar strands look like tight junctions, and
have recently been shown to contain claudin-11/oligodendrocyte-specific protein (OSP), a
member of a large family of distantly related tight junction proteins (Morita et al. 1999;
Bronstein et al. 2000). The functional significance of the radial component is so far
unknown.
3.3. The Node of Ranvier and the Paranode
The first event in node formation is the clustering of axonal adhesion proteins, such as
NrCAM and NF186. In the peripheral nervous system, this initial event is probably
triggered by direct contact with the Schwann cell microvilli. In the central nervous system,
this event might be controlled by a soluble factor released by the oligodendrocytes. In the
peripheral and the central nervous systems, the next event is the recruitment of ankyrin G,
with its multiple protein-binding sites that allow the clustering of Na+ channels with NrCAM
and NF186 (Figure 5). The presence of bIV spectrin is a critical factor for the stability of
these newly formed clusters. Heminodal clusters can form in contact with one myelinating
cell and, as wrapping of the myelinating cell proceeds, be pushed towards the
neighbouring heminode until they fuse to form a complete node (Vabnick et al. 1996;
Rasband and Shrager 2000). While the periaxonal extension of the myelinating cell rolls
around the axon and compact myelin is formed, the lateral loops of the myelinating cells
become progressively compacted in a lateral direction, forming the paranodal region
(Pedraza et al. 2001). In the paranodal region, the glial cell plasma membranes abruptly
open out from compact myelin, creating cytoplasm-filled channels termed paranodal loops.
The loops are held in register with one another at least in part through adherens junctions
and MAG (Figure 5; Bartsch et al. 1989; Fannon et al. 1995; Rosenbluth et al. 1995). At
this time, septate-like junctions that connect the glial paranodal loops with the apposing
axonal membrane are formed in the paranodal region. The characterization of the
molecular organization of the paranodal septate-like junctions started to emerge only in
the past few years with the discovery of the axonal heterodimeric complex of F3/contactin
and contactin-associated protein (Caspr; Einheber et al. 1997). Caspr is a neuronal
transmembrane protein, highly concentrated in paranodal junctions. It has a large
extracellular region, a single transmembrane segment, and a short intracellular region. On
the extracellular side, Caspr was found to associate with F3/contactin. F3/contactin is a
glycosylphosphatidylinositol (GPI)-anchored cell adhesion molecule of the Ig superfamily.
An essential role in the targeting of Caspr to the plasma membrane has been recently
demonstrated for F3/contactin. In the absence of F3/contactin, Caspr remains trapped in
the endoplasmic reticulum (Faivre-Sarrailh et al. 2000).
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F3/contactin associates with Caspr by its Ig domain and appears to guide it to the cell
surface via the lipid-rafts (Boyle et al. 2001). In the absence of F3/contactin, Caspr
remains associated with the endoplasmic reticulum and fails to accumulate at paranodes.
These F3/contactin-Caspr complexes are connected to the axonal cytoskeleton through a
meshwork that probably includes protein 4.1B.
The glial binding partner of the axonal F3/contactin-Caspr complex has been discovered
only recently with the identification of the 155-kDa isoform of neurofascin (NF155; Tait et
al. 2000; Charles et al. 2002). NF155 is a member of the L1 subgroup of the Ig superfamily
and has been identified as a glial molecule enriched at the level of paranodal junctions,
thus facing the F3/contactin-Caspr complex (Figure 5B; Tait et al. 2000). Recent in vitro
studies have shown that NF155 binds specifically to the F3/contactin-Caspr complex
(Charles et al. 2002). While the extracellular domain of Caspr might be simultaneously
engaged in association with neuronal proteins (in cis) and partners expressed by the glial
cell (in trans), its intracellular region connects it to the axonal cytoskeleton, perhaps
stabilizing the complex and bringing it into close proximity with the signalling machinery.
This role is underscored by the results in the Caspr knock-out mouse whose disorganized
paranodes are characterized by the absence of the ‘‘transverse bands’’ (paranodal
septate-like junctions) linking the axolemma to the glial membrane (Bhat et al. 2001). The
enrichment of Caspr in paranodes is a relatively late event in myelination and the
myelinating glial cells are required for the paranodal localization of Caspr, since in the
ceramide-galactosyl-transferase (CGT) mutants, Caspr fails to accumulate at paranodes
(Dupree et al. 1999).
Taken together, the paranodal axon-glial junction, which is a point of strong interaction of
Figure 5 Scheme of the node of Ranvier
A: Schematic drawing showing the different
compartments of the node, paranode, and
juxtaparanode in CNS and PNS. Compact myelin is
characterized by the absence of cytoplasm and
extracellular fluid (black bars).
B: Schematic drawing of possible myelin-axon and
myelin-myelin membrane interactions between the
molecular components of nodes, paranodes and
juxtaparanodes (copied and modified from Arroyo
and Scherer, 2000)
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myelinating glial cells with the underlying axon, has several important roles: it provides
partial electrical insulation to the internodal region, allowing saltatory conduction of the
nerve impulses; it restricts the lateral mobility of axonal membrane proteins, including ion
channels; and it is likely to contribute to bi-directional signalling between axons and glial
cells. The paranodal junctions appear to play important roles in the process of myelination
and represent a site of early damage in several neuropathies and dysmyelinating
disorders (Griffiths 1996).
4. The Myelin Proteins
Myelin formation involves complex interactions between at least two cell types, the
neurons and the myelinating cells. Axonal contact and other environmental stimuli, such
as matrix molecules and growth factors, induce oligodendrocyte precursor and Schwann
cell proliferation (Salzer et al. 1980). In proliferating cells, certain myelin proteins may be
expressed at low levels, but stable glial-axonal contact appears to be essential for the up-
regulation of myelin-specific genes that accompanies myelin formation. Molecules that
have been implicated in adhesion, or recognition, such as MAG, N-cadherin (Blank et al.
1974) and neural adhesion molecule L1 (Seilheimer et al. 1989; Letourneau et al. 1991),
seem to participate in the earliest phases of myelination, where they assist in establishing
glial-axonal contact and induce the expression of other myelin-specific genes. These
genes encode proteins that play a role in the formation of the spiralling loops e.g. MAG,
protein zero (P0), in the subsequent compaction of the myelin sheath e.g. P0, myelin basic
protein (MBP) and proteolipid protein (PLP), in the determination of the correct myelin
thickness e.g. P0, MBP, peripheral myelin protein 22 (PMP22), and in the maintenance of
the myelin sheath e.g. MAG, P0, PMP22 and Connexin 32 (Cx32; see Figure 6 for a
schematic representation of some compact and non-compact myelin proteins).
Figure 6 Schematic view of the proteins of CNS and PNS myelin sheaths
CNS and PNS myelin sheaths contain distinct sets of proteins. In the PNS, compact myelin contains protein
zero (P0), peripheral myelin protein 22 kDa (PMP22), and myelin basic protein (MBP); in the CNS, it contains
proteolipid protein (PLP), oligodendrocyte-specific protein (OSP), myelin-oligodendrocyte basic protein, and
MBP. In the PNS, the non-compact myelin contains E-cadherin, myelin-associated glycoprotein (MAG), and
connexin32 (Cx32). Note that P0 and MAG have extracellular immunoglobulin-like domains (semicircles),
and OSP, PLP, PMP22 and Cx32 all have four transmembrane domains (reproduced from Arroyo and
Scherer, 2000).
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However, myelin-related cell surface molecules can play distinct, but also partially
overlapping roles, during myelin formation and maintenance (for review, see Doyle and
Colman 1993; Martini and Schachner 1997). The myelin and lymphocyte protein (MAL)
does not belong to the cell surface or structural molecules of the myelin sheath, but is
thought to be involved in lipid-raft-associated protein trafficking (Alonso and Weissman
1987; Schaeren-Wiemers et al. 1995b).
4.1. Myelin-Associated Glycoprotein - MAG
One cell adhesion protein that is expressed during myelin formation upon first contact with
the axons is MAG (Quarles 1983). In the mature myelin sheath, MAG is restricted to the
non-compacted regions, including the periaxonal location (Figure 7), suggesting a role for
MAG in maintaining the interaction between the myelinating cell and the axon (Sternberger
et al. 1979).
The MAG protein is expressed as two isoforms: large MAG (L-MAG) and small MAG (S-
MAG). They have identical extracellular and transmembrane domains and share a
common sequence of 37 amino acids adjacent to the inner surface of the plasma
membrane. But they differ at the C-terminal tails (Figure 8; Lai et al. 1987). The S-MAG
specific C-terminal tail consists of 9 amino acids, resulting in a 46-amino-acid intracellular
domain. The L-MAG specific C-terminal tail consists of 53 amino acids, resulting in a 90-
amino-acid intracellular domain. The two isoforms are generated through the alternative
splicing of exon 12. Exon 12 is the only alternatively spliced exon within the coding region.
It encodes the S-MAG specific C-terminal tail, while the proceeding exon 13 encodes the
L-MAG specific C-terminal tail (Miescher et al. 1997). Very recently, it could be shown that
the nuclear localized quaking isoform 5 (QKI-5) directly represses alternative splicing of
MAG pre-mRNA that is necessary for the formation of L-MAG (Wu et al. 2002). The
natural occurring quaking mouse mutant lacks the QKI-5 nuclear factor and, therefore,
does not express L-MAG.
The two isoforms are differentially expressed during myelin formation and maintenance.
Early in the myelination process, the expression of L-MAG predominates, whereas S-MAG
accumulates at later stages and in the adult. L-MAG is expressed in the adult CNS, but not
in adult PNS myelin (Inuzuka et al. 1991). The cytoplasmic tail of L-MAG contains a
Figure 7 Ultrastructural location of MAG in the mouse optic nerve
When compact myelin (M) has formed, expression of MAG becomes
restricted to the periaxonal space. Primary anti-MAG antibodies have
been visualized with gold-conjugated secondary antibodies. Ax: axon;
M: myelin sheath (reproduced from Bartsch et al., 1989).
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tyrosine phosphorylation site, suggesting a role in the regulation of L-MAG function
(Jaramillo et al. 1994). Furthermore, the non-receptor tyrosine kinase Fyn, a member of
the Src family, has been identified as a signalling molecule downstream of L-MAG. The
analysis of the CNS of Fyn-deficient mice revealed a 50% reduction in the amount of
myelin (Umemori et al. 1994). Beside Fyn, the calcium binding protein S100b and the
phospholipaseCg have been shown to be isoform specific binding partners of L-MAG
(Jaramillo et al. 1994; Kursula et al. 1999). Therefore, L-MAG seems to have, besides the
properties of a cell adhesion molecule, characteristics of a transmembrane receptor that
could transduce extracellular signals to the inside of oligodendrocytes and Schwann cells.
The S-MAG specific domain has been reported to bind to tubulin and microtubules,
supporting a role for S-MAG as a cell adhesion molecule linking the axonal surface and
the myelinating glial cell cytoskeleton (Kursula et al. 2001).
The extracellular domain of MAG has eight sites for N-linked glycosylation and contains
about 30% by weight carbohydrate (Spagnol et al. 1989; Burger et al. 1993). The
oligosaccharides are very heterogeneous. Most are of the complex type and negatively
charged, due to sialic acid and/or sulfate, and many are bisected by GalNAc. Like P0 and
PMP22, MAG contains in many species the adhesion-related HNK-1 carbohydrate epitope
(Bajt et al. 1990).
A very important, unanswered question about MAG concerns the identity of the putative
axonal binding-partner(s). An important clue about its identity emerged from the
determination that MAG is in a subgroup of the Ig superfamily, whose members exhibit
high homology in the first two amino-terminal V and C2 type Ig-like domains and bind to
sialic acid-containing oligosaccharides (Crocker et al. 1998). This is the ‘siglec’ family for
‘sialic acid-binding immunoglobulin-like lectins’, and members differ in their affinity for
different sialyloligosaccharides, depending on the carbohydrate configurations. There are
now at least 10 members of this family, including sialoadhesin, CD22 and CD33, most of
which are expressed primarily on cells of the immune system (Crocker 2002). MAG
(Siglec-4a) was reported to bind best to oligosaccharides with a2,3-linked sialic acid (2,3-
SA) on a core structure of Gal b1-3GalNAc (Kelm et al. 1994). As such, MAG showed a
preference for binding to O-linked oligosaccharides on glycoproteins and to some
gangliosides, such as the major GD1a and GT1b brain gangliosides (Kelm et al. 1994;
Yang et al. 1996). However, an investigation of glycoproteins in a neuroblastoma cell line
that bound to MAG demonstrated that most binding was to N-linked oligosaccharides with
terminal 2,3-SA, so the reported specificity for glycoproteins with O-linked
oligosaccharides is not absolute (Strenge et al. 1999). However, the fact that MAG binds
to oligosaccharides on both glycoproteins and gangliosides indicates that there are likely
to be several binding partners on the axolemma. A particularly interesting aspect of this
argument is that mice engineered to lack complex gangliosides exhibit some of the same
abnormalities of myelinated axons as MAG-null mice (Sheikh et al. 1999). Recently, a
novel glycosylated form of microtubule-associated protein 1B (MAP1B) expressed at the
surface of axonal membranes, was identified as a binding partner or MAG (Franzen et al.
2001), which could be relevant to the effects of MAG on the microtubular cytoskeleton and
stability of myelinated axons.
In 2002, several reports appeared implicating GD1a and GT1b gangliosides and/or a
GT1b/neurotrophin receptor p75 complex as functional MAG-binding partners involved in
the inhibition of neurite outgrowth (Figure 8; Vyas et al. 2002; Yamashita et al. 2002).
However, another very recent paper reported that MAG inhibits neurite outgrowth by
acting as an additional ligand for the Nogo receptor (Figure 8; Domeniconi et al. 2002).
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The binding partners discussed above are those on neuronal membranes that could
interact with MAG in the periaxonal glial membranes, but MAG localized in mesaxons,
loops and incisures of Schwann cells may interact with the same, or different molecules on
adjacent Schwann cell membranes. These structures are very dynamic during the process
of active myelination. Along this line, MAG has been shown to bind to extracellular matrix
components such as collagen (Probstmeier et al. 1992; Bachmann et al. 1995), tenascin-R
(Yang et al. 1999) and fibronectin (Strenge et al. 2001). However, the physiological
relevance of its binding to components of the extracellular matrix is not clear, because
most MAG is localized in sequestered periaxonal and other spiralled glial membranes.
Binding to these molecules could be relevant to MAG’s effect on neurite outgrowth, and
tenascin-R was shown to neutralize the inhibition of neurite outgrowth by MAG (Yang et al.
1999).
Figure 8 Schematic summary of the mechanisms by which MAG may mediate interactions and signaling
between myelin-forming cells and axons.
The extracellular domain of MAG mediates axon-glia interactions by binding to an unknown component on
the axonal surface membrane. Because MAG has lectin properties and binds to oligosaccharides with 2,3-
SA, its axonal binding partner is likely to be a ganglioside or a glycoprotein. In the PNS, the primary role of
MAG in the Schwann cell periaxonal membrane appears to be as a ligand that binds to an axonal receptor,
which activates a signal transduction cascade that is necessary for the normal maintenance of myelinated
axons. The signaling causes increased phosphorylation of neurofilaments by cdk5 and ERK 1/2, leading to
greater axonal caliber. In the CNS, the most important signaling appears to be in the reverse direction with
MAG acting as a receptor to enhance the vitality of oligodendrocytes and their capacity to form and maintain
myelin. The different C-termini of the L and S isoforms of MAG are shown in green and red, respectively, and
may interact selectively with the various glial components shown as part of MAG’s function.
Binding of MAG to the ganglioside GT1b on neuronal cells results in p75 dependent activation of Rho,
leading to inhibition of neurite outgrowth. MAG can also bind the Nogo receptor in a sialic-acid-independent
manner and is functionally important in MAG-dependent neurite inhibition.
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In vitro experiments showed that MAG can influence neurite outgrowth in a bifunctional
manner. Whereas it promotes neurite outgrowth of neurones at early stages of
development, such as in embryonic dorsal root ganglia, it inhibits neurite outgrowth of
neurons at later stages, such as in adult dorsal root ganglia or early postnatal cerebellum
(Mukhopadhyay et al. 1994; DeBellard et al. 1996). A very recent study showed that L-
MAG, but not S-MAG, promotes neurite outgrowth of cerebellar neurons (Shimizu-Okabe
et al. 2001).
Mice with a null mutation in the MAG gene show a delay in CNS myelin formation (Li et al.
1994; Montag et al. 1994; Bartsch et al. 1997). Moreover, oligodendrocytic cytoplasmic
collars of mature CNS myelin are frequently missing or reduced. Compact myelin
containing an increased presence of oligodendroglial cytoplasmic loops and compact
myelin coursing away from the axon were other abnormalities associated with MAG
deficiency. The biochemical analysis of myelin from mice lacking MAG indicated
pathological abnormalities in oligodendrocytes. Substantial reductions of CNPase, N-
CAM120, tubulin and Fyn tyrosine kinase were found in 14-month-old mice, and
reductions of CNPase and N-CAM120 were already found in 2-month-old mice, showing
that abnormalities begin at a relatively early age (Weiss et al. 2000). In contrast, PNS
myelin formation proceeds normally in MAG mutant mice, but older mutants display PNS
axonal and myelin degeneration, indicating that MAG plays a critical role in maintaining
PNS integrity (Fruttiger et al. 1995). Furthermore, axon calibres in peripheral nerves of
MAG mutants surrounded by morphologically intact myelin were significantly smaller than
in wild-type controls. Reduced axon calibre correlated with reduced neurofilament spacing
and a decrease in neurofilament phosphorylation (Yin et al. 1998). These data
demonstrate that the MAG null mutation might have deleterious secondary effects on
neurons. Recently, an isoform-specific L-MAG mutant mouse line was generated,
displaying most of the CNS, but not the PNS, pathological features of the MAG null mutant
(Fujita et al. 1998). These observations demonstrate a differential role of the L-MAG
isoform in CNS and PNS myelin and indicate that S-MAG may be sufficient for PNS myelin
maintenance.
Although the neurological deficit in MAG-null mice is mild, double knockouts, in which the
absence of MAG is combined with the genetic ablation of other proteins, results in more
severe phenotypes than either knockout alone and have provided further insight into MAG
function. One example is provided by mice in which both MAG and Fyn tyrosine kinase are
absent (Biffiger et al. 2000). It is well established that Fyn has an important role in the
formation of CNS myelin, and the CNS of Fyn-null mice is hypomyelinated. However, in
the absence of both Fyn and MAG, there is a much more severe hypomyelination of the
CNS. This may relate to the report of a direct Fyn-MAG interaction in signal transduction
(Umemori et al. 1994). Another example, in which combining a MAG deficiency with the
absence of another oligodendroglial component exacerbates CNS pathology, is the
MAG/UDP-galactose:ceramide galactosyl transferase (CGT) double knockout (Marcus et
al. 2002). CGT-null mice are unable to synthesize galactocerebroside (GalC) or sulfatide,
which are characteristic lipids of myelin and lipid-rafts (for more aspects of the CGT
mutant, see below in section 5.3.). Similarly to the MAG-null mice, myelination is not
dramatically impaired in these mutants, but they exhibit a more severe pathology in the
CNS with aging and die at about 90 days. Particularly noteworthy are defects in axo-glial
interactions, such as splitting of the periaxonal space along the internodes and a severe
disorganization and breakdown of the tight glia-axon junctions in the paranodal regions.
The normal developmental increase in the amount of the small MAG isoform relative to the
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large isoform in the CNS is impaired in the CGT knockouts (Coetzee et al. 1998). In
MAG/CGT double knockouts, the defects of axon-glia interactions are much more severe,
and the degeneration in the paranodal region progresses much more rapidly, leading to
death by about 3 weeks of age. Interestingly, careful examination of the paranodal region
in the CNS of single MAG knockouts revealed mild degeneration of these structures, but
they did not progress to the extent that occurs in the CGT single knockout, or in the double
knockout. It is of interest that the paranodal junctions in the PNS of CGT and MAG/CGT
double knockouts are only mildly affected. Thus, there appears to be some overlap of
function between MAG and galactolipids in glia-axon interactions of the CNS, despite the
very different structure and properties of these molecules. Furthermore, because MAG is
localized in the internodal periaxonal membrane, it is easy to understand how its absence
contributes to splitting at this location. However, since it is not clear if MAG is expressed in
the CNS paranodal loops, although there is at least one report claiming so (Bartsch et al.
1989), it is much less easy to understand how the absence of MAG contributes to the
degeneration of the loops. If MAG is in fact expressed in the paranodal loops, the absence
of the adhesion properties of MAG and/or the absence of the autotypic MAG-mediated
signalling (glia-glia) between adjacent membranes could cause a loosening of this
structure. Alternatively, if MAG is not expressed in this region, MAG-mediated signalling
(axon-glia) could provide trophic support that increases the vigour of oligodendrocytes in
general, and its absence may exacerbate the structural or functional defects caused by the
absence of galactolipids.
The culturing of oligodendrocyte precursor cells on a substratum containing N-CAM, or
MAG itself, increased both cell survival and the generation of myelin-like membranes
(Gard et al. 1996). The effect of MAG suggests the possibility of autotypic MAG-mediated
signalling between adjacent, loosely spiralled, oligodendroglial membranes that enhances
the myelination process.
4.2. Myelin and Lymphocyte Protein - MAL
The myelin and lymphocyte protein, MAL, has been cloned independently by several
groups from different tissues. In 1987, MAL was cloned from human T lymphocytes
(Alonso and Weissman 1987). In 1995, MAL was cloned from rat primary oligodendrocytes
(Schaeren-Wiemers et al. 1995a) and from the kidney cell line MDCK (Zacchetti et al.
1995). Furthermore, MAL was shown to be expressed in the myelinating glial cells of both
the peripheral and the central nervous systems (Schaeren-Wiemers et al. 1995b).
Colocalization of MAL with MBP and PLP, shown by immunoelectron microscopy,
suggested a main localization in compact myelin (Frank et al. 1998). Recently, MAL was
shown to colocalize with MAG in the Schmidt-Lanterman incisures of peripheral myelin
(Erne et al. 2002). During development of the CNS, MAL became detectable at P10 in the
rat spinal chord, and at P15 in the cerebellum, which was about 5-6 days later than MBP
and PLP (Frank et al. 1999). In the rat PNS, MAL was detectable at E17 and at birth MAL
was also widely expressed in Schwann cells that had not formed myelin (Frank et al.
1999).
In the kidneys, MAL is expressed at the apical lamina surface of the tubuli (Frank et al.
1998; Frank 2000). Besides the kidney, MAL is also expressed in the apical plasma
membrane of the gastro-intestinal tract (Magyar et al. 1997), including the stomach (Frank
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et al. 1998), and in the thyroid (Martin-Belmonte et al. 1998). MAL was originally identified
as a marker of human T lymphocytes (Alonso and Weissman 1987) and is in fact
expressed in various human T cell lines and in the human thymus. However, in rodents,
MAL transcripts were only detectable in the spleen and not in the thymus (Schaeren-
Wiemers et al. 1995b).
The proteolipid MAL is a tetraspan protein with 153 amino acids and a molecular mass of
17 kDa (Alonso and Weissman 1987). All cloned cDNAs show an amino acid identity of
about 90% relative to the human homologue. Proteolipids are defined as proteins
extractable into organic solvents under conditions used to isolate cell lipids (Schlesinger
1981). Along this line, extraction of kidney and spinal chord plasma membranes, as well
as myelin membrane, with chloroform/methanol trapped MAL in the organic phase (Frank
et al. 1998).
Lipid rafts can be isolated as DIGs (detergent-insoluble glycolipid-enriched complexes)
after extraction with Triton X-100 or CHAPS at 4°C (see below: Introduction, Chapter 6:
Lipid-rafts). MAL has been isolated from DIGs of MDCK cells, human mature T cells,
human peripheral blood lymphocytes, rat thyroid cells, primary mature oligodendrocytes,
as well as of rat kidney and spinal chord plasma membranes (Kim et al. 1995; Zacchetti et
al. 1995; Millan et al. 1997a; Frank et al. 1998). The C-terminal LIRW sequence of MAL
was postulated to be necessary for its incorporation into DIGs (Puertollano and Alonso
1998). However, this LIRW motif is not sufficient to direct other proteins into DIGs,
indicating that other features of MAL, such as lipid-binding or global physical properties
are also required (Puertollano et al. 1997; Frank et al. 1998; Puertollano and Alonso
1998).
Increasing the gene dosage of MAL controlled by its own regulatory elements in
transgenic mice resulted in increased MAL levels in organs and tissues that also express
MAL in the wild-type animal. These include the kidney, the stomach and the nervous
system. Whereas peripheral myelin appeared normal, a striking segregation of non-
myelinated axons became pronounced with increasing age. In the CNS, signs of mild
hypomyelination with an increased number of unmyelinated axons and focal myelin
alterations were observed. Severe cyst formation and cortex atrophy were found in the
kidney of the transgenic animals (Frank et al. 2000).
MAL was suggested to be involved in apical transport in epithelial cells, since it was
largely localized in vesicular structures of the trans-golgi network and in transport vesicles
(Zacchetti et al. 1995; Millan et al. 1997a; Millan et al. 1997b). It was also shown that MAL
cycles between the trans-golgi network and apical membranes (Puertollano et al. 1999).
Recently, two groups provided evidence that MAL is involved in the transport of apically
destined proteins. Both groups blocked MAL expression in MDCK cells by different
antisense techniques and studied the transport of molecules that are known to be lipid-
raft-associated and apically transported, such as HA (influenza virus protein Haemaglutin)
and YFP-GPI (yellow fluorescent protein fused to a GPI-anchor; (Cheong et al. 1999;
Puertollano et al. 1999; Martin-Belmonte et al. 2000). The transport of all considered
proteins to the apical membrane was reduced, suggesting an involvement of MAL in raft-
associated trafficking. The fact that the decreased MAL expression in MDCK cells leads to
a decrease in the solubility of HA, which is coupled to a decrease in surface transport of
HA in these cells, suggests that MAL might stabilize the association of transport cargo
within rafts in the trans-golgi network as a prerequisite for apical sorting (Puertollano et al.
1999; Puertollano et al. 2001). Interestingly in this context is the observation that non-
transported proteins remained in the golgi (Cheong et al. 1999). However, a role for MAL
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in vesicle formation cannot be excluded since ectopic expression of MAL in insect cells
induced vesicle formation (Puertollano et al. 1997). MAL seems to be a rate-limiting
component in the process of apical transport since overexpression of MAL in MDCK cells
leads to an increased apical surface delivery of HA and YFP-GPI (Cheong et al. 1999).
These studies also revealed that detergent-soluble proteins, such as p75 (neurotrophin
receptor) and gp114 (an endogenous membrane protein of MDCK cells), are also impaired
in their apical sorting and trafficking upon MAL depletion, suggesting a general role for
MAL in apical transport (Cheong et al. 1999; Martin-Belmonte et al. 2000). To date, it is
not clear whether the transport of raft-associated and non-raft proteins occur via the same,
or different vesicles.
4.3. Proteolipid Protein - PLP
Proteolipid protein PLP is the most abundant protein of the CNS white matter. PLP
comprises four hydrophobic a-helices spanning the whole thickness of the lipid bilayer at
the intraperiod and major dense line of compact myelin (Weimbs and Stoffel 1992).
Alternative splicing of the PLP gene gives rise to a minor isoform known as DM20. PLP
and DM20 share complete sequence identity, except for a 35 amino acid intracelluar
segment, while the full-length gene encodes the PLP isoform with a length of 276 amino
acids and a molecular mass of 30 kDa. During development, DM20 is the predominant
isoform, which can already be detected in oligodendrocyte precursor cells (Dickinson et al.
1996). PLP and DM20 are synthesized by oligodendrocytes on membrane-bound
polysomes directly as the mature protein, and are transported through the Golgi to the cell
surface where they are incorporated into compact myelin. The half-life of PLP in myelin is
approximately 90 days (Messier and Bizzozero 2000). Despite its net basic charge, PLP is
a highly hydrophobic protein. Its hydrophobic character is further increased by the
presence of covalently bound long-chain fatty acids, predominantly palmitic acid (Messier
and Bizzozero 2000).
Numerous functions have been proposed for PLP and DM20 in the CNS, including
membrane adhesion and compaction of myelin, formation of the myelin intraperiod line,
maturation of oligodendrocytes, involvement in early stages of oligodendrocyte/axon
interactions and wrapping of the axon, and maintenance and survival of axons. PLP-null
mice have oligodendrocytes that can assemble compacted myelin sheaths, but with a
condensation of the intraperiod line and a decreased physical stability, confirming a likely
role for PLP in compaction and stabilization of myelin sheaths (Boison and Stoffel 1994;
Klugmann et al. 1997).
4.4. Myelin Basic Protein - MBP
The 'classic' Myelin Basic Proteins (MBP) are major protein components of myelin,
comprising ~30% of CNS myelin protein and ~18% of PNS myelin protein. The 'classic'
MBP gene comprises seven exons, of which three (exons II, III and VI) are alternatively
spliced, accounting for all four major isoforms of mouse MBPs (Figure 9; Zeller et al. 1984;
Roach et al. 1985; Takahashi et al. 1985; Mentaberry et al. 1986; Newman et al. 1987).
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The transcript corresponding to the 21.5-kDa isoform contains the sequences encoded by
all seven exons, the transcript for the 18.5-kDa isoform results from the splicing out of
exon II, the transcript for the 17-kDa isoform results from the splicing out of exon III and VI,
and the transcript for the 14.5-kDa isoform results from the splicing out of exon II and VI.
In the CNS, the 21.5-kDa and the 17-kDa isoforms are expressed during myelination,
whereas the 14.5-kDa and the 18.5-kDa isoforms are expressed in mature myelin (Carson
et al. 1983).
The MBP proteins contain an unusually high percentage (25%) of basic residues evenly
distributed throughout the polypeptide chain. These residues are thought to interact with
the negatively charged phospholipids of the lipid bilayer. Therefore, MBPs are believed to
participate in the compaction and maintenance of the myelin sheath by holding together
the inner leaflets of the myelin membranes (see Figure 6; Omlin et al. 1982).
However, the picture was recently complicated by the demonstration that, in both mice and
man, the MBP gene is contained within a large genetic locus of 105-180 kbp, which has
been called the golli-MBP transcription unit (Campagnoni et al. 1993; Pribyl et al. 1993).
The two major transcription start sites present in this complex give rise to two families of
transcripts: those that encode the 'classic' MBPs, which are expressed only in myelin-
forming cells, and those derived from a distal, upstream promoter, that encode the
structurally and immunologically related golli proteins (Figure 8). Indeed the two major golli
proteins contain MBP peptide sequences in their C-terminal region. While they may be
involved in the early development and maintenance of neurons in the PNS, the golli
proteins are not myelin proteins (Landry et al. 1997).
MBP mRNAs are targeted to the developing myelin sheath, where they are translated on
free polysomes (Colman et al. 1982; Verity and Campagnoni 1988). The subcellular
trafficking pathway for MBP mRNA in the oligodendrocyte involves three distinct sorting
steps: (a) assembly into granules, (b) transport along the processes, and (c) localization to
the myelin compartment. Specific regions in the 3' untranslated regions (UTR) of MBP
mRNA are required for the last two of these steps. The RNA transport sequence (RTS) is
necessary and sufficient for the transport of mRNA along oligodendrocyte processes.
Figure 9 Structure of the myelin basic protein (MBP) gene.
The arrangement of the mouse MBP gene is illustrated. The 'classic' MBP exons are shown in roman
numbers while golli exons are shown in arabic numbers. The three transcription start sites (Tss) are
indicated with arrows. Exonic structures of BG21, J37 and TP8 golli isoforms, the four main isoforms of MBP
and M41-MBP are shown (according to Givogri et al. 2000).
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Homologous sequences are found in other transported mRNAs, suggesting that the RTS
represents a general signal to direct RNAs to the transport apparatus of the cell. The
second is a RNA localization region (RLR) with a predicted stable secondary structure,
which is required for localization of MBP mRNA to myelin. The RLR may be involved in
anchoring or stabilizing MBP mRNA in the myelin compartment of the oligodendrocyte
(Ainger et al. 1997). A transgene consisting of a truncated cDNA fragment encoding the
14-kDa MBP isoform and containing the RTS and RLR of mouse, was able to completely
rescue the shiverer mutation (see below), consisting of a deletion of the endogenous MBP
gene (Kimura et al. 1989), suggesting that these regions are sufficient for normal targeting
of MBP expression in vivo.
The shiverer mutation comprises a 20-kbp deletion of the 'classic' MBP gene, that results
in the absence of MBPs (Roach et al. 1983; Roach et al. 1985; Molineaux et al. 1986). The
shiverer mutant, first observed in 1973, is deficient in CNS myelin. Homozygous mice
exhibit a distinct behavioural pattern, including a generalized action tremor (shivering),
appearing around postnatal day 12, convulsions and early death. Morphological analysis
of the CNS revealed an almost total lack of myelin in the brains of affected mice (Bird et al.
1978) with few thinly myelinated axons. The existing myelin was abnormal, presenting no
major dense line (Privat et al. 1979). It was thus concluded that the MBPs are necessary
for the formation of the major dense line in the CNS myelin. In contrast, the PNS myelin of
the shiverer mouse appears to be both qualitatively and quantitatively normal, with normal
thickness, lamellar structure, and periodicity (Privat et al. 1979; Rosenbluth 1980). Only
relatively minor abnormalities were reported, such as cytoplasmic invaginations of the
innermost and outermost layers and aberrant terminations of lamellae in the internodes
(Rosenbluth 1980; Inouye et al. 1985). Biochemical studies of shiverer PNS myelin
revealed changes in the proportions of some lipids, including an increased amount (+20%)
of negatively charged sulfatide (Inouye et al. 1985). Nevertheless, the absence of MBP
does not prevent the formation of compact myelin in the PNS. Its absence is possibly
compensated by another PNS myelin protein, probably P0 (Martini et al. 1995).
4.5. Myelin/Oligodendrocyte Glycoprotein - MOG
MOG is a 26–28-kDa glycoprotein specifically expressed in oligodendrocytes (Linington et
al. 1984). Like MAG, MOG is a member of the Ig superfamily, is a quantitatively minor
component of the myelin sheaths and is localized in membranes distinct from compact
myelin. However, unlike MAG, MOG is not expressed in the PNS and is not localized in
the adaxonal/periaxonal membranes, but in the abaxonal myelin membrane and on
oligodendrocytes. Therefore, MOG is well situated to interact with components in the
extracellular environment. MOG has a single Ig-like variable region domain, one site for N-
linked glycosylation, and two hydrophobic, potential transmembrane domains. However,
topographical studies of MOG have indicated that the second hydrophobic domain does
not transverse the membrane completely, but is located within the membrane, so the
carboxy terminus of MOG is in the oligodendroglial cytoplasm (Kroepfl et al. 1996). It is of
interest that the cytoplasmic domain of MOG contains targeting signals that direct it to the
basolateral domain of MDCK cells and presumably account for its selective localization on
the surface of oligodendrocytes and myelin sheaths (Kroepfl and Gardinier 2001). Several
experiments performed by Dyer and colleagues (Dyer et al. 1994) have identified another
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possible function for MOG. They showed that the addition of monoclonal anti-MOG
antibodies to oligodendrocytes in culture causes the MOG/anti-MOG complex to
redistribute over internal domains of MBP and a subsequent depolymerization of
microtubules. As microtubules are stabilized by the cytoplasmic domains of MBP (Pirollet
et al. 1992), they suggested that MBP might have an important role in this process. A
similar depolymerization of microtubules in oligodendrocytes was provoked by the addition
of antibodies to GalC (Dyer 1993). Thus, it appears that MOG and GalC may share at
least one function in common: regulation of microtubule stability through local degradation
of MBP. The common mechanism of the glycoprotein MOG and the galactolipid GalC may
be explained by an interaction of the lipid-bilayer-associated second hydrophobic domain
of MOG, via its two palmitoylated cysteine residues, with the fatty acid portion of GalC.
Furthermore, MOG is highly immunogenic and immunization with this protein alone can
induce severe experimental allergic encephalomyelitis (EAE) in rodents and primates.
EAE has often been used as an animal model for MS.
5. Myelin Lipids
5.1. General
All the major lipid classes (phospholipids, glycolipids and cholesterol) and their respective
subclasses encountered in other membranes, are also represented in the myelin
membrane and thus, strictly speaking, there are no myelin-specific lipids. But one of the
major biochemical characteristics that distinguishes myelin from other biological
membranes is its high lipid-to-protein ratio. Myelin contains 70-80% lipids and 20-30%
proteins. Perhaps the most striking feature of the myelin lipid composition when compared
to that of other biological membranes, is the high content in galactolipids (GalC: ~25% and
sulfatides: ~5%) and cholesterol (~25%, for review, see Norton and Cammer 1984). The
myelin lipids are asymmetrically arranged within the myelin lipid bilayer with glycolipids
and cholesterol found in the outer leaflet and phospholipids in the inner leaflet. Myelin also
contains gangliosides (sphingolipids with an oligosaccharide head-group including one, or
more sialic acid residues; Fong et al. 1976). About 90% of the total gangliosides are
monosialogangliosides, such as sialosyllactoneotetraosylceramide (LM1, GM1, GM3 and
GM4; Chou et al. 1982). Interestingly, mice lacking complex gangliosides (GM2 and GD2)
develop both CNS and PNS pathologies, the latter being characterized by demyelination
and axonal degeneration (Sheikh et al. 1999).
5.2. Cholesterol
Cholesterol accumulates continuously throughout the period of neo-myelinogenesis and
during the subsequent period of myelin maturation (Yates and Wherrett 1974; Juguelin et
al. 1986). This accumulation pattern is consistent with the role proposed for this lipid in the
stabilization and the compaction of the multilamellar myelin membrane (Nussbaum et al.
1969; Detering and Wells 1976). Disturbed cholesterol synthesis in young weanling rats
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through the inclusion of tellurium in their diet, produces a severe peripheral neuropathy,
which is manifested clinically by a hind limb paralysis (Lampert et al. 1970). Tellurium
intoxication predominantly damages the myelinating Schwann cells (Lampert and Garrett
1971; Hammang et al. 1986). The process of demyelination stops about one week after
the onset of the exposure, and a period of rapid remyelination begins, even if the exposure
to tellurium continues (Said and Duckett 1981; Takahashi 1981; Wiley-Livingston and
Ellisman 1982). Remyelination is complete within 30 days after starting the exposure to
tellurium (Lampert and Garrett 1971; Duckett et al. 1979; Takahashi 1981; Hammang et al.
1986). Thus, the lack of cholesterol required for the formation of new myelin and the
maintenance of pre-existing myelin leads to a highly synchronous demyelination.
Importantly, the cholesterol deficit also leads to a coordinate down-regulation of the
mRNAs coding for myelin-related proteins, indicating that there is a coordinated regulation
of the entire program for myelin synthesis and assembly in Schwann cells (Toews et al.
1990; Toews et al. 1996; Toews et al. 1997).
5.3. Myelin Glycolipids
GalC (15-25% of myelin lipids) and its sulphated derivate sulfatide (5-10% of myelin lipids)
are the major glycolipid lipid components characteristic of myelin (Garbay et al. 2000).
GalC is synthesized by the addition of activated galactose to a ceramide molecule by the
enzyme UDP-galacose:ceramide galactosyl transferase (CGT). Further addition of a
sulfate group that derives from 3'phosphoadenosyl-5'phosphosulfate (PAPS) by the
enzyme 3'phosphoadenylylsulfate:GalC 3'sulfotransferase (CST) leads to the formation of
sulfatide. Despite the fact that the myelin membrane is continuous with the plasma
membrane surrounding the cell body of an oligodendrocyte, GalC and sulfatide are only
present within the myelin-forming membrane (Abe and Norton 1979). During development
GalC and sulfatide start to be expressed in immature oligodendrocytes with a peak
synthesis during postnatal development paralleling the period of myelination. After
myelination is complete, they remain expressed at high levels throughout life (Burkart et al.
1983). Application of the monoclonal anti-sulfatide (O4) and anti-GalC (O1) antibodies
reversibly inhibit the onset of terminal differentiation at the pre-GalC immature OL interface
into mature oligodendrocytes (Bansal et al. 1999). These data suggest that these anti-
galactolipid antibodies mimic a lipid-binding ligand and initiate a constitutive inhibitory
signal across the plasma membrane via interaction with GalC and/or sulfatide.
Further, interaction of sulfatide in the oligodendrocyte membrane with the extracellular
matrix molecule tenascin-R suggests a function in cell recognition and adhesion (Pesheva
et al. 1997).
The formation of subcellular microdomains by glycolipids, so-called 'lipid-rafts', is thought
to be associated with protein trafficking and signalling in various cell types. GalC has been
characterized as a transmembrane signal transducer, since cultured oligodendrocytes
treated with an anti-GalC antibody exhibit distorted membrane morphology, calcium flux
and cytoplasmic microtubule networks (Dyer and Benjamins 1989, 1990). Similar
conclusions were drawn from a study that examined the effects of GalC/sulfatide-
containing liposomes on cultured oligodendrocytes (Boggs and Wang 2001). The
liposome–cell membrane interaction causes depolymerization of microtubules and actin
filaments, along with the redistribution of membrane GalC and MBP.
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Despite the in vitro work describing the necessity of galactolipids for normal
oligodendrocyte differentiation and myelin formation, CGT-null mutant mice are capable to
myelinate axons in the CNS and PNS. Overall, the myelin sheaths appears normal but the
mice develop a tremor, starting around 2 weeks of age, and exhibit splayed hind limbs in
conjunction with an uncoordinated gait. As the mutants age, the hind limbs develop
paralysis and the mice rapidly lose mobility. The CGT mutants die prematurely, with few
surviving beyond 90 days (Dupree et al. 1998a). Despite the formation of myelin, the
abnormal CGT-/- behavioural phenotype was strongly suggestive of dysmyelinated fibre
profiles. Although myelin is able to form in the absence of galactolipids, there are a
number of more subtle ultra structural abnormalities that are associated with myelination in
the mutant CNS. Spinal chord axons display thinner myelin sheaths, with myelin thickness
being reduced by about 30% relative to age-matched controls (Coetzee et al. 1996).
Schmidt–Lanterman incisures are also abnormally found in the mature mutant CNS
(Coetzee et al. 1996; Dupree et al. 1998b). These cytoplasm-filled clefts normally occur in
PNS myelin, but their persistence in the mutant CNS might reflect a compensatory
structure for compromised sheath integrity. There is an increase in mutant axons that are
abnormally myelinated by multiple oligodendrocytic processes, suggesting defective
axon–glial, or glial–glial contacts. Galactolipid-deficient myelin can also bear an immature
morphology, such as cytoplasm retention within myelin lamellae and redundant myelin
profiles (Bosio et al. 1998; Dupree et al. 1998b). Significant alterations in myelin
ultrastructure are not seen in the PNS of CGT mutants, indicating that galactolipids are not
absolutely essential for peripheral myelin formation (Dupree et al. 1998b). Interestingly,
the CGT-/- and the MAG-/- single mutant mice produce abnormal myelin containing similar
ultra structural abnormalities. The absence of the galactolipids results in a disruption in
paranodal axon-glial and/or glial-glial interactions, which exist, albeit less severe, also in
the developing MAG mutant. In the double-mutant mice, maintenance of glial-glial
adhesion is significantly more affected than in the single mutants. Nodes of Ranvier form
normally in the absence of both MAG and the galactolipids, but they rapidly destabilize
thereafter (for more details about the MAG/CGT mutant, see above in section 4.1.).
6. Lipid-Rafts
In the prevailing view of cellular membrane structure, lipids in the bilayer function mainly
as a solvent for membrane proteins (Singer and Nicolson 1972). But in the fluid bilayer,
different lipid species are asymmetrically distributed over the exoplasmic and cytoplasmic
leaflets of the membrane (van Meer 1989). The lipids are also organized in the lateral
dimension and impose more short- and long-range order than was previously recognized
(Kusumi and Sako 1996). This lateral organization probably results from preferential
packing of sphingolipids and cholesterol into moving platforms, or rafts, onto which specific
proteins attach within the bilayer. Simons and Ikonen (Simons and Ikonen 1997) proposed
a new model for membrane structure that describes the organization of these lipid
microdomains and presented evidence that proteins can selectively be included or
excluded from these microdomains. They concluded that the function of these
microdomains is to serve as rafts for the transport of selected membranes or as relay
stations in intracellular signalling.
Simons and Ikonen (1997) based their lipid-raft concept on earlier studies on the delivery
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of newly synthesized sphingolipids in epithelial MDCK cells that had showed that a simple
glycosphingolipid, glucosylceramide, was preferentially transported to the apical
membrane (Simons and van Meer 1988; van Helvoort et al. 1996). To explain delivery to
the apical domain, it was proposed that glycosphingolipid clusters formed within the
exoplasmic leaflet of the Golgi membrane (Simons and van Meer 1988): these
microdomains were considered to be sorting centres for proteins destined for delivery to
the apical plasma membrane. In support of this model, glycosylphosphatidylinositol (GPI)-
anchored proteins use glycolipid anchors as apical sorting determinants (Brown and Rose
1992). Moreover, caveolae, small invaginations of the plasma membrane that are devoid
of clathrin coats and are present in many cell types (Parton 1996), contain clusters of
glycosphingolipids (Tran et al. 1987), and need cholesterol to function (Rothberg et al.
1990). As caveolae may be involved in endocytosis (Tran et al. 1987), and transcytosis
(Ghitescu et al. 1986) a function for sphingolipid-rafts in membrane trafficking was
plausible (Dupree et al. 1993).
Sphingolipid–cholesterol rafts are insoluble in the detergent TritonX-100 at 4°C, in which
they form glycolipid-enriched complexes (Brown and Rose 1992; Parton and Simons
1995). Because of their high lipid content, these detergent-insoluble, glycolipid-enriched
complexes (DIGs) float to a low density during sucrose gradient centrifugation (Brown and
Rose 1992), which enables any associated proteins to be identified and distinguishes
DIGs from other detergent insoluble complexes. Milder detergents such as octylglucoside
will solubilize lipid-rafts (Schroeder et al. 1994). Glycosphingolipids are insoluble by
themselves, and sphingomyelin is resistant to detergent extraction in the presence of
cholesterol (Schroeder et al. 1994). One problem with TritonX-100 extraction is that the
original subcellular locations of DIGs are unknown. Confusion has been created because
sphingolipid-rafts in apical transport vesicles, in caveolae, and even in plasma membranes
from cells devoid of morphologically recognizable caveolae, all form DIGs after Triton X-
100 extraction (Skibbens et al. 1989; Sargiacomo et al. 1993; Fra et al. 1994). Only by
isolating specific organelles before detergent extraction can the origin of DIGs be
determined; neither can it be assumed that two proteins are in contact with each other on
the basis of their partitioning into DIGs.
The raft model of protein sorting and trafficking and signalling has also been applied to the
myelinating cells of the peripheral and central nervous system. Along this line, TrionX100-
resistant membrane domains have been isolated from primary oligodendrocytes and
myelin that are enriched in GalC, sulfatide, and the GPI-linked adhesion molecules
NCAM120 and F3/contactin as well as src-family kinases Fyn and Lyn (Kramer et al.
1997). These raft complexes are proposed to be functionally involved in axon-glia
recognition and in the compartmentalisation of signalling cascades, one of which utilises
the tyrosine kinase Fyn in the initial phase of myelination (Kramer et al. 1999; Trotter et al.
2000). The non-compact myelin proteins CNPase and MOG were also shown to fulfil
criteria for raft association when solubilized from purified myelin and a role of these rafts in
signalling processes along non-compacted myelin regions was suggested (Kim and
Pfeiffer 1999). The advantage of utilising rafts for the generation of myelin could be the
efficiency of a self-driven assembly of the specific myelin lipids. These form a membrane
of specific biophysical characteristics (liquid-ordered phase, high melting temperature, low
fluidity) that facilitates electric insulation of the axon. The myelin and lymphocyte protein
(MAL) is a component of glycosphingolipid-rafts in myelinating glial cells (for more aspects
about MAL and rafts, see section 4.2.; Schaeren-Wiemers et al. 1995b; Frank et al. 1998;
Frank 2000).
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Motivation and Aim of the Work
Myelin is generated during a relatively short time during development and must be
maintained throughout life. To meet the requirements imposed by its different functions,
the structure of myelin is unique and comprises several compartments. We do know only
little about the signals involved in myelination initiation, the interplay of the different
molecular components to achieve myelin wrapping, formation and maintenance and how
myelin components, which are synthesized in the cytoplasm, are sorted and targeted to
their respective sites of assembly.
The myelin-associated glycoprotein isoforms L- and S-MAG are believed to be
multifunctional proteins intervening at several levels of the myelination process. As such,
they constitute key components of the myelin sheath and the elucidation of their function
emerges as an important step towards understanding myelin formation, maintenance and
disease. We planned to generate transgenic mice expressing both MAG isoforms as
individually fluorescent protein-tagged fusion proteins, since the generation of antibodies
specifically recognizing the two mouse isoforms had failed. These mouse lines were
planned to be used, for instance, to investigate the isoform-specific expression pattern
within the different structures of the brain, within the different domains of the myelin sheath
during development and in the adult and in mouse models for primary demyelinating
neuropathies.
Investigations of L- and S-MAG expression in sural nerve biopsies from patients with
primary demyelinating hereditary peripheral neuropathies (CMT1A and HNPP) had
revealed a significant increase of L-MAG-positive fibres compared to control autoptic sural
nerves (Lützelschwab 1998; Schaeren-Wiemers et al. 1999). The analysis of the L- and S-
MAG-specific mRNAs in the corresponding mouse models, however, showed a significant
up-regulation of S-MAG, but not L-MAG (Adlkofer et al. 1995; Adlkofer et al. 1997;
Lützelschwab 1998; Schaeren-Wiemers et al. 1999). The cross-breeding of these animal
models with the fluorescent protein-tagged MAG mice should have allowed to verify
whether these mice also up-regulate S-MAG at the protein level, as suggested by the
mRNA, or if the L-MAG protein is up-regulated in a manner similar to that observed in the
human sural nerve biopsies.
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Materials and Methods
1. Molecular Biology
1.1. RNA Isolation and cDNA Synthesis
RNA was isolated from ~2x106 Oli-neu cells with the SV Total RNA Isolation kit (including
a DNAse treatment, Promega Corporation, Madison, USA) or from whole mouse brains
with the RNeasy Mini Kit (Qiagen). About 10 mg total RNA could be isolated from 106 Oli-
neu cells. cDNA synthesis was performed with 5 mg total RNA using the Oligo(dT)15 Primer
and the M-MLV Reverse Transcriptase (Promega Corporation, Madison, USA). A typical
cDNA synthesis reaction contained: 5 mg total RNA, 1 mg Oligo(dT)15 Primer, 25 units
rRNasin Ribonuclease Inhibitor (Promega), 200 units M-MLV Reverse Transcriptase
(Promega), 0.5 mM dNTP, 1 x reaction buffer, in a final volume of 25 ml. The RNA was
incubated together with the primer for 5' at 70°C and cooled on ice thereafter. The other
reagents were then added and the synthesis was carried out at 42°C for one hour.
1.2. Primer List
The following Table 1 lists all primers used in PCR amplifications for semi-quantitative and
quantitative RT-PCR and for cloning.
Primer Sequence (5' to 3')
3'13a-BamHI CACGGATCCCTTGACTCGGATTTCTGCATA
3'13b-BglII-SacII GAGCCGCGGAGATCTGATGGTCTCTTCTGGCTCTT
3'amusL TGCTTCTCACTCTCATACTTA
3'DsRed-HindIII CACAAGCTTCTACAGGAACAGGTGGTGG
3'exon13-A TCTCCATGGCCTTGACTCGGATTTCTGCATAC
3'exon13-B ATGTAGGCAAGGAATGTTG
3'GFP-NarI CTCGGCGCCTTACTTGTACAGCTCGTCCAT
3'GFP-SmaI ACACCCGGGACCTACCTCCTGGGCTCTCACTTGTACAGC
3'GFP-SpeI GAGACTAGTCACTTGTACAGCTCGTCCATG
3'IgkSP-StuI CACAGGCCTAGCAGGAGACTGTGTCAGC
3'L-MAG-NcoI TCTCCATGGCCTTGACTCGGATTTCTGCATAC
3'L-MAG-XbaI CGCTCTAGACTCACTTGACTCGGATTTCTG
3'MAG-NdeI-HindIII CTCAAGCTTCATATGTTTAGCAAGTGATTGAGCTA
3'MAG-SalI CTCGTCGACTTTTCAGCGGGTATATAAATG
3'mGAPDHrpaXbaI TGGTTCACACCCATCACAAAC
3'mMAG-LC TCCCTCTCCGTCTCATTCACAGTC
3'mMAL-537 CCACTGCGGCGATGTTTTC
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3'mPLP/DM20-960 GCGAAGTTGTAAGTGGCAGCAATC
3'S-MAG-BamHI CACGGATCCGTGACAATCCCGGGTAGAG
3'S-MAG-NcoI TCTCCATGGCGTGACAATCCCGGGTAGAG
3'S-MAG-VSVG-XbaI
CGCTCTAGATCACTTGCCCAGGCGGTTCATCTCGATGTCGGTG
TAGCCGTGACAATCCCGGGTAGAG
3'S-MAG-XbaI CGCTCTAGACTCAGTGACAATCCCGGG
3'VSVG-SmaI GCGCCCGGGACCTACCTCCTGGGG
5'13b-SpeI GAGACTAGTGGGGGCTGGCCCTGTG
5'DsRed-BamHI CACGGATCCGGTAGTACCATGGTGCGCTCCTCC
5'exon10 CACCTCGAGTCGCCTTTGCCATCCTGATT
5'exon11/13 TGATAAGTATGAGAGTGAGAAG
5'exon12 TCCAGAGAGGTCTCTACCC
5'GFP-BamHI CACGGATCCATGGTGAGCAAGGGCGAG
5'GFP-SmaI ACACCCGGGATTGTCACGCCATGGTGAGCAAGGGCGAGG
5'IgkSP-HindIII CACAAGCTTATCCACCATGGAGACAGAC
5'MAG16760 CACAAGCTTCCAAAAGGGTGGTCCAACC
5'MAG-gs-RsrII CACCGGACCGGTAGTGGAAGTGGAGGGGGCCACTGGGGT
5'MAG-HindIII-NarI GAGAAGCTTGGCGCCTGGGGGCTGGCCCTGTG
5'MAG-NdeI GAGCATATGATATTCCTCGCCACCC
5'MAG-NotI GAGGCGGCCGCGATCCACTCCCCGGTCTAA
5'MAGrpaXhoI GTCGCCTTTGCCATCCTGATT
5'MAG-StuI CACAGGCCTACCATGATATTCCTCGCCACCC
5'MAG-XbaI CACTCTAGAAGATGATATTCCTCGCCACC
5'mGAPDHrpaXhoI GACCCCTTCATTGACCTCAA
5'mMAG-LC GTTTGCCCCCATAATCCTTCTG
5'mMAL-208 CCACCTTCCCTGACTTGCTCTTC
5'mPLP/DM20-641 ACTGTTGTATGGCTCCTGGTGTTTG
5'S-MAG-HindIII CACAAGCTTGATCGTCCAAGGTTGAAAGG
5'VSVG-SmaI CTACCCGGGATTGTCACGGCTACAC
1.3. Semi-Quantitative RT-PCR
To amplify the MAG mRNA region of exons 10 to 13, we used the primer pair 5’exon10
and 3’exon13-A. This primer pair amplifies a L-MAG-specific product of 338 bp and a S-
MAG-specific product of 383 bp. L-MAG-specific mRNAs were amplified with the
5’exon11/13 and 3’exon13-B primer pair, whereas S-MAG specific mRNAs were amplified
with the 5’exon12 and 3’exon13-B primer pair. The 5’exon11/13 primer is L-MAG-specific,
because its sequence is homologous to the exon 11/exon 13 junction. The 5’exon12
primer is S-MAG specific, because its sequence is homologous to the S-MAG specific
exon 12. For detailed localization of the primers see Figure 22A. Transcripts for
Table 1 List of Primers
All primers used for PCR amplifications are listed in alphabetical order. The primer sequences are writen
from 5' to 3'. The names of so-called ‘forward’ (hybridizing to the antisense DNA strand) and ‘reverse’
(hybridizing to the sense DNA strand) primers begin with the 5'- and 3'-nucleotides, respectively.
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glyceraldehyde-3-phosphate dehydrogenase (GAPDH), employed as an internal standard,
were amplified with the primer 5’GAPDHrpaXhoI and 3’GAPDHrpaXbaI.
1.4. Quantitative RT-PCR
The analysis was carried out using the Roche LightCycler with the FastStartDNA Master
SybrGreenI. The following primer pairs were used: GAPDH: 5'GAPDHrpaXhoI x
3'GAPDHrpaXbaI; MAL: 5'mMAL-208 x 3'mMAL-537; total MAG: 5'mMAG-LC x 3'mMAG-
LC; L-MAG: 5'MAGrpaXhoI x 3'amusL; PLP/DM20: 5'mPLP/DM20-641 x 3'mPLP/DM20-
960. The following plasmids were used as internal standards: pBlue-GAPDH (insert:
5'GAPDHrpaXhoI x 3'GAPDHrpaXbaI; clone IV.1 04/11/99); pBlue-MAL (insert: cDNA
library clone (gift from the Suter lab, Zürich); clone: 1.1 19/09/01); pBlue-L-MAG (insert:
clone 3a1 13/08/99); pPCR-Topo-PLP/DM20 (insert: 5'mPLP/DM20-641 x 3'mPLP/DM20-
960; clone 3 22/08/02). The standard curve was created by the analysis of the following
plasmid copy numbers: 109, 108, ..., 103, 102. The primers, the plasmid DNA and the cDNA
were diluted in 5 mM Tris pH 8,5. A 20-ml reaction had a final concentration of 4 mM MgCl2
and contained the following ingredients: 8.6 ml H2O, 2.4 ml MgCl2, 2 ml SybrGreenMix, 1 ml
5'primer 5 mM, 1 ml 3'primer 5 mM and 5 ml template. The annealing temperature was set to
57°C for all reactions. In each analysis, two internal standards (106 and 105 copies) were
included to connect the values of the samples with the standard curve.
1.5. Cloning of The cDNA Expression Constructs
The cloning of the native MAG and the different fusion protein cDNA expression constructs
described below are schematically represented in Figure 15. Primers with incorporated
restriction sites were used for subcloning of PCR products. The mouse L- and S-MAG
open reading-frames were cloned from adult mouse brain by RT-PCR.
1.5.1. Cloning of the L-/S-MAG Expression Vectors
For the L- and S-MAG expression constructs, the primer 5’MAG-StuI and 3’L-MAG-XbaI,
for L-MAG, and 3’S-MAG-XbaI, for S-MAG, were used. The products were subcloned at
the position of GFP into the b-actin-GFP expression vector (kindly provided by Prof. A.
Matus, FMI, Basel, Switzerland).
                                                                                                            Materials and Methods
38
1.5.2. Cloning of the L-/S-MAG-GFP Expression Vectors
For the L- and S-MAG-GFP fusion protein constructs, the primers 5’MAG-StuI and 3’L-
MAG-NcoI and 3’S-MAG-NcoI were used, respectively. The products were cloned into the
b-actin-GFP vector upstream of, and in frame with, the GFP sequence.
1.5.3. Cloning of the S-MAG-DsRed1 Expression Vector
For the S-MAG-DsRed1 construct, the DsRed1 sequence (Clontech, Heidelberg,
Germany) was amplified with the primers 5’DsRed1-BamHI and 3’DsRed1-HindIII. This
product was subcloned into the pcDNA3.1 expression vector (Invitrogen AG, Basel,
Switzerland), resulting in the cmv-DsRed1 expression vector. In a second step, S-MAG
was amplified with the primers 5’MAG-XbaI and 3’S-MAG-BamHI and subcloned in front
of, and in frame with, the DsRed1 sequence.
1.5.4. Cloning of the S-MAG-VSVG Expression Vector
For the S-MAG-VSVG construct, S-MAG was amplified with the primers 5’S-MAG-HindIII
and 3’S-MAG-VSVG-XbaI and subcloned into pcDNA3.1. The antisense primer introduced
a 3’ extension encoding the VSVG-tag (Vesicular Stomatitis Virus Glycoprotein).
1.5.5. Cloning of the GFP-L-MAG/GFP-S-MAG Expression Vectors
For GFP-MAG fusion protein constructs, the Igk light chain signal peptide and cleavage
site sequence was amplified from mouse spleen with the primers 5’IgkSP-HindIII and
3’IgkSP-StuI and subcloned into the b-actin-GFP vector upstream of, and in frame with,
the GFP sequence. In a second step, L- and S-MAG were amplified with the primers
5’MAG-gs-RsrII and 3’L-MAG-XbaI and 3’S-MAG-XbaI, respectively. The 5’MAG-gs-RsrII
primer replaced the MAG signal peptide by a sequence coding for a five amino acid
glycine/serine stretch. These products were subcloned downstream of the IgkSP-GFP
sequence.
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1.6. Cloning of the Genomic Mouse MAG Expression Constructs
Genomic constructs encoding MAG-GFP fusion proteins were generated from the intact
19 kb C57Bl mouse MAG gene, including the 1.8-kb promoter and all exons that were
included on a cosmid (cos301). The MAG gene was subcloned into Bluescript pBSKS.
The plasmid used for further cloning (pmag-MAG) is schematically shown in Figure 18.
1.6.1. Cloning of the pmag-MAG-e13GFP Construct
The pmag-MAG-e13GFP genomic expression construct was generated by the insertion of
the GFP sequence before the stop codon within the mag exon 13 (Figure 10 and 18B: 2).
This insertion required three sequential and reversible subcloning steps. In a first step, the
HindIII fragment (Æ HindIII-F) of the pmag-MAG plasmid was excised (HindIII sites: 10316
and 16756 bp) and the vector was ligated to yield: pmag-MAGyHindIII fragment (Æ NotI-
SalI-F). In a second step, the 2315 bp HindIII-SalI fragment (HindIII site: 16756 bp and
SalI site: 19070 bp) from this plasmid was isolated and subcloned into pBluescript II KS+
(Æ HindIII-SalI-F). In a third step, the HindIII-BglII fragment (HindIII site 16756 bp and BglII
site 17867) of the HindIII-SalI-F was replaced with a HindIII-e13GFP-BglII fragment. This
HindIII-e13GFP-BglII fragment was generated by sequential ligation of three PCR
products. The 5’ part was amplified from the pmag-MAG with the primers 5’MAG16760
and 3’13aBamHI (Æ 13-A), the middle part from the b-actin-GFP vector with 5’GFP-BamHI
and 3’GFP-SpeI (Æ EGFP), and the 3’ part (Æ 13-B) from the pmag-MAG with 5’13b-SpeI
and 3’13b-BglII-SacII. This HindIII-e13GFP-SalI fragment was cloned into the pmag-
MAGyHindIII fragment by replacing the wild-type HindIII-SalI fragment. The cloning of the
HindIII fragment into pmag-MAGyHindIII fragment-e13GFP resulted in the pmag-MAG-
e13GFP construct.
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Figure 10 Cloning of the pmag-MAG-e13GFP genomic expression construct.
top: wild-type pmag-MAG mouse MAG genomic clone (size 19 kb); bottom: pmag-MAG-e13GFP clone
containing the EGFP-encoding DNA sequence before the stop codon of mag exon 13; white boxes: non-
coding exons; black boxes: coding exons; green boxes: EGFP DNA sequence; F: DNA fragment.
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1.6.2. Cloning of the pmag-MAG-e12GFP Construct
The pmag-MAG-e12GFP genomic expression construct was generated by the insertion of
the GFP sequence before the stop codon within the mag exon 12 (Figure 11 and 18B: 3).
The HindIII fragment was excised from pmag-MAG and subcloned into the pSP70 cloning
vector (Æ  HindIII-F; pSP70 from Promega Corporation, Madison, USA). The SmaI
fragment (SmaI-F; restriction sites: 16395 and 16430 bp) within the HindIII fragment
contained the stop codon of exon 12 and was replaced by a SmaI-e12GFP-SmaI
fragment. This was amplified by PCR from the pbactin-EGFP vector with the primer
5’GFP-SmaI and 3’GFP-SmaI. The resulting HindIII-e12GFP fragment was cloned back
into pmag-MAG by replacing the wild-type HindIII fragment.
1.6.3. Cloning of the pmag-MAG-e12VSVG Construct
The pmag-MAG-e12VSVG genomic expression construct was generated by the same
approach as that used for pmag-MAG-e12GFP. However, the SmaI fragment was
replaced by a SmaI-e12VSVG-SmaI fragment. This was amplified by PCR from the cmv-
S-MAG-VSVG vector with the primers 5’VSVG-SmaI and 3’VSVG-SmaI.
1.6.4. Cloning of the pmag-MAG-e12VSVG-e13GFP Construct
The pmag-MAG-e12VSVG-e13GFP genomic expression construct was generated by
cloning of the HindIII-e12VSVG fragment (from the pmag-MAG-e12VSVG cloning) into the
pmag-MAGyHindIII fragment-e13GFP vector (from the pmag-MAG-e13GFP cloning)
(Figure 18B: 4).
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1.6.5. Cloning of the pmag-L-MAG-GFP Construct
The pmag-L-MAG-GFP expression construct was generated by a sequential cloning of the
pmag-MAG 5'-region upstream of the start codon within mag exon 4, the L-MAG-GFP
coding sequence and the pmag-MAG 3'-region downstream of the stop codon within mag
exon13 (Figure 12 and 18B: 5). In detail, the 3'-region of pmag-MAG was amplified by
PCR with 5'MAG-HindIII-NarI and 3'MAG-SalI and subcloned into pBluescript. In a second
step the 5'-region of pmag-MAG was amplified by PCR with 5'MAG-NotI and 3'MAG-NdeI-
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Figure 11 Cloning of the pmag-MAG-e12GFP genomic expression construct.
top: wild-type pmag-MAG mouse MAG genomic clone (size 19 kb); bottom: pmag-MAG-e12GFP clone
containing the EGFP encoding-DNA sequence before the stop codon of the mag exon 12; white boxes: non-
coding exons; black boxes: coding exons; green boxes: EGFP DNA sequence; F: DNA fragment.
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HindIII, and subcloned into pBluescript upstream of the 3'-region. In the last step, the L-
MAG-GFP open reading frame was amplified with 5'MAG-NdeI and 3'GFP-NarI from
pbactin-L-MAG-GFP and subcloned into pBluescript between the pmag-MAG 5'- and 3'-
region, resulting in the pmag-L-MAG-GFP construct.
PCR amplifications were carried out with the Expand High Fidelity PCR System (Roche,
Diagnostics GmbH, Mannheim, Germany). Recombinant plasmids were grown in
Escherichia coli DH5a cells. The orientations of all inserts were analysed by restriction
mapping and PCR analysis. Sequence analysis for verification of the correct sequence
was performed after all PCR amplification steps (Microsynth, Balgach, Switzerland).
Figure 12 Cloning of the pmag-L-MAG-GFP expression construct.
top: wild-type pmag-MAG mouse MAG genomic clone (size 19 kb); bottom: pmag-L-MAG-GFP clone having
the sequence between the start codon within exon 4 and the stop codon within exon 13 replaced by the L-
MAG-GFP coding sequence; white boxes: non-coding exons; black boxes: coding exons; green boxes:
EGFP DNA sequence; horizontal arrows: position of primers used for amplification and subcloning.
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2. Generation of Transgenic Mice
All three plasmids were treated with the restriction enzymes SalI and NotI to cut out the
inserts from the pBluescript cloning vector. The inserts were separated from the cloning
vectors by agarose gel electrophoresis using TAE buffer at 4°C. The DNAs were purified
from the agarose gel using the GENECLEAN SPIN Kit (Q-BIO gene/Bio 101) and were
further purified using the ELUTIP-D-COLUMN-SET (Schleicher & Schuell).
The transgenic mice were generated by Dr. Cécile Goujet-Zalc at the CNRS, UPS 44,
Villejuif, Paris, France. The linearized DNA was injected into C56BL/6+DBA2 oocytes.
About 1 pg of linearized DNA was injected per oocyte. For the pmag-MAG-e12GFP DNA,
153 oocytes were injected, of which 80 were implanted into 4 females. From the two born
mice, one was transgenic. For the pmag-MAG-e13GFP DNA, 220 oocytes were injected,
of which 160 were implanted into 4 females. From the 13 born mice, one was transgenic.
For the pmag-L-MAG-GFP DNA 210 oocytes were injected, of which 117 were implanted
into 7 females. From the 19 born mice, 7 were transgenic.
3. Cell Culture
The mouse oligodendrocyte precursor cell line Oli-neu (Jung et al., 1995; kindly provided
by Prof. J. Trotter, Heidelberg, Germany) was cultured in Sato medium containing 1%
horse serum, on poly-L-lysine coated culture dishes (Dulbecco’s modified Eagle’s Medium
DMEM from Gibco BRL/Invitrogen; medium additives and poly L-lysine from Sigma
Chemical CO., St. Louis, USA). Cells were plated at a density of 2500 to 6000 cells per
cm2. For differentiation, Oli-neu cells were cultured in the presence of 1 mM dbcAMP
(Sigma) for up to 12 days, as described previously (Jung et al. 1995). COS7 monkey
kidney cells (Gluzman 1981) were cultured in DMEM containing 10% foetal calf serum
(Gibco BRL/Invitrogen). COS7 cells were plated at a density of 2500 cells per cm2. Oli-neu
and COS7 cells were cultured at 37°C and 5% CO2. Transfection was carried out one day
after plating with Fugene6 (Roche Diagnostics GmbH, Mannheim, Germany), according to
the manufacturer’s protocol. Briefly, 3 ml Fugene6 were mixed with 100 ml DMEM (37°C)
before 2 mg plasmid DNA was added. After 30 minutes incubation at room temperature,
the transfection mix was added to the cells. Routinely, transfection efficiency of COS7
cells was about 50% and of Oli-neu cells about 40 to 50%.
4. Biochemical Methods
4.1. Generation and purification of an anti-L-MAG polyclonal antibody
To generate a polyclonal anti-L-MAG-specific polyclonal antibody, a 19-amino-acid peptide
corresponding to the mouse L-MAG-specific C-terminus: (KDSYTLTEELAEYAEIRVK) was
synthesized (nanoTOOLS, Denzlingen, Germany). The KLH-coupled peptide was used for
the immunization of two rabbits (NZW). For the immunisation, about 100 mg of the peptide
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were dissolved in 0.5 ml PBS and emulsified with an equal volume of Complete Freund’s
Adjuvant. About 20 sites of the back of the rabbit were injected subcutaneous with about
0.05 ml of emulsified antigen. The first and second boosts were done with the same
emulsion that was prepared with Incomplete Freund’s Adjuvant. The first boost was done
4 weeks after the first immunisation, while the second boost was done 3 weeks after the
first boost. The blood was taken 10 days after the second boost.
Affinity purification: the column (KDSYTLTEELAEYAEIRVK peptide coupled to matrix,
made by nanoTools) was washed for 1 h with PBS 0.05% Tween20 (PBST), for 30 min
with 100 mM glycine, pH 2.5, and again for 1 h with PBST. 500 ml rabbit serum (L1 12 Wo
1. 2.Boost 725716) were mixed with 1.5 ml PBST and applied five times to the column.
Unbound antibodies were washed away for 2 h with PBST. Specifically bound antibodies
were eluted with 100 mM glycine pH 2.5. 1.3-ml fractions of the eluate were collected in
1.5-ml tubes containing 150 ml 1 M Tris pH 8 on ice. The eluate was ultrafiltrated and
washed with PBS four times using Centricon YM-10 tubes for 45 min with 600 g at 4°C.
The following protein measurement revealed a total amount of about 100 mg antibodies
per 0,5 ml serum.
4.2. Immunocytochemistry
Cells were fixed in ice-cold paraformaldehyde (4%) for 10 min and rinsed twice with
Hank’s Balanced Salts (HBSS Gibco BRL/Invitrogen). Subsequently, cells were incubated
with blocking buffer (1% normal goat serum, 2% Teleostean gelatine (Sigma Chemicals
CO., St. Louis, USA) and 0.02% Triton X-100 (Fluka Chemie GmbH, Buchs, Switzerland)
in PBS) for 1 hour at room temperature and thereby permeabilized. Primary antibodies
were incubated in blocking buffer for 1 hour at room temperature. After rinsing with PBS,
the secondary antibodies were incubated in blocking buffer for 30 minutes. Cells were
rinsed three times with PBS and once with water and embedded with FluorSaveTM
Reagent (Calbiochem/Merck KGaA, Darmstadt, Germany). To specifically analyse the
extracellular localization of MAG and/or GFP, living cells were rinsed with Hank’s Balanced
Salts and incubated with 5% FCS/HBSS for 5 minutes at room temperature. The primary
antibodies were diluted in 5% FCS/HBSS and added to the cells for 10 minutes. Then the
cells were washed twice with HBSS for 5 minutes. After rinsing once with ice-cold HBSS,
the cells were fixed and processed as described above.
Primary antibodies used: polyclonal anti-L-MAG (own production; dilution 1: 3’000),
monoclonal anti-VSVG (kindly provided by Prof. A. Matus, FMI, Basel, Switzerland; dilution
1:50), polyclonal anti-MAG (kindly provided by Dr. A. Heape, Oulu, Finland; dilution
1:5000) and monoclonal anti-MAG (clone 513, Roche; dilution 1:500). Secondary
antibodies used: Cy2-, Cy3- or Cy5-coupled anti-rabbit or anti-mouse IgG antibodies
(Jackson ImmunoResearch Laboratories, Inc., West Grove, USA; dilution 1:500). A Zeiss
LSM510 confocal scanning microscope was used. An optical slice of 10 mm was used, if
no other value is stated.
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4.3. Myelin Purification
Fresh frozen brain samples (stored at -80°C) were thawed on ice and homogenized, with a
12- mm polytron, for about 10 seconds in 4 ml 250 mM sucrose/10 mM Hepes/2 mM
EGTA pH 7.4 (buffer A containing 1 mg/ml aprotinin, 2 mg/ml leupeptin, 1 mg/ml pepstatin
and 100 mg/ml PMSF) and cooled on ice for 5 min, before a second homogenisation step.
Non-homogenized tissue was pelleted by a centrifugation step with 2000 rpm for 3 min at
4°C, in a SW rotor. The supernatant was poured into a new 15-ml tube and adjusted to 3.7
ml with buffer A. Furthermore, 6.7 ml 2 M sucrose/10 mM Hepes/2 mM EGTA pH 7.4
(buffer C) was added and mixed by rotation for 5 min, to reach an sucrose concentration of
1.4 M. Thereafter the sucrose gradient was set up in a 14 ml Beckmann 14x95 mm
Polyallomer tube starting with 1.1 ml buffer C (2 M sucrose), followed by the 10 ml
homogenate (1.4 M sucrose), 2.2 ml buffer B (850 mM sucrose) and 0.75 ml buffer A (250
mM sucrose). The gradient was centrifuged for 20 h with 25’000 rpm at 4°C in a TST-41-
14 swing-out with a Centrikon T-1055 ultracentrifuge. The myelin and plasma membrane
phases, that accumulated in the 250 mM and 850 mM sucrose layers, respectively, were
transferred to a new 15-ml tube using a spatula or by a pipette. The samples were
homogenized once in 4 ml 10 mM Hepes/2 mM EGTA, pH 7.4, with the 12-mm polytron
and the volume was adjusted to 14 ml. These homogenates were pelleted at 25’000 rpm,
for 3 h at 4°C. The supernatant was discarded and the pellets were resuspended in 200 -
500 ml water by intensive vortexing using a yellow micropipette tip. The samples were
stored at -80°C.
4.4. Myelin Protein Quantification
Proteins were quantified by the Bradford assay. A protein dilution series was done,
creating a standard curve with 100, 200, 400, 600 and 800 ng/ml BSA (in water). Two
dilution series, with water, were done for each myelin sample to reach the following
dilutions: 1:5, 1:10, 1:20, 1:40 and 1:80. The Bradford reagent was diluted 1:5 in water
before 20 ml sample, or standard, were mixed with 200 ml diluted Bradford reagent. For the
creation of the linear standard curve, only those samples, which were within the linear
range (OD590nm relative to protein concentration), were included. The same criteria were
applied to the measured sample dilutions.
4.5. DIGs Isolation
600 mg membrane protein were suspended in a final volume of 1.5 ml containing 2%
CHAPS or TritonX-100, 10 mM Tris, 150 mM NaCl, 5 mM EDTA, pH 8, and 1 mM PMSF,
in a 2 ml tube, on ice in the cold-room. This was done by mixing together 600 mg protein
(dissolved in water) with 500 ml 6% CHAPS, or TritonX-100, in 3xTNE (30 mM Tris, 450
mM NaCl, 15 mM EDTA, pH 8), 15 ml 100mM PMSF and water up to 1,5 ml. Then the
samples were sonicated 2 times for 15 seconds on ice and incubated on a rotating wheel
at 4°C for 30 minutes. Afterwards, 1.5 ml 80% sucrose in 1xTNE were added to the 1.5 ml
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sample and mixed on the wheel for several minutes. To set up the gradient, 2 ml of the
sample (containing 400 mg protein) was poured into a 14-ml ultracentrifuge tube and
carefully overlaid with 5 ml 30% sucrose in 1xTNE and 5 ml 5% sucrose in 1xTNE. After
21 hrs of ultra centrifugation at 4°C and with 36'000 rpm, the 12 ml of the gradient were
collected, starting from the top, as 1-ml fractions with a syringe, and stored at -80°C.
4.6. SDS-PAGE and Western Blot Analysis
The gels were prepared according to Laemmli (Laemmli 1970) with some modifications.
The resolving gel contained 8, or 15% Acrylamide/Bis, 375 mM Tris, pH 8.8, and 0.1 %
SDS, and was polymerised with 50 ml 10 % APS and 5 ml Temed per 10 ml gel. The
stacking gel contained 5% Acrylamide/Bis, 125 mM Tris, pH 6.8, and 0.1 % SDS, and was
polymerised with 50 ml 10 % APS and 10 ml Temed per 10 ml gel. The 4x sample buffer
contained 40% glycerol, 8 % SDS, 0.5 % bromophenol blue, 80 mM Tris, pH 6.8, and 20%
b-mercaptoethanol (added just before use). The samples were denatured for 1 h at 37°C.
The separation buffer contained 25 mM Tris-base, 14.4 % glycine and 1 % SDS. The gels
were run overnight with 15 V. Before the protein transfer, the gels were washed once in
running buffer and once in transfer buffer (25 mM Tris-base, 14.4 % glycine). The proteins
were blotted to Immun-Blot PVDF Membrane (Biorad) using the Mini Trans-Blot
Electrophoretic Transfer Cell (Biorad) with 50 V for 90 minutes. The blots were washed
once in TBST (500 mM NaCl, 20 mM, Tris pH 7.5, and 0.05 % Tween20) before they were
blocked in 3 % TopBlock (JuroSupply GmbH) in TBST for 3 h at room temperature. The
primary antibody (see below) was incubated in 1 % TopBlock (TBST) overnight at 4°C.
The primary antibody was washed away 3 times in TBST for 20 minutes before the
secondary antibody (see below) was incubated in 1 % TopBlock (TBST) for 1 h at RT.
After washing three times with TBST and once with TBS, the protein bands were detected
with the ECL Western Blotting Detection Reagents (Amersham Pharmacia) and exposed
to Hyperfilm ECL (Amersham Pharmacia).
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4.7. Antibodies used for brain myelin Western blot analysis
Primary Antibodies Source Dilution
pAb L-MAG Own production (see section 3.1.) 500
pAb total MAG Anthony Heape, Oulu, Finland 5000
mAb MOG Richard Reynolds, London, England 2000
mAb MBP (Nr.1118099) Boeringer Mannheim, Germany 1000
pAb PLP/DM20 Klaus Nave, Goettingen, Germany 1000
pAb F3/contactin Jacky Trotter, Heidelberg, Germany 500
pAb Caspr Ori Peles/Ivo Spiegel, Rehovot, Israel 1000
Secondary Antibodies Source Dilution
goat-anti-rabbit IgG
peroxidase-coupled
Jackson Laboratories 5000
goat-anti-mouse IgG
peroxidase-coupled
Jackson Laboratories 5000
4.8. Densitometric quantification of Western blot results
For this quantification, equal amounts of myelin protein from the three MAL wild-type and
knock-out brain myelin samples were pooled for further Western blot analysis. In one
Western blot experiment, 5 different protein amounts from both pools were analysed in
parallel. For example, 5 mg (100%), 4 mg (80%), 3 mg (60%), 2 mg (40%) and 1 mg (20%)
myelin protein of each genotype (myelin protein pool) were separated on one gel, blotted
and analysed with the MBP antibody. Different amounts of protein were set to 100% for
the different antibodies used, to achieve an optimal relation between the analysed protein
amount and the signal intensity. Therefore, for the analysis of MBP, MAL, F3/contactin and
Caspr, 5 mg myelin proteins were set to 100%, whereas for the analysis of total MAG, L-
MAG, PLP und MOG 1 mg of myelin proteins were set to 100%. For the analysis of DIGs,
equal volumes of fraction number 6 from the three sucrose gradient fractions of both
genotypes were pooled and 37.5 ml and 5 ml were set as 100% for e.g. MBP and e.g. total
MAG, respectively. To quantify the resulting bands on the film after a short exposure, the
films were read with the AlphaInnotech Corporation MultiImage Cabinet and Camera and
analysed with the 'Spot Denso' module of the Chemilmager v5.5 software. The
background, estimated above the specific band in each lane, was subtracted. The signal
intensities were plotted against the amount of analyzed myelin protein and trend lines
through the values obtained for the wild-type and the knock-out samples were added. The
ratio of the slopes of the knock-out and the wild-type trend lines was the value that directly
reflected the amount of the analysed myelin protein in the MAL knock-out relative to the
wild-type. As an example, the analysis of the MBP levels in brain myelin is shown in Figure
13.
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Figure 13 Illustration of the method for the quantification of a Western blot analysis.
For the analysis of the MBP levels in the MAL knock-out relative to wild-type mouse brain myelin samples,
five different myelin protein amounts of both genotypes were analysed in a single Western blot analysis. The
signal intensities from the densitometric analysis of the bands were plotted against the corresponding
amount of analysed myelin protein. The calculated equations of the trendlines of both genotypes are
indicated in the top left of the graph. The ratio of their slopes indicates the MBP levels in the knock-out
samples relative to the wild-type samples (0.72; shown in the bottom right of the graph). The knock-out
myelin contains 72% of the MBP protein level observed in the wild-type myelin.
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Results
1. Characterization of the L- and S-MAG mRNA Levels in Oli-neu Cells
upon cyclicAMP Stimulation
To investigate the regulation of MAG transcription and its alternative splicing into L-and S-
MAG, we characterized which MAG isoforms are expressed by the oligodendroglial cell
line Oli-neu and whether they are differentially expressed upon cAMP stimulation. Oli-neu
cells grown in SATO medium proliferate and most of them have a bipolar shape. Grown
under the influence of cAMP Oli-neu cells stop their proliferation, develop a radial
morphology and up-regulate the expression of MAG (Jung et al. 1995). Analysis of the
endogenous MAG expression revealed that about 10% of the cells express MAG, whereas
upon stimulation with cAMP for 10 days about 35% of the cells express MAG. We
performed an RT-PCR analysis to determine the endogenous L- and S-MAG expression
levels in Oli-neu cells stimulated with cAMP for 0, 4, or 12 days (Figure 14). We used a
single set of primers, which amplified the exon 10 – 13 region (5’exon10 and 3’exon13-A)
leading to L- and S-MAG-specific products. The L-MAG-specific product was, due to the
absence of exon 12, 45 bp shorter than the exon 12 containing S-MAG product. Our
results show that in unstimulated Oli-neu cells, most of the primary transcripts were spliced
into the L-MAG variant, whereas stimulation with cAMP for 4 days revealed an up-
regulation of S-MAG. Stimulation for 12 days led to a strong expression of S-MAG as the
main expressed isoform, while L-MAG was expressed at a lower level.
size
marker
0 days
cAMP
4 days
cAMP
12 days
cAMP
GAPDH
S-MAG
L-MAG
500
400
300
400
300
Figure 14 Effects of cAMP treatment on L- and S-MAG mRNA levels in Oli-neu cells
Oli-neu cells were grown in Sato medium containing 1 mM dbcAMP (dibutyryl-cyclicAMP) for 0, 4 and 12
days. The alternative splicing of exon 12 was analysed by the amplification of the region of exon 10 to 13
using a single primer pair (5’exon10 and 3’exon13-A, see Figure 22A). This reaction produced a L-MAG
specific product of 338 bp and a S-MAG specific product of 383 bp in length. In unstimulated Oli-neu cells, L-
MAG was the predominant splice variant, whereas after 12 days of cAMP stimulation more S- than L-MAG
was detected. As an internal standard, GAPDH mRNA was amplified in parallel. The molecular standard
bands (M) are indicated in bp.
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2. MAG-GFP Fusion Proteins show normal Biosynthesis and Membrane
Incorporation
To determine whether cAMP treatment leads to an S-MAG up-regulation in all MAG-
expressing Oli-neu cells independently of their extent of morphological differentiation, we
investigated the isoform-specific protein expression at the cellular level. To differentiate
between the two isoforms, L- and S-MAG were expressed as individually tagged isoforms
under the control of their promoter and regulatory region. To first study the expression and
unimpaired export of these gene products, we generated cDNA expression constructs
encoding L- and S-MAG fusion proteins with N- or C-terminal tags (Figure 15).
b-actin
L-MAG (1878 bp)
b-actin
S-MAG (1746 bp)
b-actin
L-MAG (1878 bp) GFP (720 bp)
b-actin
GFP (720 bp)
1
2
3
4
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S-MAG (1746 bp) GFP (720 bp)
5
cmv
S-MAG (1746 bp) VSVG (36 bp)
6
b-actin
SPIgk
10
S-MAG (1689 bp)GFP (720 bp)  GS
b-actin
L-MAG (1821 bp)GFP (720 bp)  GSSPIgk
9
b-actin
L-MAG (1821 bp)GFP (720 bp)SPMAG
7
b-actin
S-MAG (1689 bp)GFP (720 bp)SPMAG
8
Figure 15 Schematic drawing of the different cDNA MAG fusion protein expression constructs
The promoters are drawn as a line: mouse b-actin-promoter (1-5, 7-10) and cmv-promoter (6). The open
boxes of the cDNA expression constructs represent the open reading-frames. In the b-actin-magSP-GFP-
MAG constructs (7,8), the GFP sequence is preceded by the MAG signal peptide sequence, whereas in the
b-actin-IgkSP-GFP-MAG constructs (9,10), the GFP sequence is preceded by the signal peptide sequence
of the Igk-light-chain k and the sequences of GFP and mature MAG are linked with a DNA stretch encoding
a linker peptide of five Glycine and Serine residues (GS).
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2.1. L-MAG-GFP: C-terminal GFP
All experiments described below for L-MAG were also carried out for S-MAG. Since the
expression patterns of the two isoforms were indistinguishable, the data for the S-MAG
isoform is not shown. The expression pattern of native L-MAG and L-MAG-GFP fusion
proteins were analysed in COS7 cells (Figure 16). Native L-MAG and L-MAG-GFP (Figure
15-1, 15-4) were both detected in the endoplasmic reticulum (ER), the Golgi apparatus
(Figure 16A,C arrow), and in the plasma membrane, including cellular processes (Figure
16A,C arrowhead). The incorporation of L-MAG and L-MAG-GFP into the plasma
membrane was confirmed by surface staining with a monoclonal antibody recognizing an
extracellular MAG epitope (Figure 16B,D). L-MAG-GFP showed a distinct expression
pattern when compared to soluble GFP in living cells. L-MAG-GFP was detected by its
autofluorescent signal mainly in the rER and Golgi (Figure 16F, arrow) and in the plasma
membrane (Figure 16F, arrowhead). Soluble GFP, however, was mainly detected in the
nuclear region (Figure 16E, asterisk) and in the surrounding ER (Figure 16E, arrow), but
not in the plasma membrane.
2.2. GFP-L- and GFP-S-MAG: N-terminal GFP
In parallel to the C-terminal fusion constructs, we also investigated whether fusion of GFP
to the extracellular N-terminus of MAG interferes with the latter's biosynthesis and
membrane incorporation. These constructs would have been required in case the C-
terminal fusion proteins proved to interfere with cell viability, as seen for other C-terminal
tagged GFP fusions (Caduff et al. 2001). To direct the GFP-MAG fusion protein into the
secretory pathway, as seen for native MAG, the MAG signal peptide (amino acids 1-26,
including 7 amino acids following the putative cleavage site) was cloned into the N-
terminus of GFP. The L-MAG open reading-frame (amino acids 20-627, missing its signal
peptide) was cloned into the C-terminus of GFP resulting in the bactin-magSP-GFP-L-
MAG construct (Figure 15-7, 15-8). COS7 cells transfected with this construct showed no
GFP autofluorescence, nor an anti-GFP or anti-MAG immunosignal (data not shown). In a
second expression construct, the MAG signal peptide sequence was replaced with that of
the mouse Igk light chain. Additionally, the GFP and the L-MAG sequences were linked
with a DNA sequence encoding a five-amino-acid linker peptide consisting of glycine and
serine residues. This bactin-IgkSP-GFP-gs-L-MAG construct (Figure 15-9, 15-10) led to
the expression of GFP-gs-L-MAG in COS7 cells (Figure 16G,H). The expression pattern
was comparable to that observed for L-MAG or L-MAG-GFP (Figure 16A-D). The
immunofluorescent surface staining was carried out using either anti-GFP polyclonal
(Figure 16H), or the anti-MAG monoclonal antibodies (data not shown). Both surface
stainings showed a homogeneous distribution of GFP-gs-L-MAG, comparable to L-MAG or
to that of L-MAG-GFP on the plasma membrane. The GFP autofluorescence signal
intensity in living COS7 cells expressing L-MAG-GFP or GFP-gs-L-MAG fusion proteins
were comparable. It is note worthy that paraformaldehyde fixation did not remarkably alter
the GFP autofluorescence intensity of L-MAG-GFP, while the GFP autofluorescence
intensity of GFP-gs-L-MAG, with GFP located extracellularly, was clearly reduced (data
not shown).
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2.3. Comparable Expression Patterns of L-MAG-GFP and S-MAG-VSVG in Oli-neu
Cells
To check the correct sorting and transport of the L- and S-MAG fusion proteins in
oligodendroglial cells, we analysed their expression pattern in Oli-neu cells (Figure 17).
The strong increase in L-, or S-MAG expression levels upon transfection of Oli-neu cells
revealed no obvious differences in their subcellular localization (Figure 17A,B). Both
Figure 16 L-MAG-GFP and GFP-gs-L-
MAG fusion protein expression patterns in
COS7 cells. Laser scanning confocal
microscopy was performed on COS7 cells
upon transient transfection. To analyse
membrane incorporation, living cells were
incubated with the anti-MAG monoclonal
antibody (B and D), or with a polyclonal
anti-GFP antibody (H) before fixation. A, B:
L-MAG-expressing cells were stained with
an anti-L-MAG antibody (A), recognizing
the intracellular C-terminus, or with anti-
MAG mAb 513 (B), recognizing an
extracellular epitope (“living staining”). C,
D: L-MAG-GFP expressing cells were
visualized by the GFP autofluorescence
(C) or living cells were incubated with the
MAG mAb 513 (D). E, F: Living cells
expressing soluble GFP (E) or L-MAG-GFP
(F) were visualized by the GFP
autofluorescence. The rather diffuse GFP
signal originates from the analysis of living
cells. G, H: GFP-gs-L-MAG-expressing
cells (GFP at the extracellular N-terminus
of MAG) were visualized by the GFP
autofluorescence (G), or living cells were
incubated with an anti-GFP antibody (H).
Arrows point to the ER and Golgi;
arrowheads point to cellular processes
(A,C) and plasma membrane (F); asterisks
mark the position of the nucleus. Note that
COS7 cells show a high degree of
heterogeneity within their cellular
morphology. MAG and its GFP fusion
proteins were detected in all cells
irrespective of their morphology. Bar: A, B:
35 mm, C: 38 mm, D: 36 mm, E: 44 mm, F:
26 mm, E, F: 49 mm.
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isoforms were detected in the rER and Golgi and the immunofluorescent surface staining
revealed a homogeneous distribution of L-MAG (Figure 17A) and S-MAG (Figure 17B) in
the Oli-neu plasma membrane, indicating that the two isoforms are not sorted differently in
these cells. L-MAG-GFP (Figure 17C,D) and the S-MAG-VSVG fusion proteins (Figure 15-
6 and 17E,F) revealed both a subcellular localization in the rER, Golgi (Figure 17C,E
arrow) and in the plasma membrane, including cellular processes (Figure 17C,E
arrowhead). Their immunofluorescent surface staining illustrated their incorporation into
the plasma membrane (Figure 17D and F, respectively). The overall expression patterns
of L-MAG-GFP and S-MAG-VSVG, and their distribution within the plasma membrane of
Oli-neu cells, are comparable to the patterns of native L- and S-MAG (Figure 17A and B,
respectively), indicating that the fusion of GFP to L-MAG and the fusion of the VSVG-tag
to S-MAG seem to influence neither their synthesis and transport, nor their distribution
within the plasma membrane in Oli-neu cells.
Figure 17 Expression pattern of L-MAG,
S-MAG, L-MAG-GFP and S-MAG-VSVG
in Oli-neu cells. Laser scanning confocal
microscopy was performed on Oli-neu
cells upon transient transfection. To
analyse membrane incorporation, living
cells were incubated with the anti-MAG
monoclonal antibody before fixation
(A,B,D,F). A,B: L-MAG- (A), or S-MAG-
(B) expressing cells were visualized by
the anti-MAG mAb before fixation. C,D: A
L-MAG-GFP-expressing cell was
visualized by its GFP autofluorescence
(C) or by the anti-MAG mAb
immunofluorescent signal (D) in an
optical slice of 4 mm at the position of its
nucleus. E,F: S-MAG-VSVG-expressing
cells were stained with an anti-VSVG
antibody (E), or visualized by the anti-
MAG mAb signal before fixation (F).
Arrows point to the ER and Golgi;
arrowheads point to the cellular
processes; asterisks mark the position of
the nucleus. Bar: A, B: 36 mm, C, D: 23
mm, 17 mm, F: 38 mm.
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3. Expression of Individually Tagged MAG Isoforms from Genomic
Expression Constructs
3.1 Expression of L- and S-MAG from a Genomic Mouse MAG Clone in Oli-neu Cells
We have used a mouse MAG gene cDNA clone to generate genomic expression
constructs encoding individually tagged L- and S-MAG isoforms. This genomic clone has a
length of about 19 kb and includes a 1.8 kb promoter sequence and all 13 exons: pmag-
MAG (Figure 18A, 18B-1).
Transfection of Oli-neu cells with pmag-MAG and cAMP stimulation led to a significant
increase of the MAG expression levels (Figure 19), showing that this genomic MAG clone
contains all promoter elements necessary to induce transcription. The percentage of Oli-
neu cells expressing surplus MAG following transfection with pmag-MAG and cAMP
stimulation was around 10%. The transfection efficiency of Oli-neu cells with the 22-kb
pmag-MAG plasmid DNA could not be determined, since not all transfected cells are
expected to express MAG protein from the transfected DNA due to the MAG-specific
Figure 18 Schematic drawing of the mouse MAG gene clone and the genomic MAG fusion protein
expression constructs
The genomic mouse MAG clone (A) has a length of 19 kb, including a 1.8 kb MAG promoter sequence. The
5’ non-coding exons are drawn in open boxes while the coding exons are drawn as black boxes. Restriction
sites for the subcloning into pBluescript KS- are indicated above the line: NotI (N) and SalI (S), whereas the
sites used for the insertions into exon 12 and 13 are indicated below the line: HindIII (H), BglII (B) and SmaI
(S, two neighbouring sites). The alternative splicing of exon 12 is indicated with continuous lines for its
inclusion, while its skipping is drawn with a dashed line. The positions of the start and stop codons are
indicated (arrows) for all genomic expression constructs (B): 1: pmag-MAG (wild-type), 2: pmag-MAG-
e13GFP, 3: pmag-MAG-e12GFP, 4: pmag-MAG-e12VSVG-e13GFP, 5: pmag-L-MAG-GFP. Abbreviations:
S: S-MAG C-terminus; L: L-MAG C-terminus; G: GFP; V: VSVG-tag.
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promoter. However, given that about 35% of the Oli-neu cells express endogenous MAG
(activate the MAG promoter) and the transfection efficiency of Oli-neu cells using the 5-kb
pbactin-EGFP plasmid DNA was around 40-50%, the 10% of Oli-neu cells expressing
MAG from the pmag-MAG plasmid are in the expected range. Thus, the transfection
efficiencies of Oli-neu cells with the 5-kb (pbactin-EGFP) or the 22-kb (pmag-MAG)
plasmid DNAs seem to be comparable.
L-MAG was mainly localized in bipolar cells shown by the specific anti-L-MAG antibody
(Figure 20B arrow), whereas immunofluorescence for both MAG isoforms revealed strong
staining also of the radial-shaped cells with many processes (Figure 20A arrow),
suggesting the expression of the S-MAG isoform. These results indicate that primary MAG
transcripts are synthesized from pmag-MAG and are alternatively spliced into L- and S-
MAG specific mRNAs.
3.2. Expression of L-MAG-GFP in Bipolar Oli-neu Cells from pmag-MAG-e13GFP
To generate a single genomic expression construct that encodes L-MAG-GFP and
untagged S-MAG, we inserted the GFP DNA sequence directly into the L-MAG specific C-
terminus-encoding exon 13 of pmag-MAG (Figure 18B-1). This pmag-MAG-e13GFP
(Figure 18B-2, for the cloning strategy see Figure 10) construct was reintroduced into Oli-
neu cells to analyse the alternative splicing of primary transcripts originating from this
construct and the corresponding expression of the L-MAG-GFP and S-MAG protein. Both,
tagged L-MAG-GFP and untagged S-MAG were expressed from this construct (Figure
20C,D). The expression of L-MAG-GFP could be shown by the overlapping anti-L-MAG
immunofluorescense (Figure 20C main picture), GFP-autofluorescence (Figure 20D) and
anti-MAG immunofluorescent signal (not shown). The L-MAG-GFP-expressing cells
always possessed few processes, independently of the cAMP stimulation time. In contrast,
the expression of untagged S-MAG was detected in cells with a radial shape following
cAMP stimulation (Figure 20C,D inset). Unexpectedly, the number of L-MAG-GFP
Figure 19 Expression of MAG from the wild-type genomic mouse MAG clone pmag-MAG in Oli-neu cells
Laser scanning confocal microscopy was performed on Oli-neu cells upon transient transfection with the
wild-type genomic mouse MAG plasmid DNA. pmag-MAG-transfected (A) and -untransfected (B) cells after 3
days cAMP treatment were stained with anti-MAG mAb. Transfected cells show a much higher MAG
expression compared to the endogenous expression in untransfected cells. Bar: A: 46 mm, B: 59 mm.
A B
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expressing cells following transient transfection with the pmag-MAG-e13GFP construct
was much lower (beneath 1%) compared to number of cells expressing surplus L-MAG
following transfection with the wild-type pmag-MAG construct.
Figure 20 Expression of individually tagged MAG isoforms from genomic constructs in Oli-neu cells
Laser scanning confocal microscopy was performed on Oli-neu cells upon transient transfection with the
genomic expression constructs. A,B: pmag-MAG-transfected cells after 6 days cAMP treatment were stained
with anti-MAG mAb (A) recognizing both isoforms and anti-L-MAG specific antibody (B). C,D: pmag-MAG-
e13GFP (GFP for L-MAG) transfected, but unstimulated cells were detected with anti-L-MAG antibody (C) or
by its GFP autofluorescence (D); the top right inset within C, D: 6 days cAMP-treated cells were stained with
anti-MAG mAb (C, inset), or detected by its GFP autofluorescence (D, inset). E,F: pmag-MAG-e12GFP (GFP
for S-MAG) transfected cells after 6 days cAMP treatment were stained with anti-MAG mAb (E) or detected
by its GFP autofluorescence (F). The position of the nucleus is marked by an asterisk (C, D). Bar: A, B: 97
mm, C, D: 21 mm, E, F: 61 mm.
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The expression of untagged S-MAG was analysed at the mRNA level. RT-PCR and
subsequent sequence analysis showed exon 12 inclusion in stimulated cells, confirming
that splicing for S-MAG occurred normally. In conclusion, the pmag-MAG-e13GFP
construct demonstrated that L-MAG is predominantly expressed in bipolar cells,
independently of the cAMP stimulation.
3.3. Expression of S-MAG-GFP, or S-MAG-VSVG in Radial Oli-neu Cells from pmag-
MAG-e12GFP, or -e12VSVG
To characterize specific S-MAG expression, GFP was introduced into the S-MAG-specific
exon 12 of pmag-MAG (Figure 18B-1). The analysis of this pmag-MAG-e12GFP construct
(Figure 18B-3, for the cloning strategy see Figure 11) in Oli-neu cells illustrated S-MAG-
GFP expression exclusively in cells with a radial shape and many processes (Figure
20E,F). Immunofluorescence (Figure 20E) and GFP autofluorescence (Figure 20F) shows
that S-MAG-GFP is evenly distributed within the plasma membrane of the Oli-neu cells.
The number of S-MAG-GFP-expressing cells was strongly increased with prolonged cAMP
stimulation, whereas, in untreated cells, S-MAG-GFP-expressing cells were not detected.
The overall number of S-MAG-GFP expressing cells was comparable to the number of
cells expressing surplus MAG following transfection with the wild-type pmag-MAG
construct. To detect, whether L-MAG is alternatively spliced from the pmag-MAG-e12GFP
construct, immunofluorescent analysis for L-MAG was performed. For this, we used the L-
MAG specific antibody recognizing the C-terminal epitope lying within exon 13: no specific
immunosignal could be detected (data not shown). RT-PCR and subsequent sequence
analysis showed that the S-MAG-GFP-encoding mRNA contained all exons, including
exon 13, correctly joined together. The L-MAG mRNA originating from the pmag-MAG-
e12GFP construct could not be analysed, because the transcript derived from the
construct cannot be distinguished specifically from the endogenous one.
Our analysis showed that the insertion of the GFP DNA sequence (720 base pairs) into
exon 12 (45 bp) did not disturb the generation and regulation of mRNAs including exon 12
and 13, but unexpectedly disturbed the skipping of the elongated exon 12. To check
whether this is due to the large size of GFP, we have chosen the shorter VSVG-tag (36
bp). Analysis of the pmag-MAG-e12VSVG construct in Oli-neu cells, however, showed the
same characteristics as the pmag-MAG-e12GFP construct, namely the expression of S-
MAG-VSVG exclusively in radial Oli-neu cells following cAMP treatment, and the absence
of untagged L-MAG expression (data not shown). These results from the pmag-MAG-
e12GFP and the pmag-MAG-e12VSVG constructs indicate that the length of the DNA
inserted in front of the exon 12 stop codon is not critical, but rather the insertion per se
seems to disturb the joining of exon 11 to exon 13 necessary for L-MAG expression.
However, both constructs revealed that S-MAG is exclusively expressed in cells with a
radial morphology following cAMP treatment. In addition, the number of cells expressing
either GFP-, or VSVG-tagged S-MAG is comparable to that observed using the wild-type
pmag-MAG construct.
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3.4. Simultaneous Expression of S-MAG-VSVG and ‘Soluble GFP’ from the Genomic
Expression Construct pmag-MAG-e12VSVG-e13GFP
The construction of a genomic expression vector containing the VSVG-tag in exon 12
(fused to S-MAG) together with GFP in exon 13 (fused to L-MAG) revealed more aspects
of the impaired alternative splicing of tagged exon 12.
3.4.1. The Protein Expression Pattern of S-MAG-VSVG and L-MAG-GFP within Single
Cells
The analysis of the pmag-MAG-e12VSVG-e13GFP construct (Figure 18B-4) in Oli-neu
cells displayed both an anti-VSVG signal (Figure 21A) and an GFP autofluorescent signal
(Figure 21B). The GFP signal (corresponding to L-MAG-GFP) was detected in cells with a
bipolar shape, whereas the VSVG signal (corresponding to S-MAG-VSVG) was detected
in more radial cells. Cells with an intermediate process number were positive for both GFP
and VSVG (Figure 21). The subcellular distribution of the VSVG signal (Figure 21A) was
comparable to that of MAG (Figure 20A,B), or S-MAG-GFP (Figure 20E,F). This pattern
includes the rER (Figure 21A, arrow), plasma membrane and processes (Figure 21A
arrowheads), but clearly excludes the nuclear region (Figure 21A, asterisk). The GFP
signal, however, resembles that of soluble GFP, namely localization in the ER (Figure
21B, arrow), cytoplasm and in the nuclear region (Figure 21B asterisk), but excluding the
plasma membrane processes. This pattern was clearly different to the one seen for L-
MAG-GFP in Oli-neu cells transfected either with the bactin-L-MAG-GFP (Figure 17C,D),
or pmag-MAG-e13GFP constructs (Figure 20C,D).
Figure 21 Expression of individually tagged MAG isoforms from a single genomic construct in Oli-neu cells
Laser scanning confocal microscopy was performed on Oli-neu cells upon transient transfection with the
pmag-MAG-e12VSVG-e13GFP (VSVG for S-MAG, GFP for L-MAG) genomic expression construct. A,B:
transfected cells were treated for 4 days with cAMP and were stained with anti-VSVG antibody (A) or
detected by its GFP autofluorescence (B). Note that the GFP autofluorescent signal in B mainly highlights
the nucleus (asterisk) and the ER (arrow), whereas the anti-VSVG signal detects exclusively the rER, Golgi
(arrow) and plasma membrane and cellular processes (arrowhead). The position of the nucleus is marked by
an asterisk (A, B). Bar: A, B: 32 mm.
A B
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In addition, the GFP-positive cells, transfected with the pmag-MAG-e12VSVG-e13GFP
construct, did not show any L-MAG immunosignal, which is in line with our previous
observations with the S-MAG-GFP, or S-MAG-VSVG constructs. The number of GFP-, or
VSVG-positive cells was comparable to the number observed for the expression of surplus
MAG from the wild-type pmag-MAG construct. Taken together, the insertion of the VSVG
tag-encoding DNA into exon 12 does not seem to disturb the expression of S-MAG-VSVG,
but results in a disturbed skipping of exon 12 leading to the translation of GFP instead of
L-MAG-GFP. However, the pmag-MAG-e12VSVG-e13GFP construct revealed the
expression of GFP (skipped exon 12) in bipolar cells and of S-MAG-VSVG (including exon
12) in radial Oli-neu cells, indicating that the regulation of L-/S-MAG mRNA splicing
occurred correctly.
3.4.2. L-MAG-GFP and S-MAG-VSVG mRNAs Show Normal Length and Regulation
To obtain further insight into the regulation and splicing of L- and S-MAG-specific
transcripts from the pmag-MAG-e12VSVG-e13GFP construct, we performed a RT-PCR
analysis. The L- and S-MAG mRNA levels were specifically amplified by the use of the L-
and S-MAG-specific forward primers 5’exon11/13 and 5’exon12, respectively (Figure 22A).
We compared the endogenous L- and S-MAG mRNA levels with those from pmag-MAG-
and pmag-MAG-e12VSVG-e13GFP-transfected Oli-neu cells. The cells were stimulated
with cAMP for 6 days to achieve the co-expression of L- and S-MAG mRNAs. Both
constructs elevated the L- and S-MAG mRNA levels (Figure 22B1,B2: lane 2,3) in a similar
manner compared to the endogenous levels (Figure 22B1,B2: lane 1). The S-MAG-VSVG
product (Figure 22B1: lane 3) had a correct length and no product of false length was
amplified, showing the correct joining of exon 12 to exon 13 in the 3’ non-coding region of
the S-MAG-VSVG mRNA. The L-MAG-GFP-specific product (Figure 22B2: lane 3) also
showed the expected length and no product of false length was detected. This L-MAG-
GFP-specific product represents mRNAs having exon 11 joined to exon 13. To investigate
the existence of a full-length L-MAG-GFP mRNA from the pmag-MAG-e12VSVG-e13GFP
construct, we amplified the coding sequence by RT-PCR. The unique SmaI restriction site
in exon 12 was used to digest all the products containing exon 12. This digest revealed
that all products contained exon 12 and none encoded L-MAG-GFP. The same
experiment carried out with pmag-MAG revealed L- and S-MAG-specific full-length
products (data not shown). In summary, the specific amplification of mRNAs having exon
11 joined to exon 13 did not confirm the expected disturbed skipping of exon 12 for
transcripts from pmag-MAG-e12VSVG-e13GFP. However, the absence of full-length
mRNAs without exon 12 still underlines the possibility that the skipping of exon 12
containing VSVG generates a fragmented mRNA encoding GFP instead of L-MAG-GFP.
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3.5. Constitutive Expression of L-MAG-GFP from the Genomic Expression Construct
pmag-L-MAG-GFP
For a constitutive expression of L-MAG-GFP under the control of the endogenous mag
promoter, we have replaced the region of pmag-MAG between its start codon (within exon
4) and the second stop codon (within exon 13), with the open reading-frame of L-MAG-
GFP (Figure 18B-5). This pmag-L-MAG-GFP construct was reintroduced into Oli-neu cells
to analyse the expression of the L-MAG-GFP protein. Upon cAMP stimulation, L-MAG-
GFP was also expressed in rather differentiated cells containing various processes (Figure
23A,B). This shows that the L-MAG-GFP is constitutively expressed under the control of
the mag promoter and is no longer restricted to the less differentiated bipolar cells due to
the absence of the alternative splicing. The subcellular distribution of the L-MAG-GFP
fusion protein, detected by the anti-L-MAG signal (Figure 23A) and the GFP-
autofluorescence signal (Figure 23B), was restricted to the rER and Golgi (arrow) and the
various cellular processes, whereas the nuclear region was negative (arrowhead). This
pattern is comparable to that of L-MAG-GFP expressed from the bactin-L-MAG-GFP
(Figure 17C,D) or the pmag-MAG-e13GFP (Figure 20C,D) expression constructs.
Figure 22 RT-PCR analysis of L- and S-MAG mRNA levels transcribed from the pmag-MAG-e12VSVG-
e13GFP genomic construct in cAMP treated Oli-neu cells.
A: Schematic drawing spanning the mouse MAG genomic sequence from exon 10 to 13. The colored boxes
in exon 12 and 13 represent the VSVG-tag (36 bp) and the GFP sequence (720 bp). Below the primers are
shown in respect to their position. The primer 5’exon11/13 was designed to hybridise with the exon 11/13
junction. B1, B2: Oli-neu cells were grown in Sato medium containing 1 mM cAMP for 6 days (B1,B2: lane 1)
and were transfected with wild-type pmag-MAG (B1,B2: lane 2) or with pmag-MAG-e12VSVG-e13GFP
(B1,B2: lane 3). B1: The primer pair 5’exon12 x 3’exon13-B amplified specifically S-MAG mRNAs due to the
position of the 5’ primer in exon 12. The corresponding wild-type S-MAG products have a size of 409 bp,
while the S-MAG-VSVG products have a size of 1165 bp, due to the additional 36 bp of the VSVG sequence
in exon 12 and the 720 bp of the GFP sequence in exon 13. B2: The primer pair 5’exon11/13 x 3’exon13-B
amplified specifically L-MAG products due to the hybridisation of the 5’ primer with the exon 11/13 junction.
The corresponding wild-type L-MAG products have a size of 377 bp, while the L-MAG-GFP products have a
size of 1097 bp, due to the additional 720 bp of the GFP sequence. The molecular standard bands (M) are
indicated in bp.
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However, the number of L-MAG-GFP-expressing cells was relatively small (beneath 1%),
comparable to the situation observed for the expression of L-MAG-GFP from the genomic
expression construct pmag-MAG-e13GFP.
In summary the analysis of the genomic expression constructs encoding individually
tagged MAG isoforms revealed that L-MAG is the predominant isoform in unstimulated,
bipolar Oli-neu cells, whereas S-MAG expression is induced following cAMP stimulation in
radial-shaped Oli-neu cells. Furthermore, the insertion of the GFP, or VSVG DNA
sequences into the S-MAG-specific exon 12 leads to expression of the corresponding S-
MAG fusion protein in a normally regulated manner and with a normal expression level.
However, these insertions into exon 12 did affect the skipping of exon 12 for the
expression of L-MAG. On the other hand, the insertion of the GFP DNA sequence into the
L-MAG specific exon 13 led to expression of both isoforms in the expected regulated
manner, but the number of L-MAG-GFP expressing cells was too small compared to those
expressing L-MAG from the wild-type construct. A similarly small number of L-MAG-GFP-
expressing cells could be observed when employing the pmag-L-MAG-GFP construct.
Figure 23 Constitutive expression of L-MAG-GFP driven by the mag promoter in Oli-neu cells
Laser scanning confocal microscopy was performed on Oli-neu cells upon transient transfection with the
pmag-L-MAG-GFP genomic expression construct. Transfected cells were treated for 6 days with cAMP and
were stained with anti-L-MAG antibody (A) or detected by its GFP autofluorescence (B). Note the relatively
high degree of morphological differentiation of this L-MAG-GFP-positive cell. The position of the nucleus is
marked by an arrowhead, and the position of the rER and Golgi is marked by an arrow. Bar: A, B: 43 mm.
BA
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4. Generation of MAG-GFP Transgenic Mouse Lines
For a better investigation of the differential expression and localization of L- and S-MAG
during myelin formation and maintenance and in mouse models for demyelinating
neuropathies, we have generated three different transgenic mouse lines. We have used
the following three constructs:
• pmag-MAG-e13GFP line (expression of L-MAG-GFP and untagged S-MAG under the
control of the mag promoter and the regulatory process of alternative splicing)
• pmag-MAG-e12GFP line (expression of S-MAG-GFP under the control of the mag
promoter and the regulatory process of alternative splicing)
• pmag-L-MAG-GFP line (constitutive expression of L-MAG-GFP under the control of the
mag promoter in the absence of the regulatory process of alternative splicing)
The tail biopsy PCR analysis of the born animals that had developed out of the injected
oocytes, revealed that one animal had incorporated the pmag-MAG-e13GFP DNA, one
animal had incorporated the pmag-MAG-e12GFP DNA, and 7 animals had incorporated
the pmag-L-MAG-GFP DNA into their genome. The sex and the date of birth of these
founder animals are given in Table 2.
Construct: Founder
Number
Sex Date of
Birth
pmag-MAG-e13GFP 6 male 29/07/02
pmag-MAG-e12GFP 2 male 28/07/02
pmag-L-MAG-GFP 1 female 29/07/02
pmag-L-MAG-GFP 2 male 29/07/02
pmag-L-MAG-GFP 3 female 29/07/02
pmag-L-MAG-GFP 6 male 29/07/02
pmag-L-MAG-GFP 9 male 29/07/02
pmag-L-MAG-GFP 12 female 29/07/02
pmag-L-MAG-GFP 15 female 29/07/02
Table 2 List of founder animals that contain either the pmag-MAG-e13GFP, or the pmag-MAG-e12GFP, or
the pmag-L-MAG-GFP transgenes.
4.1. The pmag-MAG-e13GFP Mouse Line
To analyse the L-MAG-GFP expression of the single founder animal, we performed
immunohistochemistry on a tail biopsy that was taken at the age of one month. These tail
peripheral nerves gave neither a GFP autofluorescence signal, nor an anti-GFP signal.
The anti-MAG staining produced a periaxonal signal comparable to that observed in wild-
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type animals. The L-MAG expression in the peripheral nervous system reaches its highest
level around postnatal day 10, whereas at the age of one month, only background levels of
L-MAG can be expected. The absence of the GFP and the anti-GFP signals might
therefore result out of a predominant splicing of the primary MAG transcripts into the S-
MAG splice variant.
The analysis of the L-MAG-GFP expression in the central nervous system has not been
possible until now, because the founder animal has not yet passed the transgene on to the
F1 animals (46 animals have been analyzed so far).
4.2. The pmag-MAG-e12GFP Mouse Line
4.2.1. The pmag-MAG-e12GFP Peripheral Myelin
To analyse the S-MAG-GFP expression of the single founder animal, we performed
immunohistochemistry on a tail biopsy that was taken at the age of one month. In these
peripheral nerves of the tail, a strong GFP autofluorescence, together with an overlapping
anti-GFP signal was detected (Figure 24A,B).
S-MAG-GFP
mergeanti-P0
anti-GFP
A
DC
B
Figure 24 Analysis of the S-MAG-GFP expression in a tail biopsy from the pmag-MAG-e12GFP mouse
Laser scanning confocal microscopy was performed on a tail biopsy. The S-MAG-GFP expression was
visualized by the GFP autofluorescent signal (green) and an anti-GFP signal (red). The anti-P0 signal (blue)
depicts the compact myelin. Note the periaxonal localization of S-MAG-GFP (arrow, green and red signal),
whereas P0 (blue) is localized in the compact myelin sheath. S-MAG-GFP expression in the region of
'compact myelin' together with low levels of P0 probably reflects Schmidt-Lanterman incisures (arrowheads).
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Interestingly, S-MAG-GFP was localized within the periaxonal region, where MAG is
known to be expressed. This expression pattern was clearly different from the pattern of
the compact myelin protein zero (P0; Figure 24C). The expression pattern of the S-MAG-
GFP shows that the C-terminal fusion of GFP to S-MAG does not affect its targeted
trafficking and incorporation into the periaxonal membrane of peripheral myelin.
To analyse the S-MAG-GFP expression in the mouse sciatic nerve, we prepared teased
fibres from a 2-month-old pmag-MAG-e12GFP transgenic mouse. The S-MAG-GFP was
directly visualized by its GFP autofluorescent signal. Preliminary data showed a S-MAG-
GFP localization in the periaxonal region (Figure 25, arrow), but only in a subset of all
fibres. Interestingly, the expected localization in the paranodal region was almost
undetectable.
Figure 25 Analysis of S-MAG-GFP in a teased fibre preparation from pmag-MAG-e12GFP sciatic nerve
Laser scanning confocal microscopy was performed. The periaxonal signal is not detectable in all fibres, but
is clearly visible in a subset of all fibres (arrow). The GFP signal of S-MAG-GFP often highlights ring-, or
spiral-like structures (arrowhead). A typical V-shaped Schmidt-Lanterman incisure is indicated in C by a
double arrowhead.
A
C
B
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Furthermore, S-MAG-GFP was detected in many spiral, or ring-like structures (Figure 25,
arrowheads) that are at least in some cases localized on the myelin sheath surface (Figure
25B, arrowhead on the left side). These ring-like structures were also detected in wild-type
preparations by immunohistochemistry (data not shown). It was not evident whether these
structures reflect Schmidt-Lanterman incisures, or some other as yet non-characterized
MAG expression domain. However, S-MAG-GFP was also detected in typically V-shaped
Schmidt-Lanterman incisures (Figure 25C, double arrowhead).
4.2.2. The pmag-MAG-e12GFP Central Myelin
To characterize the overall MAG and L-MAG levels in the brain of pmag-MAG-e12GFP
transgenic mice, we isolated the myelin fraction from two one-month-old transgenic F1
animals and compared its levels with those of two age-matched wild-type animals (Figure
25). The hybridisation with the anti-MAG antibody showed the higher molecular weight of
the S-MAG-GFP fusion protein relative to wild-type L- and S-MAG. The level of untagged
MAG was slightly reduced in the transgenic animals, but the transgenic animals express
the additional S-MAG-GFP fusion protein and might, therefore, express overall MAG levels
comparable to those of wild-type animals. Interestingly, the L-MAG specific analysis
showed no visible difference between transgenic and wild-type animals.
anti-t-MAG
tgtg wt wt tg tg wt wt
anti-L-MAG
S-MAG-GFP
L-/S-MAG
anti-GFP
tgtg wt wt
S-MAG-GFP
124 kDa
83 kDa
206 kDa
124 kDa
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206 kDa
Figure 26 Western blot analysis of MAG isoforms in brain myelin from pmag-MAG-e12GFP mice
Brain myelin was isolated from one-month-old animals. Equal amounts of brain myelin from two transgenic
and two wild-type animals were analysed using the t-MAG (total MAG) antibody that recognizes a common
epitope of L- and S-MAG, the L-MAG specific antibody and the GFP-specific antibody. The S-MAG-GFP
fusion protein expression is shown by the two bands detected by the t-MAG antibody and by the band
detected by the anti-GFP antibody. The fusion protein has a higher molecular weight due to the additional 27
kDa from GFP. The wild-type MAG levels in the transgenic mice are slightly decreased, while their L-MAG
levels are comparable to those observed in the wild-type mice; t-MAG: total MAG.
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To analyse the S-MAG-GFP expression pattern in the brain, we performed confocal
colocalization studies on a one-month-old transgenic F1 animal (Figure 27). The S-MAG-
GFP autofluorescence signal clearly highlighted the myelinated fibre tracts of the
cerebellum, the corpus callosum, the striatum, the hippocampus and the optic nerve.
The comparison of the anti-L-MAG (red) and anti-MAG (blue) staining with the S-MAG-
GFP autofluorescence signal (green) revealed that the two MAG isoforms are differentially
expressed within different brain structures.
Two neighbouring fibre tracts within the striatum (Striatum medullaris thalami) show a
preferential expression of either L-MAG, or S-MAG (Figure 27A). The overall MAG levels
were comparable in both fibre tracts. The long projecting fibres of the corpus callosum
predominantly expressed S-MAG-GFP, whereas the underlying fibres were surrounded by
a myelin sheath containing a higher amount of L-MAG (Figure 27B).
Taken together, the pmag-MAG-e12GFP transgenic animals seem to express comparable
total MAG and L-MAG levels and revealed a differential expression of L- and S-MAG in
distinct fibre tracts in the striatum and a prominent S-MAG expression in the corpus
callosum.
4.3. The pmag-L-MAG-GFP Mouse Line
To analyse the L-MAG-GFP expression of the founder animals, we performed
immunohistochemistry on tail biopsies taken from the founder animals (1, 2, 3 and 6) at
the age of one month. Due to the used L-MAG-GFP open reading-frame, alternative
splicing is excluded and we expect constitutive expression of L-MAG-GFP, in contrast to
the pmag-MAG-e13GFP line that includes alternative splicing. However, also in these tail
peripheral nerves, neither a GFP autofluorescence signal, nor an anti-GFP signal was
detectable. The anti-MAG staining produced a periaxonal signal comparable to that
observed in wild-type animals.
The analysis of the GFP autofluorescent signal in brain sections of transgenic F1 animals
from two founders (2 and 3) also revealed no L-MAG-GFP expression.
Six of the seven founders passed the transgene to the F1 animals. The founder that did
not pass the transgene to F1 generation was founder 6.
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Figure 27 Localization of S-MAG-GFP and L-MAG in brain sections from a pmag-MAG-e12GFP mouse
Laser scanning confocal microscopy was performed on sagithal sections from one-month-old animals. S-
MAG-GFP was analysed by the GFP autofluorescence (green) and immunohistochemistry for L-MAG
(red) and total MAG (blue) was carried out. Depicted brain regions: Striatum (stria medullaris thalami; A)
and Corpus callosum (B). A: The fibre tract I in the Striatum expresses more S-MAG-GFP (green) and
the fibre tract II expresses more L-MAG (red), while the total MAG expression (blue) in these two tracts is
comparable. B: High levels of S-MAG-GFP are detected in the Corpus callusom, while L-MAG seems to
be expressed in a comparable manner in the Corpus callosum and the underlying brain region.
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5. MAG Becomes Associated with Rafts in Adult CNS Myelin
Membranes
The biological function of lipid-raft microdomains (DIGs) is ascribed to a variety of
biological processes, including sorting, trafficking and signalling. Investigations of their
relevance for myelin formation and maintenance have started only recently. We have
analysed the composition of DIGs isolated from young (postnatal day 9), adult (3 months)
and old (2 years) rodent brain myelin and adult human brain myelin.
5.1. MAG is not Raft-associated during Mouse CNS Myelin Formation
The analysis of DIGs isolated from postnatal day 9 mouse brain myelin revealed that the
typical raft protein MAL was highly enriched in rafts (Figure 28A). The paranodal GPI-
linked protein, F3/contactin, was found to be partially DIGs-associated. In contrast, we
found that the two non-compact myelin proteins, L-MAG and MOG, were not recruited to
DIGs during myelin formation. The analysis of DIGs isolated from the plasma membrane
fraction of postnatal day 9 mouse brain revealed that neither F3/contactin, nor L-MAG
were DIGs-associated (Figure 28B).
5.2. MAG Is Partially Raft-associated in Adult Mouse CNS Myelin
In adult rat (Figure 29A) and mouse (Figure 32) brain myelin, the MAL protein is
exclusively localized in DIGs. In contrast to the situation during active myelination, in the
adult CNS myelin, both MAG isoforms are partially incorporated into TritonX-100-insoluble
(Figure 29A) and CHAPS-insoluble (Figure 32) DIGs. In two-years-old mouse brain myelin,
total MAG is still incorporated to some extent into TritonX-100-insoluble DIGs (Figure
29B), but L-MAG is almost undetectable in the DIGs fraction. This is probably a matter of
detection limits, because L-MAG seems to be poorly expressed in two-years-old mouse
brain. The additional analysis of PLP and its splice variant DM20 in the two-years-old
mouse brain myelin revealed that PLP is predominantly DIGs associated, whereas DM20
is almost exclusively incorporated into DIGs (Figure 29B, arrow).
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5.3. MAG is Almost Exclusively Raft-associated in the Adult Human Brain
In the old adult human brain myelin, we found a completely different situation for L-MAG
(Figure 29C). L-MAG was found to be almost exclusively localized in DIGs. The same
analysis using an antibody that recognizes both MAG isoforms, revealed the same
distribution (not shown). The additional analysis of MBP showed that the MBP isoforms
were partially DIGs-associated.
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L-MAG
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MAL
A: Mouse P9 Brain Compact Myelin TX-100 DIGs
DIGs Soluble
F4 F5 F6 F7 F8 F9 F10 F11 F12
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L-MAG
B: Mouse P9 Brain Plasma MembraneTX-100 DIGs
DIGs Soluble
F4 F5 F6 F7 F8 F9 F10 F11 F12
Figure 28 L-MAG is not associated with TritonX-100 resistant DIGs (lipid-rafts) from P9 mouse brain
myelin
Myelin, or plasma membrane preparations were incubated for 30 minutes with 1% TritonX-100 at 4°C.
The samples were adjusted to 40% sucrose, and 2 ml containing 400 mg protein were transferred to SW
41 centrifuge tubes; overlaid with 30% and 5% sucrose (5 ml each), and centrifuged for 21 hours at
36'000 rpm. Twelve 1 ml fractions (F1-F12) were collected from the top. Equal volumes of the fractions 4
to 12 were analysed by Western blotting. Detergent-insoluble complexes DIGs float to a low density on
the sucrose gradient, due to the low density of the lipids associated with the proteins (F5 and F6).
Detergent-soluble proteins stay in the bottom fractions F11 and F12. A: F3/contactin and MAL, but not L-
MAG and MOG are incorporated into DIGs in compact brain myelin isolated from postnatal day 9 mice. B:
F3/contactin and L-MAG are not found in DIGs of brain plasma membranes isolated from postnatal day 9
mice.
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Figure 29 MAG is associated with TritonX-100-resistant DIGs (lipid-rafts) from adult rodent and human brain
myelin
Detergent extraction and sucrose gradient ultracentrifugation were performed as described for Figure 15. A:
MAL is fully and L- and S-MAG are partially incorporated into DIGs in brain compact myelin isolated from 3-
months-old rat brain. B: MAG is only to a small extent, while PLP/DM20 is to at least 50%, incorporated into
DIGs in brain myelin isolated from 2-years-old mouse brain. Note that the DM20 isoform (arrow) is found
almost exclusively in DIGs. C: L-MAG is exclusivley, and MBP is partially, incorporated into DIGs in brain
compact myelin isolated from adult human brain.
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5.4. MAG-Containing Rafts in the Human CNS are More Resistant to Detergent
Extraction Using CHAPS than when Using TritonX-100
TritonX-100 and CHAPS are non-ionic and zwitterionic detergents, respectively, used for
the isolation of detergent-insoluble rafts. We have compared the solubility of MAG-
containing DIGs from the compact myelin, the myelin and the plasma membrane fractions
isolated from autoptic adult human brain (Figure 30; autopsy A99-331). MAG-containing
DIGs proved to be less soluble in CHAPS (Figure 30A) than in TritonX-100 (Figure 30B).
Furthermore, all CHAPS and TritonX-100 detergent-insoluble MAG-containing DIGs were
found to be accumulated in the compact myelin fraction and were absent from the myelin
and plasma membrane fractions.
Figure 30 Comparison of CHAPS and TritonX-100 resistant DIGs (lipid-rafts) isolated from adult human
brain myelin.
Detergent extraction and sucrose gradient ultracentrifugation were performed as described for Figure 15.
CHAPS- (A) and TritonX-100- (B) resistant DIGs were isolated from the human brain compact myelin, myelin
and plasma membrane fractions. All blots were processed in parallel and exposed to the same film to
achieve comparable readouts. All L-MAG-containing detergent-resistant DIGs were found in the compact
myelin fraction. More than half of L-MAG in the compact myelin was found to be localized in DIGs. L-MAG-
containing DIGs are slightly more resistant to extraction with CHAPS than with TritonX-100.
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6. The Incorporation of MAG and MBP into Brain Myelin Membranes is
Dependent on MAL
Since the proteolipid MAL has been shown to be involved in the apical sorting within
polarized cells (Cheong et al. 1999; Puertollano et al. 1999), and is highly enriched in
myelin DIGs (lipid-rafts; Figure 28 and 29), we were interested in the functional implication
of MAL on the myelin protein transport and their raft association. For this, we investigated
the MAL knock-out mouse to study whether sorting and trafficking of particular myelin
proteins are dependent on MAL.
6.1. The Myelin Protein Levels of MAG and MBP are decreased in 4-month-old MAL
Deficient Mouse Brains
To analyse the myelin protein composition of adult (4-months-old) MAL-deficient mouse
brains (Figure 31), we isolated myelin from 3 age-matched MAL knock-out and 3 wild-type
animals. Therein, we analysed the relative myelin protein levels by Western blot analysis
of MAL itself, two compact myelin proteins (PLP/DM20 and MBP), two non-compact
myelin proteins (MAG and MOG), and two proteins that are involved in the attachment of
the paranodal loops to the axonal membrane (F3/contactin and Caspr).
Interestingly, the levels of L-MAG and MBP were remarkably reduced in the MAL knock-
out relative to the wild-type samples. Furthermore, the levels of F3/contactin and Caspr
appear to be decreased in the knock-out brain myelin samples as well, whereas no
significant difference could be observed for the protein levels of PLP/DM20 and MOG. The
analysis of all 6 samples revealed very small inter individual differences within both
genotypes, reflecting an accurate protein concentration measurement.
6.2. Reduced MAG Levels in the Detergent-Resistant and -Soluble Fractions isolated
from MAL-Deficient Mouse Brain Myelin
For the investigation of the effect of the MAL depletion on the raft association of these
MAG and MBP, we isolated the CHAPS-resistant DIGs from each of the 3 wild-type and
the 3 knock-out brain myelin samples by detergent extraction and separation on a sucrose
gradient (Figure 32). The fractions of each sucrose gradient were analysed separately by
Western blot to determine whether the DIGs were floating in the same fractions in all
gradients. All 6 gradients presented indistinguishable distributions: the large majority of the
rafts were accumulated in fraction 6, while a minor part was found in the overlying fraction
5. Therefore, fraction 6 of each gradient was used to compare the raft association of the
selected proteins between the wild-type and knock-out brain myelin samples. The same
was true for the sucrose gradient fractions 11 and 12 that contain the detergent-soluble
proteins. Therefore, the corresponding three fractions of each genotype were pooled for
further analysis. This analysis showed in wild-type mice that the MAL-containing DIGs or
the MAL molecules themselves, are not solubilized by the detergent CHAPS as they are
with TritonX-100 (Figure 28 and 29).
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The most prominent effect in the MAL-deficient mice was the profoundly decreased level
of L-MAG protein in DIGs (F06, Figure 32). However, L-MAG was also decreased in the
detergent-soluble fractions (F11 and F12; Figure 32). Besides the reduction of L-MAG, a
significantly reduced level of MBP was visible in DIGs (F6; Figure 32). The analysis of
PLP/DM20 revealed no obvious difference between the MAL knock-out and wild-type
samples and both isoforms exhibited a high DIGs association, but the DM20 isoform
showed a higher DIGs association than the PLP isoform (Figure 32).
wt-1 wt-2 wt-3 ko-1 ko-2 ko-3
MAL wt brain myelin MAL ko brain myelin
MAL
L-MAG
MBP
PLP/
DM20
MOG
F3
Caspr
Figure 31 Western blot analysis of myelin protein levels from adult mouse MAL wild-type and knock-out
brains
Brain myelin has been purified from three age-matched 4-month-old MAL-deficient and wild-type mice.
Equal protein amounts from each myelin preparation was analysed by Western blotting. Besides the
absence of the MAL protein, significantly reduced L-MAG and MBP protein levels were observed in the
brain myelin of the three MAL knock-out animals. The levels of F3/contactin and Caspr seem to be
slightly decreased in the MAL-deficient animals, whereas for PLP/DM20 and MOG no alteration was
detectable. Note that the interindividual difference within each genotype are quite small, indicating an
accurate protein measurement and equal loading.
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6.3. Quantification of the Myelin Protein Levels in The MAL-Deficient Mouse Brain
Myelin And Myelin-DIGs
To quantify the differences observed in the Western blot analysis of the brain myelin and
their DIGs fractions from MAL wild-type and knock out animals, we established a Western
blot protocol that allows a semi-quantitative readout (see Material and Methods section
3.8.).
The semi-quantitative analysis of the total MAG and L-MAG levels revealed, for both the
brain myelin and the brain myelin DIGs fraction, a reduction to about 61-62% in the knock-
out compared to wild-type animals (Figure 33). The analysis of the S-MAG-specific levels
was not possible due to the lack of an S-MAG specific antibody, but the almost identical
MAL
wt     ko wt     ko wt     ko wt     ko wt     ko
— F06 — — F09 — — F10 — — F11 — — F12 —
— rafts — —————— soluble fractions ——————
L-MAG
MBP
PLP/
DM20
MOG
F3
Caspr
Figure 32 Analysis of the DIGs (lipid-raft) association of myelin proteins in MAL wt and ko adult (4 months)
mouse brains using the detergent CHAPS
Detergent extraction and sucrose gradient ultracentrifugation were performed as described for Figure 15.
The three myelin samples from both genotypes had been processed separately during detergent extraction
and sucrose gradient centrifugation, but the corresponding fractions of each genotype were pooled
thereafter. Equal volumes of the CHAPS-resistant fraction 6 (F06) and the soluble fractions 9 to 12 (F09-
F12) were analysed by Western blotting. L-MAG and MBP showed a significant decrease in the DIGs
fraction in the MAL knock-out samples compared to the wild-type levels. No significant alterations in the
DIGs association were observed for PLP/DM20, MOG, F3/contactin and Caspr. Note, that DM20 shows a
higher degree of raft association, or resistance to CHAPS extraction, than its larger isoform PLP; F3:
F3/contactin.
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results for both isoforms (total MAG) and for L-MAG alone, point to a similar reduction of L-
and S-MAG. Taken together, the two MAG isoforms exhibited a similar reduction to about
61-61% in the myelin and myelin DIGs fractions of MAL knock-out mice relative to wild-
type mice.
In a similar manner, MBP also exhibited a reduction in the myelin and myelin DIGs
fractions of the knock-out brain samples. The myelin MBP levels were reduced to 75%,
whereas the MBP levels in the DIGs were reduced to 67% of normal levels in MAL knock-
out mice. The difference in the reduction of MBP in the myelin and myelin DIGs fractions
was not statistically significant.
The analysis of the major myelin protein PLP, together with its splice variant DM20
revealed an increase of PLP/DM20 in the brain myelin of knock-out animals to 124% of the
wild-type levels, whereas the PLP/DM20 levels in the myelin raft fraction were almost
unaltered (98% of the wild-type levels). The elevated PLP/DM20 levels in the knock-out
myelin are statistically different (p<0.0001) from the almost unaltered levels in the knock-
out myelin DIGs.
In contrast, the non-compact myelin protein MOG was the only protein that showed almost
normal levels in myelin (97%), but a significant reduction (to 83%) in DIGs of MAL knock-
out compared to wild-type brains. The difference between the MOG levels in myelin and in
myelin DIGs (97 and 83% of wild-type levels) was statistically significant (p<0.0001).
Caspr, F3/contactin and Neurofascin155 have been shown to form a complex that is
responsible for the attachment of the paranodal loops to the axonal membrane (septate-
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Figure 33 Quantitative analysis of the myelin protein levels and their DIGs (lipid-raft) association of MAL wt
and ko adult (4 months) mouse brains
The relative protein levels in the brain myelin and in its CHAPS-insoluble fraction (F06) were analysed by
Western blotting. For the detailed protocoll see Material and Methods. The values of the wild-type levels
were set to 100%. The number of experiments included in this quantification of the myelin and myelin DIGs
protein levels were as follows: total MAG: 3 and 3; L-MAG: 3 and 4; MBP: 3 and 3; PLP/DM20: 3 and 6;
MOG: 7 and 5; F3/contactin: 3; Caspr: 3. Statistically significant differences and standard errors are shown
by asterisks and bars, respectively.
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like junctions). Caspr and F3/contactin are localized on the axonal side, whereas
Neurofascin155 is the glial binding partner. Since many paranodal loops are curving away
from the paranode and the expression patterns of Caspr and Neurofascin155 are more
diffuse in adult MAL deficient brains, we analysed their overall protein levels in MAL
knock-out and wild-type brains. F3/contactin and Caspr revealed comparable reductions
down to 81% and 82%, respectively, in knock-out compared to wild-type brains. The
realization of the Western blot analysis of the glial binding partner Neurofascin155 was not
possible due to the low affinity of the available anti-serum. The semi-quantitative analysis
of the Caspr and F3/contactin DIGs levels was not carried out, but they are both found to
be mainly raft-associated in both the wild-type and the MAL knock-out brain samples.
6.4. MAG and PLP Protein Levels in two-years-old MAL-Deficient Mouse Brains
To analyse the affects of two years of MAL depletion on the myelin protein composition in
mouse brains, we purified myelin from two-years-old MAL wild-type and knock-out mouse
brains (Figure 34). The analysis of the total MAG- and the L-MAG-specific protein levels in
the two genotypes, revealed decreased MAG levels in the MAL deficient mouse brains
(Figure 34A). In contrast, the analysis of the PLP/DM20 levels showed a rather strong
increase in the myelin isolated from the MAL-deficient mouse brains. We have not yet
quantified the alterations of the PLP/DM20 protein levels in the two-years-old MAL
deficient mouse brains, as we did it for the four-months-old brains. But the increase of the
PLP/DM20 protein levels in the two-years-old MAL deficient mice (Figure 34A) seems to
be even bigger than the 24% increase in the four-months-old knock-out mice (Figure 31
and 33). The analysis of the DIGs association of MAG and PLP/DM20 in the two-years-old
MAL-deficient and wild-type mouse brains (Figure 34B) revealed no significant differences
for L-MAG and total MAG between the two genotypes, whereas the PLP/DM20 levels
were increased in both the soluble and the insoluble fractions of the MAL knock-out
compared to wild-type brains (Figure 34B).
In comparison to the situation after 4 months of MAL depletion, the depletion of MAL for 2
years results in a comparable, or milder reduction of the MAG levels, whereas the
PLP/DM20 levels in total myelin and myelin DIGs seems to increase with age.
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Figure 34 MAG and PLP levels in myelin and myelin DIGs from 2-years-old MAL wt and ko brains
Brain myelin was isolated from two 2 years old mouse brains from both genotypes. A: The total MAG and the
L-MAG levels are decreased, whereas the PLP/DM20 levels are increased in the MAL deficient brains. B:
CHAPS extraction and sucrose gradient ultracentrifugation were performed as described for Figure 15.
Equal volumes were loaded and blots incubated with the same antibody were processed in parallel and
exposed to the same film to achieve comparable readouts. No significant alteration in the DIGs-association
was observed for total- and L-MAG in the MAL deficient animals. But, a rather strong increase of PLP/DM20
levels could be observed in the CHAPS-insoluble DIGs fraction, as well as in the soluble fraction in the MAL-
deficient brains.
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7. MAG and PLP/DM20 Transcription are Altered in the MAL Knock-Out
Brain in a Compensatory Manner
Since the lack of MAL led to reduced MAG levels in adult mouse brains (4 months), we
analysed the total MAG and the L-MAG mRNA levels in 4- and 12-months-old MAL knock-
out and wild-type mouse brains. This analysis should unravel the question of whether the
reduced MAG levels are caused by an impaired trafficking and myelin membrane
incorporation of the protein, or by an already decreased MAG transcriptional level. In
addition to MAG, we also analysed the mRNA levels of PLP/DM20, MAL and GAPDH
(internal standard).
7.1. Total-MAG and L-MAG mRNA Levels are Increased in the Adult MAL Knock-Out
Brain
The analysis of the total MAG mRNA levels, using a primer pair that does not discriminate
between the L- and S-MAG splice variants, and of the L-MAG-specific mRNA levels
revealed that the total MAG mRNA levels were elevated in the 4-months-old MAL deficient
mouse brains to about 140% of the wild-type levels (Figure 35). This is in clear contrast to
the reduction of the MAG protein levels to about 60% of the wild-type levels. The analysis
of 1-year-old MAL-deficient mouse brains revealed an up-regulation of the total MAG and
L-MAG specific mRNA levels to about 122% and 167%, respectively, of the wild-type
levels (Figure 35). Taken together, there seems to take place a general up-regulation of
the MAG transcription to about 140% of the wild-type levels in the 4-months-old MAL
deficient mouse brains. This up-regulation seems to be the result of a feedback
mechanism that results in a compensatory up-regulation.
The overall MAG transcription levels in 4-month- and 1-years-old wild-type mouse brains
were very similar (Figure 35; about 5.5% of the GAPDH levels). The comparison of the
total MAG and the L-MAG-specific mRNA levels in the 4-months-old mouse brains
revealed that about 23% of the primary MAG transcripts were spliced to the L-MAG-
specific splice variant in a similar manner in both genotypes (Figure 36), whereas about
12% and 15% of the primary MAG transcripts are spliced to the L-MAG splice variant in
the 1-years-old wild-type and MAL knock-out brains, respectively (Figure 36). Taken
together, there seems to be no difference in the MAG transcriptional level between the
ages of 4 and 12 months in wild-type brains, but the relative amount of the L-MAG-specific
splice variant is decreased from 23% to 12% between the ages of 4 and 12 months in
wild-type mouse brains. Interestingly, although the overall transcriptional level was
increased in the MAL knock-out brains, the percentage of primary transcripts that are
spliced to the L-MAG splice variant was almost identical in wild-type and knock-out brains.
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Figure 35 Analysis of total MAG and L-MAG mRNA levels in MAL knock-out and wild-type mouse brain
Quantitative RT-PCR analysis (LightCycler) was carried out to determine the total MAG and L-MAG-specific
mRNA levels in 4-months- and 1-years-old MAL knock-out and wild-type mouse brains. Total RNA was
isolated from 3 mouse brains per age and genotype, while each sample was analysed once (n=3). The
transcriptional levels were normalized to GAPDH. The error bars indicate the standard deviations. The
differences in the transcriptional levels between the two genotypes were not significant. The analysis shows
an increase of the MAG mRNA levels in the knock-out samples from both time points. On the right side, the
results from the protein analysis (Figure 33) are shown for comparison.
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Figure 36 MAG alternative splicing: decreasing L-MAG mRNA levels in mouse brain with increasing age
The relative amount of L-MAG-specific mRNAs in 4-month-old wild-type mouse brains was about 22% of the
total MAG (L- and S-MAG) mRNAs. In one-year-old mice, the relative amount of L-MAG specific transcripts
was decreased to 12%. This decrease was almost significant (n=3; p=0.0655). In the MAL knock-out mice,
the L-MAG fraction dropped from 22% to 15%.
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7.2. Decreased PLP/DM20 mRNA Levels in Adult MAL-Deficient Brains
We originally chose to analyse the PLP/DM20 mRNA levels in the MAL knock-out brains
as an internal control of a myelin protein that, before the quantitative Western blot analysis
had been carried out, seemed not to be affected by the depletion of MAL. However, the
quantitative PCR analysis did not reveal an up-regulation, but a reduction of the
PLP/DM20 mRNA levels to 73% and 86% of the wild-type levels in the 4- and 12-months-
old MAL deficient mouse brains, respectively (Figure 37). The PLP/DM20 mRNA levels in
the 4- and 12-months-old mouse wild-type brains were comparable (Figure 37). In contrast
to the situation observed for MAG, which exhibited reduced protein and increased mRNA
levels, PLP/DM20 seems to exhibit the same compensatory feedback mechanisms with
reversed premises, namely increased protein levels and with reduced mRNA levels.
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Figure 37 Analysis of PLP/DM20 mRNA levels in MAL knock-out and wild-type mouse brain
Quantitative RT-PCR analysis (LightCycler) was carried out to determine the PLP/DM20 mRNA levels in 4-
months- and 1-year-old MAL knock-out and wild-type mouse brains. The primers were designed in a way
that they do not discriminate between the PLP and the DM20 splice variant. Total RNA was isolated from 3
mouse brains per age and genotype, while each sample was analysed once (n=3). The transcriptional levels
were normalized to GAPDH. The error bars indicate the standard deviations. The differences in the
transcriptional level between the two genotypes were not significant. But, the analysis shows a decrease of
the PLP/DM20 mRNA levels in the knock-out samples from both time-points. On the right side, the results
from the protein analysis (Figure 33) are shown for comparison.
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7.3. Lack of Exon 1-Containing MAL Transcripts in MAL Knock-Out Brains
The analysis of the MAL mRNA levels in the 4- and 12-months-old MAL knock-out and
wild-type mouse brains revealed no significant difference between the two time points in
the wild-type animals. Since the used primer pair was located in the MAL exon 1, which
had been replaced in the MAL knock-out animals, the MAL transcripts were not detectable
in the knock-out animals (Figure 38).
0.000
0.005
0.010
0.015
0.020
0.025
0.030
0.035
0.040
re
la
tiv
e 
to
 G
A
P
D
H
MAL mRNA levels in MAL ko brain
mRNA levels
1 year4 months
wt kowt ko
Figure 38 Analysis of the MAL mRNA levels in MAL knock-out and wild-type mouse brain
Quantitative RT-PCR analysis (LightCycler) was carried out to determine the MAL mRNA levels in 4-months-
and 1-year-old MAL knock-out and wild-type mouse brains. The primers were designed to hybridize within
the MAL exon 1. Since the exon 1 sequence is replaced in the knock-out mice, these primers are not
expected to produce any signal in the knock-out mice. Total RNA was isolated from 3 mouse brains per age
and genotype, while each sample was analysed once (n=3). The transcriptional levels were normalized to
GAPDH. The error bars indicate the standard deviations. The differences in the transcriptional level between
the 4-months- and the 1-year-old wild-type mice were not significant. The analysed knock-out samples did
not express detectable levels of MAL exon 1-containing mRNAs, as expected.
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Discussion
The myelin sheath is a unique and fundamental adaptation of both the central and
peripheral nervous systems of vertebrates and is needed for rapid and efficient nerve
impulse conduction. The formation of myelin around axons proceeds in various steps,
requiring complex and reciprocal interactions between axons and myelin-forming
oligodendrocytes and Schwann cells in the CNS and PNS, respectively. First, myelin-
forming glial cells have to recognize those axons that are competent to become
myelinated. The processes of myelin-forming glial cells have then to adhere to these
axons and to envelope them. One molecule that has been implicated in the formation and
maintenance of the axon-glia interaction is the MAG. The observations in MAG mutant
mice support the role of MAG as a cell adhesion and receptor molecule that transduces
signals into the interior of myelin-forming glial cells and contributes to the cross-talk
between myelinating glia cells and axons. Interestingly, MAG does not appear to be
necessary for the initial interactions between the myelinating glial cell and the axon, but for
the maintenance of the axon-glia interaction in the adult.
The differential expression of the L-MAG and S-MAG isoforms (Inuzuka et al. 1991;
Miescher et al. 1997) is likely to bear important consequences for signal transduction
cascades, since the two isoforms have distinct intracellular domains (Lai et al. 1987). The
non-receptor tyrosine kinase Fyn, has been identified as a signalling molecule
downstream of L-MAG (Umemori et al. 1994). Beside Fyn, the calcium-binding protein
S100beta has been shown to bind to the L-MAG specific domain (Kursula et al. 1999). The
S-MAG specific domain has been reported to bind to tubulin and microtubules (Kursula et
al. 2001). Therefore, L-MAG seems to have properties of a transmembrane receptor that
transduces extracellular signals to the inside of oligodendrocytes and Schwann cells,
whereas the S-MAG isoform appears to link the extracellular ligand to the cytoskeleton of
the myelinating glial cell.
Differential Expression of L- and S-MAG in Oli-neu Cells upon
CyclicAMP Treatment
To get further inside in the regulation of the differential expression of L-MAG and S-MAG,
we have characterized their differential expression upon stimulation with cAMP in the
mouse Oli-neu oligodendroglial cell line (Jung et al. 1995).
In vitro and in vivo studies showed that Oli-neu cells mimic in many aspects the behaviour
of primary oligodendrocytes (Jung et al. 1995; Koch et al. 1997; Kramer et al., 1997;
Kramer et al. 1999; Klein et al. 2002). The cells express the typical myelin lipids, GalC and
sulfatide (Jung et al. 1995), and have been shown to express the GPI-anchored proteins,
F3/contactin and NCAM120 (Koch et al. 1997), and the microtubule-associated proteins,
Tau-1 and Tau-5 (Klein et al. 2002), in a manner similar to primary oligodendrocytes.
Furthermore, Oli-neu cell transplantation into demyelinated CNS lesions showed that they
express the components necessary for axonal interaction (Jung et al. 1995). Proliferating
Oli-neu cells have a bipolar shape. Under the influence of cAMP, Oli-neu cells exit the cell
cycle and develop a radial morphology with many processes. In parallel to their
morphological maturation, they up-regulate the expression of MAG (Jung et al. 1995).
We have investigated the expression of the L- and S-MAG-encoding splice variants
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following cAMP stimulation in the Oli-neu cells by RT-PCR. Furthermore, we have
generated genomic expression constructs to express the individually tagged isoforms,
regulated by the process of alternative splicing, under the control of their own promoter.
These genomic constructs were reintroduced into Oli-neu cells to investigate the L- and S-
MAG-specific protein expression upon cAMP stimulation in relation to the cellular
morphology.
Our analysis revealed that elevated cAMP levels influenced the alternative splicing of the
primary MAG transcripts. We observed a switch from primarily L-MAG to predominant S-
MAG mRNA levels upon stimulation with cAMP. In addition, we could show, at both the
cellular and the protein levels, that L-MAG was mainly expressed in bipolar cells, whereas
the S-MAG up-regulation upon cAMP stimulation was restricted to the most
morphologically differentiated cells having developed a radial shape. Our observations are
in line with the differential expression of L- and S-MAG during development in the rodent
CNS (Inuzuka et al. 1991; Ishiguro et al. 1991; Pedraza et al. 1991). L-MAG precedes S-
MAG expression during myelination, whereas L- and S-MAG are co-expressed in the
adult. The analysis of the L- and S-MAG levels in primary oligodendrocyte cultures and in
the CG4 oligodendroglial cell line showed, on the contrary, a clear predominance of the L-
MAG splice variant (Yim et al. 1995; Richter-Landsberg and Gorath 1999). In line with our
data is the observation that primary oligodendrocytes co-cultured with neuronal cells
showed a similar S-MAG up-regulation (Matsuda et al. 1997). In parallel to the S-MAG up-
regulation, a morphological differentiation was induced upon neuronal co-culturing
(Matsuda et al. 1997) comparable to that which we observed upon cAMP stimulation. It is
very intriguing to speculate that the co-ordinate change in the MAG alternative splicing and
the increase in morphological complexity are controlled by the same cAMP-responsive
differentiation step mediated by neurons via a single, or multiple mechanisms, resulting in
elevated cAMP levels. This hypothesis is supported by earlier observations, indicating that
the absence of neuronal signals might cause a modulation of mRNA splicing (Barbarese
and Pfeiffer 1981; Richter-Landsberg and Gorath 1999) and by the findings of Cohen and
Almazan that cAMP levels of cultured oligodendrocytes can be elevated by a receptor-
mediated interaction with neuroligands (Cohen and Almazan 1993). Interestingly, in
oligodendrocytes isolated from postnatal day 2 rat cerebrum CREB was phosphorylated
by neuroligands known to elevate Ca2+-levels (e.g. histamine, carbachol, glutamate and
ATP), whereas in primary oligodendrocytes from postnatal day 11, a time-point
immediately preceding myelination, CREB phosphorylation was only stimulated by
treatment with the b-adrenergic agonist isoproterenol, a neuroligand known to elevate
cAMP levels (Sato-Bigbee et al. 1999). This is in line with the observations that S-MAG
up-regulation occurs between postnatal day 10 and 15 in the rat cerebrum (Frail and
Braun 1984; Matthieu et al. 1986; Inuzuka et al. 1991). Recently, the nuclear localized
quaking isoform, QKI-5, was shown to repress the inclusion of exon 12 in the mature MAG
mRNA and, therefore, promote the splicing leading to the L-MAG splice variant (Wu et al.
2002). QKI-5 is a product of the locus that is deleted in quaking mice (Ebersole et al.
1996). Quaking mice have a dysmyelinating phenotype and show a strong increase of S-
MAG mRNA relative to the L-MAG level (Fujita et al. 1990). Therefore, QKI-5 was
postulated to act as a negative regulator of MAG exon 12 integration (Wu et al. 2002).
Hence, the elevated cAMP level may induce, besides an enhanced MAG transcription, a
reduction of the transcription, or activity, of the nuclear factor QKI-5. Very recently,
adenosine has been shown to act as a potent axon-glial transmitter that inhibits
oligodendrocyte precursor proliferation, stimulates differentiation, and promotes the
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formation of myelin (Stevens et al. 2002). This axon-glial signal provides a molecular
mechanism for promoting oligodendrocyte development and myelination in response to
impulse activity. Interestingly, the G-protein coupled adenosine receptors expressed by
the oligodendrocyte precursors are known to activate adenylyl cyclase and, therefore,
elevate the oligodendrocyte cAMP levels (Dunwiddie and Masino 2001). Therefore, cAMP
appears to be the physiological mediator of the neuronal signal adenosine that promotes
the exit of the oligodendrocyte from the cell cycle and its subsequent differentiation. The
elevation of the MAG transcriptional level and the isoform type switch from L- to L- and S-
MAG appear to be part of these early, cAMP-mediated, processes of the axon-glia
interaction.
The Effect of Exonic Insertions on the Alternative Splicing of the MAG
Pre-mRNAs
The genomic expression constructs encoding individually tagged L- and S-MAG isoforms
were generated by the insertion of the tag-encoding DNA into the isoform specific exons.
The compatibility of these exonic insertions with the process and regulation of alternative
splicing of the primary MAG transcripts are discussed in the following section. The
insertion of the GFP sequence into L-MAG specific exon 13, in the pmag-MAG-e13GFP
genomic expression construct led to expression of L-MAG-GFP and untagged S-MAG. L-
MAG-GFP was expressed mostly in bipolar cells, but the number of cells expressing L-
MAG-GFP was decreased relative to the L-MAG-expressing cells from the wild-type
construct. Interestingly, we also observed a decreased number of L-MAG-GFP-expressing
Oli-neu cells from the pmag-L-MAG-GFP construct that was expected to constitutively
express L-MAG-GFP under the control of the mag promoter. Hence, the L-MAG-GFP
encoding mRNA might be less stable than the wild-type counterpart, or the L-MAG-GFP
fusion protein gets targeted to the degradation pathway. However, the expression of the L-
MAG-GFP fusion protein and wild-type L-MAG from the cDNA expression vectors (bactin-
promoter) both revealed comparably high expression levels and numbers of positive Oli-
neu cells. However, the high level transcription due to the potent bactin-promoter might
have masked the hypothesized implications of the L-MAG-GFP mRNA and/or protein.
On the other hand, the elongation of exon 13 did not affect the splicing of exon 12. This
contrasts with the insertion of the GFP, or VSVG sequences into the S-MAG specific exon
12. These two constructs led to the expression of tagged S-MAG (S-MAG-GFP, or S-
MAG-VSVG), but not to the expression of L-MAG. The depletion of L-MAG was probably
not due to a strong increase in inclusion of the elongated exon 12, because S-MAG-GFP
and S-MAG-VSVG were expressed in multipolar rather than bipolar Oli-neu cells, a
regulation comparable to that seen for S-MAG with the wild-type construct. In addition, our
findings are supported by a recent report, showing that the regulatory element for exon 12
alternative splicing lies outside of exon 12, within the adjacent intron 12 (Wu et al. 2002).
Since, we have not altered any intron sequence, the absence of the L-MAG splice variant
cannot result from a strongly increased inclusion of exon 12 due to an alteration of the
regulatory element within intron 12, or within any other intron. Interestingly, in the study by
Wu and colleagues (2002), the sequence of exon 12 was replaced by that of exon 11,
resulting in a strong increase in the inclusion of the modified exon 12. This increase of
exon 12 inclusion was thought to be induced by the elongation of the exon from 45 to 100
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bases since shorter fragments allowed repression of exon 12 inclusion by QKI-5. In our
study, we did not observe enhanced inclusion of exon 12 due its elongation from 45 to 81
bases (S-MAG-VSVG), or even 762 bases (S-MAG-GFP). Therefore, the enhanced
inclusion of the exon 12 replaced by the exon 11 sequence in the study of Wu et al. (2002)
may be due to the presence of a strong exon splicing enhancer (ESE) within exon 11.
Furthermore, the analysis of the pmag-MAG-e12VSVG-e13GFP construct demonstrated
that the exon 12 is not included in bipolar cells, as shown by the sole expression of GFP
(“soluble” GFP). These data indicate that it is the not regulation, but rather the skipping of
exon 12 that is disturbed, generating a truncated “L-MAG-GFP” transcript that leads to the
synthesis of GFP alone. This translation of GFP was probably initiated at the start codon
of GFP itself. Otherwise, the upstream sequence of exon 13 would have been translated
and the product would have been recognized by the L-MAG specific antibody, which was
generated against this sequence.
Taken together, the results of the analysis of the differential expression of L- and S-MAG
in Oli-neu cells demonstrated that this mouse oligodendroglial cell line is a valuable tool for
analysing the regulation and mechanism of alternative splicing of L- and S-MAG mRNAs.
The observed switch bears a resemblance to the situation observed during myelin
formation in CNS development. Therefore, we hypothesize that the regulation of the MAG
alternative splicing and the morphological differentiation in oligodendroglial cells may be
controlled by a similar cAMP-responsive differentiation step. This step is probably
mediated by adenosine, which is released by axons in activity dependent manner
(Stevens et al., 2002). However, introducing VSVG, or GFP, into exon 12 interfered with
the correct skipping of exon 12, but not its regulation.
Differential Expression of L- and S-MAG in the Adult Mouse Brain
We have generated three different transgenic mouse lines expressing individually tagged
L-MAG-GFP, or S-MAG-GFP fusion proteins. The individually tagged MAG isoforms
should allow us to investigate the differential expression during development, in the adult,
during injury-induced regeneration and under hereditary de- and remyelinating conditions.
The generation of a third mouse line to constitutively express L-MAG-GFP under the
control of the MAG promoter should reveal, whether the overexpression of L-MAG leads to
alterations in the axon-glia interaction. Such an L-MAG overexpression phenotype can be
expected in both, the CNS and PNS of mice. Since L- and S-MAG are coexpressed in the
mouse CNS, a L-MAG overexpression would mimic the situation of the human CNS, which
is known to express exclusively L-MAG (Miescher et al. 1997). However, a more
prominent L-MAG overexpression phenotype can be expected in the PNS, since only
minor amounts of L-MAG are expressed during development and L-MAG is completely
absent in the adult PNS. Along this line, cell culture experiments provided evidence for a
critical role of MAG in the initiation of myelination. When levels of MAG expression were
experimentally reduced in Schwann cells by infecting them with a retrovirus expressing
MAG antisense RNA, they failed to segregate large calibre neurites of co-cultured dorsal
root ganglion (DRG) neurons and myelination of DRG neurites was impaired (Owens and
Bunge 1991). Therefore, one could imagine that L-MAG overexpression would lead to a
shift of the ratio of myelinated and non-myelinated axons towards more myelinated axons.
Such a shift would highlight the role of L-MAG as a receptor molecule that mediates the
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axon-glia interaction and transduces a myelination-promoting signal into the Schwann cell.
However, the analysis of the CNS and PNS myelin of several mouse lines expected to
constitutively express L-MAG-GFP (pmag-L-MAG-GFP), revealed no expression of the
transgene. Furthermore, we have analysed the mouse line expected to express L-MAG-
GFP (pmag-MAG-e13GFP). Unfortunately, the single founder animal has not, so far,
passed the transgene to the F1 generation. Therefore, our analysis was restricted to a tail
biopsy from the one-month-old founder animal. The analysis revealed no detectable L-
MAG-GFP expression in the myelinated fibres of the tail. This might be due to the already
low expression of L-MAG in the one-month-old mouse PNS (Inuzuka et al. 1991;
Lützelschwab 1998). Taken together with the relatively low number of L-MAG-GFP-
expressing Oli-neu cells from one of these two constructs, the fusion of GFP to the L-MAG
C-terminus seems to interfere either with the RNA stability, protein synthesis, or with
myelin incorporation.
Fortunately, the analysis of the mouse line planned to express individually tagged S-MAG-
GFP (pmag-MAG-e12GFP) revealed a prominent expression the S-MAG-GFP fusion
protein in the mouse CNS, as well as in the PNS myelin. The fusion of GFP to the S-MAG
C-terminus does not seem to affect the normal targeting and myelin incorporation of S-
MAG, since S-MAG-GFP was detected in the periaxonal membranes of PNS myelin
sheaths. The expression of S-MAG-GFP from the transgene beside the endogenous MAG
expression in the one-months-old mouse brain, leads neither to a significant MAG
overexpression, nor to an alteration in the L-MAG expression level. This finding indicates
that the MAG protein levels seem to be tightly controlled. The analysis of the pmag-MAG-
e12GFP construct used in Oli-neu cells showed that S-MAG-GFP is expressed from the
construct in a normally regulated manner, but that L-MAG expression was missing, since
an anti-L-MAG signal was absent. The lack of the anti-L-MAG signal could have been the
result of an impaired splicing of the artificially enlarged S-MAG specific exon 12 (insertion
of the GFP DNA sequence), producing a MAG protein with a truncated C-terminus. But,
the Western blot analysis of the transgenic mouse brain myelin revealed no truncated
MAG protein. Thus, normal skipping of the enlarged exon 12 may take place in vivo,
resulting in a normal L-MAG-encoding mRNA. This would be in clear contrast to the in vitro
situation observed in Oli-neu. On the other hand, the truncated 'L-MAG' mRNA, or protein,
is immediately degraded in vivo. For a final analysis of the existence of a correct L-MAG-
encoding mRNA transcribed from the pmag-MAG-e12GFP construct, transgenic mice
should be crossed with the MAG knock-out mouse. Taken together, the pmag-MAG-
e12GFP mouse line expresses MAG levels comparable to those of wild-type mice, and the
S-MAG-GFP fusion protein is targeted normally to the periaxonal membrane. Therefore,
this mouse line can be used to analyse the differential expression of L- and S-MAG using
the autofluorescence signal of S-MAG-GFP together with our L-MAG specific antibody.
In this line, our first results of the expression pattern of S-MAG-GFP and L-MAG in one-
month-old mouse brains revealed a preferential expression of S-MAG in the corpus
callosum and a reciprocal expression of L- and S-MAG in distinct fibre tracts within the
striatum (Figure 27). This pattern contrasts with the findings of Butt and colleagues
(1998b), who describe a constitutive L-MAG expression beside a specific S-MAG
expression in large diameter fibres, so-called type III/IV units, but not in small diameter
fibres, so-called type I/II type units, in the anterior medullar velum. However, care should
be taken when interpreting these data, since their S-MAG antibody was raised against a
peptide that is not absolutely S-MAG specific, but has an amino acid stretch that is
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common to both MAG isoforms. Furthermore, they worked with unpurified rabbit sera that
produced a strong unspecific signal in our hands (data not shown). Therefore, the high
expression level of S-MAG-GFP in the corpus callosum could reflect a predominant
expression of S-MAG in long projecting fibre tracts. S-MAG could help to stabilize the
myelin sheath, since S-MAG has been reported to bind to tubulin and microtubules
(Kursula et al. 2001). This hypothetical, predominant expression of the S-MAG isoform in
long projecting CNS fibres can be tested by the analysis of the L- and S-MAG expression
in the long projecting fibres of the spinal chord. This would support the role of S-MAG as a
cell adhesion molecule that links the axonal surface to the myelinating glial cell
cytoskeleton.
MAG has been shown to bind to extracellular matrix components such as collagen,
tenascin-R, fibronectin and heparin (for review see Quarles et al., 2002). However, the
physiological relevance of its binding to components of the extracellular matrix is not clear,
because most MAG is localized in periaxonal and other spiralled glial membranes. Our
investigation of teased fibres from the sciatic nerve of S-MAG-GFP expressing transgenic
mice, revealed beside a rather weak periaxonal signal a strong expression of S-MAG-GFP
in ring like structures in the outer myelin membranes (Figure 25). Since the myelinated
fibres of the peripheral nervous system are surrounded by a basal lamina, this so far
marginalized expression domain of S-MAG in the outer myelin membranes may be the
physiological sites where S-MAG does interact with these ECM molecules within the
Schwann cell basal lamina.
The analysis of the sciatic nerve teased fibres from the S-MAG-GFP transgenic mice
revealed as well that not all myelinated axons in the mouse peripheral nervous system are
surrounded by a myelin sheath with periaxonal MAG expression. The absence of the
periaxonal MAG expression in mouse peripheral nerves had often been observed in our
laboratory, but it was interpreted as a result of bad antibody penetration. But, the S-MAG-
GFP transgenic mice confirm these earlier findings.
The absence of the periaxonal MAG expression in many myelinated fibres of the mouse
PNS is clear contrast to the situation in the mouse CNS. In the mouse CNS, every
myelinated fibre appears to be surrounded by a periaxonal MAG expression. This
difference in the MAG expression between the mouse PNS and CNS might explain at
least to a certain degree why in the MAG deficient mice the myelin maintenance in the
CNS is much more affected than in the PNS (for review see, Schachner et al., 2000).
Therefore, L- and S-MAG appear to be more important for the myelin maintenance and the
axon-glia interaction in the mouse CNS compared to S-MAG in the PNS.
Raft Association of MAG During Myelination and Myelin Maintenance
A major question in the formation and maintenance of the myelin-axon interaction
concerns the coordinated translocation of myelin proteins and lipids to the different myelin
compartments. Recent results suggest that glycolipid-enriched microdomains, so-called
'lipid-rafts', are involved in particular sorting und trafficking mechanisms of membrane
proteins and lipids in polarized cells. Furthermore, lipid-rafts can selectively incorporate, or
exclude proteins, and thereby govern protein-protein and protein-lipid interactions (Brown
and London 1998; Hooper 1999). Along this line, they are thought to serve as platforms for
signal transduction mechanisms. This makes them interesting candidates as participants
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in axon-myelin interactions, as well as in interactions between the apposed myelin
membranes. Lipid-rafts are insoluble in detergents, such as non-ionic TritonX-100 and
zwitterionic CHAPS, at 4°C, in which they form glycolipid-enriched complexes. Because of
their high lipid content, these detergent-insoluble, glycolipid-enriched complexes (DIGs)
float to a low density during gradient centrifugation, which enables any associated proteins
to be identified and distinguishes DIGs from other detergent-insoluble complexes.
We could show that both MAG isoforms are recruited to TritonX-100- and CHAPS-
insoluble DIGs in the adult rodent CNS. In contrast to the situation in the adult rodent
brain, we found that, in very young rodent brain (postnatal day 9), MAG was exclusively
localized in the soluble fraction and not in DIGs. This is of special interest, since MAG has
so far described to be found mainly in the soluble fraction (Kramer et al. 1997; Kim and
Pfeiffer 1999). The finding that L-MAG is incorporated into DIGs in the adult brain
highlights the possibility that L-MAG transduces neuronal signals via the non-receptor
tyrosine kinase Fyn. This hypothesis is supported by the fact that L-MAG has been shown
to activate Fyn and Fyn-deficient mice displayed only 50-60% myelin compared to wild-
type animals (Umemori et al. 1994). Interestingly, the degree of hypomyelination in the
brain of MAG/Fyn double mutants was significantly increased when compared with MAG
and Fyn single mutants (Biffiger et al. 2000). Fyn was shown to be associated with the two
GPI-linked molecules, F3/contactin and NCAM-120, in rafts during CNS myelination
(mouse postnatal day 9), while L-MAG is not incorporated into DIGs at this early phase of
myelination (Kramer et al. 1999). However, since we could show that L-MAG is
incorporated into DIGs in the adult rodent CNS, the L-MAG-Fyn interaction may be
important for the axon-to-glia signalling to guarantee myelin maintenance during
adulthood. Furthermore, MAG has been shown to interact with the sialic acid of the
gangliosides GD1a and GT1b (Crocker et al. 1998; Collins et al. 1999). Therefore, MAG
can mediate cell-cell trans interactions (axon-to-glia and/or glia-to-glia), as well as cis
interactions with gangliosides located on the same myelin membrane (Crocker 2002). With
respect to the MAG expression domains, L-MAG-Fyn signalling, supposed to be important
for myelin maintenance, could be mediated by periaxonal (axon-to-glia) and paranodal
(glia-to-glia) L-MAG (Bartsch et al. 1989).
L-MAG could play an even more prominent role in myelin maintenance in the adult human
brain, because we could show that L-MAG represents only 22% and 12% of total MAG
mRNA in 4- and 12-month-old mouse brains, respectively (Figure 36), while, in the adult
human brain, L-MAG is the predominant MAG isoform (Miescher et al. 1997).
Furthermore, we found a surprisingly high amount of L-MAG to be incorporated into
TritonX-100- and CHAPS-insoluble DIGs isolated from adult human brain. The analysis of
two human adult cortical white matter samples revealed that almost 100% of L-MAG in the
first sample and about 60% of L-MAG in the second sample were incorporated into DIGs.
This discrepancy could reflect brain region-, or structure-specific differences in the
incorporation of L-MAG into DIGs. However, the predominance of L-MAG in the adult
human brain myelin, together with its predominant localization in DIGs, suggests an
important role for L-MAG in maintaining the integrity of the human brain myelin sheath.
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Decreased MAG and MBP Protein Levels in the Brain Myelin from MAL
Deficient Mice
During myelinogenesis, oligodendrocytes produce and target myelin membrane at a rate
that ranks amongst the highest of all known cellular membrane-producing systems
(Pfeiffer et al. 1993). Myelin is synthesized as a plasma membrane extension and
maintains a characteristic biochemical composition during adult life. One molecule that is
known to be involved in lipid-raft-associated protein sorting and trafficking, not only in
myelinating glia cells, but also in polarized epithelial cells, is MAL. To investigate the role
of MAL and rafts in CNS myelination and maintenance, we analysed the myelin protein
composition of adult MAL-deficient mouse brain myelin and myelin DIGs. The depletion of
MAL led to significant alterations in the protein levels of the non-compact myelin proteins,
MAG and MOG, the compact myelin proteins, MBP and PLP, as well as of the paranodal
proteins, F3/contactin and Caspr.
Among the analysed proteins, MAG was the protein whose incorporation into myelin
membranes was most affected by the lack of MAL. The MAG protein levels in MAL knock-
out brain myelin and myelin DIGs were reduced to about 60% of the wild-type levels.
Interestingly, the MAL mutant CNS myelin contained ultrastructural abnormalities similar to
those of the MAG mutant (Li et al. 1994; Montag et al. 1994; Marcus et al. 2002). These
abnormalities include an increased number of multiply myelinated axons, overlapping
myelinated segments, reversed paranodal glial loops (Figure 39) and periaxonal process
splitting. They reflect disturbed axon-glia and/or glia-glia interactions.
Due to the striking ultrastructural similarities between the MAL- and the MAG-deficient
CNS myelin, the reduced MAG levels in the MAL mutant CNS appears to be responsible,
at least to some extent, for the disturbed axon-glia interaction. Furthermore, mice lacking
the two galactolipids GalC and sulfatide (CGT-/-), two typical raft-associated lipids,
revealed similar ultrastructural alterations. Whether, these alterations in the CGT knock-
out mice are also caused by a partial lack of MAG is not known. The fact that the MAL-,
MAG- and CGT-deficient mutants produce abnormal myelin containing similar
ultrastructural abnormalities, suggests that these molecules may play an overlapping role
in the axon-glia interaction, either by having a function in the sorting and trafficking of the
involved receptor molecules, or by having receptor properties themselves. In line with
these observations, the MAG/CGT double-mutant mice show a significantly more affected
axon-myelin adhesion than the single mutants, supporting an overlapping function (Marcus
et al. 2002). A very important feature of these mutants is that the paranodes, flanking the
compact
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wild type CNS paranodal region
¨  compact
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¨       loops
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to axon
¨ loops not
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axon
Figure 39 Paranodal loops in the nervus opticus of adult wild-type and MAL knock-out mice
In the wild-type situation, all loops are attached to the axonal membrane, whereas in the MAL knock-out
mice, about half of the loops are not attached to the axonal membrane.
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nodes of Ranvier, form normally, independently of MAL, MAG, or galactolipids, but rapidly
destabilize in their absence. Therefore, MAL, MAG, and the galactolipids do not appear to
be necessary for the initial interactions between the oligodendrocyte and the axon, but
these myelin components contribute significantly to the stabilization of the myelin–axon
and myelin-myelin contacts in the CNS, even though they are structurally dissimilar. These
data indicate that distinct molecular mechanisms are responsible for the formation and
maintenance of axon-myelin and myelin-myelin interactions. MAG seem to play a major
role in this maintenance process, either by stabilizing directly the glia-glia interaction in the
paranodal region, as MAG is expressed in the paranodal loops at low levels in the CNS
(Bartsch et al. 1989), or indirectly by mediating internodal axon-glia interactions, as MAG
is expressed in the adaxonal (periaxonal) myelin membrane (Schachner and Bartsch
2000).
Our analysis of the MAG mRNA levels in the MAL-deficient mouse brains revealed that the
transcription is elevated, even though not statistically significant. This shows that the lack
of MAL does indeed affect the myelin incorporation of the MAG proteins. Furthermore, the
reduced MAG levels appear to induce an up-regulation of MAG transcription in a
compensatory manner.
Our investigation of the MAG protein levels in CHAPS-insoluble DIGs isolated from MAL
knock-out and wild-type brain myelin, showed the same reduction that we had observed
for MAG in the brain myelin. Thus, the detergent insolubility of total MAG and L-MAG was
not affected by the lack of MAL. Therefore, within the brain myelin membrane, MAG
appears to be still surrounded by, or interacting with, a comparable subset of myelin
proteins and, even more important, with a comparable subset of myelin lipids. Along this
line, our analysis of the lipid composition of the MAL-deficient brain myelin and brain
myelin DIGs revealed no apparent differences. Therefore, the lack of MAL seems to affect
primarily the sorting, trafficking and/or myelin membrane incorporation of MAG, and not its
raft association in the mouse brain. Therefore, MAG may be partially incorporated into
DIGs in the trans-Golgi network independently of MAL and MAL is involved in a similar
manner in the transport of the DIG- and non-DIG-associated MAG to the myelin sheath.
Alternatively, MAG may be transported to the myelin in a MAL-dependent manner as a
non-DIG protein and is only then incorporated into DIGs independently of MAL. Yet
another alternative is that in the absence of MAL, newly synthesized MAG molecules
could be mistargeted and degraded, or endocytosed MAG could be targeted to the late
endosomes/lysosomes instead of back to the myelin membranes. The analysis of the
MAG protein levels in whole brain homogenates could help to determine whether the MAG
that was not inserted into the myelin membranes in the absence of MAL, is still to some
extent present, for instance, in the degradation pathway, or in the oligodendrocyte plasma
membrane. The analysis of cerebellar slice cultures could also help to determine if and
where the MAG protein that has not been incorporated into the myelin sheath in the
absence of MAL, is localized within the myelinating oligodendrocytes.
The reduction of MAG in 2-years-old MAL-deficient mouse brains seems to be comparable
or even milder, to that seen in 4-month-old brains. Therefore, the situation observed at the
age of 4 months seems not to reflect a process of increasing reduction that had started, for
example, during myelin compaction, but rather a steady-state situation. However, it is not
known if the MAG trafficking has been already affected by the lack of MAL during the
process of active myelination, before myelin compaction. The analysis of the MAG levels
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from MAL-deficient mouse brains that are in the process of active myelination will reveal if
the transport mechanisms of MAG in the forming, non-compacted myelin and in the adult,
compact myelin sheath are both dependent on MAL, or if the transport mechanisms
operative during myelin formation are independent of MAL. In the latter case, MAL would
function especially in the transport mechanisms during the maintenance of the adult
myelin sheath.
MBPs act as intracellular adhesion molecules, holding together the intracellular leaflets of
myelin membranes to form the compact myelin (Omlin et al. 1982). Therefore, the aberrant
cytoplasmic inclusions within the compact myelin in the MAL-deficient CNS (Figure 40)
might be caused by the observed reduction of the MBP levels.
Interestingly, the non-receptor tyrosine kinase Fyn has been shown to be necessary for
MBP transcription (Umemori et al. 1999), while L-MAG is known to activate Fyn (Umemori
et al. 1994). Since L-MAG is reduced to about 60% in MAL-deficient CNS myelin and
DIGs, the lack of the L-MAG-Fyn cascade might be responsible for the reduced MBP
levels. During CNS myelination, Fyn is thought to act in rafts through its association with
F3/contactin and NCAM120, while L-MAG is not recruited to DIGs during this early
developmental stage (Kramer et al. 1999). However, since L-MAG and Fyn are recruited
to DIGs in the adult CNS myelin, L-MAG may activate Fyn in DIGs and, therefore, promote
MBP transcription during the process of myelin maintenance. Therefore, the reduction of
L-MAG in CNS myelin DIGs may be responsible for the reduced MBP transcription.
Since MBPs are basic, highly charged proteins, MBP mRNAs are selectively transported
to the myelin sheath, where they are translated on free polysomes, in order to prevent
unspecific membrane association (Colman et al. 1982; Trapp et al. 1987; Verity and
Campagnoni 1988). Since myelin incorporation of MBP is independent of the normal
protein sorting and trafficking machinery, the reduction of MBP in the MAL-deficient CNS
cannot be explained by an impaired trafficking due to the absence of MAL and therefore
supports the hypothesis that the lack of MAL results in a reduced MBP transcription
perhaps through an impaired trafficking and signalling of L-MAG.
Among the proteins analysed in the brain myelin from adult MAL-deficient mice,
Figure 40 Splitting of CNS compact myelin in the
absence of MAL
The lack of MAL leads to cytoplasmic inclusions
(arrows) within the adult optic nerve that leads to
a splitting of the compact myelin sheath.
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PLP/DM20 showed a unique pattern. In contrast with the decreased MAG, MBP and MOG
levels, the amount of PLP/DM20 protein was increased in the adult MAL-deficient brain
myelin membranes. Furthermore, in 2-years-old MAL-deficient mouse brains, the
PLP/DM20 levels were strongly increased in the myelin, as well as in the myelin DIGs
fraction. Interestingly, PLP/DM20 have other characteristics that are distinct from those of
the other myelin proteins. The trafficking of PLP/DM20 appeared to be independent of
other myelin markers, such as MAG, MOG and MBP (Hudson et al. 1989; Kramer et al.
2001). None of the latter colocalised with PLP/DM20in intracellular compartments, arguing
strongly against the existence of a common lipid-raft-dependent transport vesicle
containing all myelin components. Moreover, PLP was found to be soluble in cold TritonX-
100, contradicting one of the criteria for the association of a protein with lipid-rafts, while
the myelin proteins MAG, MBP and MOG are at least partially resistant to TritonX-100
extraction (Kramer et al. 1997; Kim and Pfeiffer 1999; Taylor et al. 2002). The transport
mechanism of the major myelin proteins PLP/DM20 seems, therefore, to be distinct from
that of MAG, MOG and MBP. Kramer and collaborators (Kramer et al. 2001) proposed the
transcytosis model as an alternative trafficking route for PLP/DM20 (Figure 41). According
to this model, newly synthesised PLP/DM20 is transported to the oligodendrocyte plasma
membrane via a general secretory pathway, independently of lipid-rafts. The incorporation
of PLP/DM20 into the myelin sheath is achieved in a second step, by endocytic uptake into
early/recycling endosomes, from where PLP/DM20 are sorted/recycled to the myelin
sheath, or to the late endosomes/lysosomes.
But how can the lack of MAL lead to an accumulation of PLP/DM20 in brain myelin?
Several in vitro overexpression experiments of PLP/DM20 led to an accumulation of
PLP/DM20 in the late endosomes/lysosomes (Gow et al. 1994; Sinoway et al. 1994; Kalwy
et al. 1997; Kramer et al. 2001; Simons et al. 2002). Therefore, the protein level of the
major CNS myelin component PLP/DM20 seem to be tightly controlled and surplus
Figure 41 Transcytosis: model for the involvment of MAL in the transport/recycling of PLP
Newly synthesized PLP molecules follow a genral secretory path from the trans-Golgi network (TGN) to the
plasma membrane (bulk flow), from where they get transported to the early endosomes (EE) by endocytic
uptake. From the early endosomes, newly synthesized, or recycled PLP gets either incorporated into the
myelin sheath through sorting endosomes (SE), or it gets directed to the late endosomes/lysosomes
(LE/Lys) for degradation. MAL appers to be involved in the regulation of the recycling/degradation of PLP in
the early endosomes, since the lack of MAL leads to an accumulation of PLP in the myelin sheath. AC: actin
cortex; Ax: axon; ER: endoplsmic reticulum; N: nucleus; copied from Kramer et. al., 2001:
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molecules are not recycled from the early/recycling endosomes back to the myelin sheath,
but are targeted to the endosomal/lysosomal pathway for degradation. MAL could be
involved in the endocytosis and recycling of PLP/DM20, since MAL has been shown to be
localized in the early and recycling endosomes (Millan et al. 1997a; Puertollano et al.
1999). The lack of MAL could lead to an imbalance between recycling and degradation of
PLP/DM20 in the early/recycling endosomes. This imbalance could lead to an increased
recycling of PLP/DM20 back to the myelin sheath and, therefore, to an accumulation of
PLP/DM20 in the brain with increasing age. An increased PLP/DM20 protein level due to
an increased PLP/DM20 transcriptional activity can be excluded, since the transcriptional
level in the MAL knock-out brains appeared to be decreased rather than elevated (Figure
37). Such a compensatory down-regulation further supports the hypothesis of an
increased recycling of PLP/DM20 in the absence MAL. A possible involvement of MAL in
the endosomal system is supported by recent findings in the Arylsulfatase-A knock-out
mice (ASA knock-out; Franken et al. 2003). Due to the lack of the Arylsulfatase-A enzyme
responsible for the normal degradation of the raft lipid sulfatide, MAL, together with
sulfatide, is accumulated in the late endosomes/lysosomes of ASA knock-out kidney cells
and maybe also in the ASA ko oligodendrocytes.
Taken together, the proteolipid MAL appears to be involved in the regulation of the
recycling/degradation of the major CNS myelin protein PLP.
In the context of a possible involvement of MAL in the regulation of the
recycling/degradation of myelin proteins in oligodendrocytes, the significantly decreased
levels of MAG and MBP in the adult MAL-deficient mouse brains could result from an
enhanced degradation of these myelin proteins via the endosomal/lysosomal system.
Therefore, the MAG and MBP levels should also be analysed in whole brain preparations
to detect possible MAG and MBP molecules that may have been misrouted to the late
endosomes/lysosomes in the absence of MAL.
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Outlook
MAL Knock-Out Brain Myelin: Analysis of the Myelin Protein
Composition at the End of the Myelination Period and after 2 Years of
Myelin Maintenance
The lack of MAL led to an altered myelin protein composition in adult (4-months-old)
mouse brains. The altered myelin protein composition is probably caused by an impaired
protein sorting/trafficking and/or recycling due to the lack of MAL. To determine if the MAL
depletion affects the protein trafficking mainly during active myelination, or during the
maintenance of the compact myelin sheath, the brain myelin composition could be
quantitatively analysed in young (3 weeks old) and old (2 years old) MAL knock-out and
wild-type mouse brains. The comparison of these new data sets with our data from adult
MAL mutants could allow to determine which proteins have never been incorporated into
myelin at normal levels during the initial phase of active myelination. Furthermore, it could
allow determining which proteins have undergone normal incorporation into myelin during
myelination, but that are affected by an impaired maintenance process and are, therefore,
expected to show an even greater alteration in old mice compared to the adult mice.
An increased targeting of MAG and MBP to the endosomal/lysosomal system might cause
their impaired levels in brain myelin from MAL-deficient mutants. Therefore, the analysis of
their protein levels in whole brain homogenates, instead of the myelin preparations used
so far, should also allow to detect these misrouted myelin proteins.
The analysis of cerebellar slice cultures from MAL knock-out and wild-type mice could be
used to investigate the subcellular distribution of those myelin proteins that are affected by
the lack of MAL. An accumulation of MAG, or MBP, in the endosomal/lysosomal system
would explain their decreased levels in the brain myelin and would support a possible role
for MAL in the regulation of the recycling of myelin proteins in early/recycling endosomes.
The verification of the MAG and PLP mRNA levels could allow to determine if the impaired
protein levels in the MAL knock-out mice really do cause a compensatory mechanism at
the transcriptional level. Furthermore, the analysis of the MBP mRNA levels could allow
determining if the decreased MBP levels are caused by a decreased transcription, or an
impaired turnover. A reduced MBP transcription would be in line with the hypothesis that a
decreased L-MAG level causes a decreased Fyn activity and, thus, a decreased MBP
transcription.
To investigate if the prominent reduction of MAG in the brain of MAL-deficient mice affects
all brain regions in a similar manner, or if certain structures are especially affected, the S-
MAG-GFP could be crossed with the MAL knock-out line. In these double transgenic mice,
the S-MAG-GFP levels could be measured directly by the fluorescent signal intensity of
the S-MAG-GFP fusion protein.
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MAG-GFP expressing mouse lines
The combination of the S-MAG-GFP-expressing transgenic mouse, together with our L-
MAG specific antibody, will allow the further characterisation of the differential expression
of the two MAG isoforms during in vivo development and in the different regions of the
adult brain. Furthermore, the cross-breeding of the S-MAG-GFP mice with animal models
for the primary demyelinating peripheral neuropathies CMT1A and HNPP will allow the
analysis of L- and S-MAG expression under the pathological conditions of de- and
remyelination. Previous experiments have shown an up-regulation of the L-MAG isoform
at the protein level in sural nerve biopsies from CMT1A and HNPP patients, while the
analysis of the mRNA in the corresponding mouse models revealed an S-MAG up-
regulation. Therefore, it will be interesting to see if these mice show an up-regulation of S-
MAG at the protein level as well, or if they show an up-regulation of L-MAG as observed in
patients.
Schmidt-Lanterman incisures are postulated to play a role in the maintenance and
turnover of the compact myelin sheath. The incorporation of S-MAG-GFP fusion proteins
into these Schmidt-Lanterman incisures should allow the investigation of their dynamics in
myelinating co-cultures by video confocal microscopy. A putative dynamic property of
Schmidt-Lanterman incisures that would move along the axon within the otherwise
compact myelin could strongly highlight their role in the turnover of myelin proteins and
lipids.
The analysis of the single pmag-MAG-e13GFP and pmag-L-MAG-GFP founder animal tail
biopsies so far revealed no L-MAG-GFP transgene expression. Since this lack of the L-
MAG-GFP fusion protein can result from the absence or instability of the corresponding
mRNA, or from the degradation of the fusion protein itself, the existence of the mRNA
should be established by RT-PCR analysis. If the L-MAG-GFP mRNA is detectable, the
transcriptional level and the sequence of the mRNA should be analysed. If these two
parameters are correct, the expression of the fusion protein should be analysed in vitro by
the use of optic nerve cultures, to exclude the possibility that the fusion protein is down-
regulated in vivo.
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